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Abstract 
 
Bioglue samples prepared in the absence and in the presence of Ag(I) ions (using 
AgNO3 and [Ag2(3,6,9-tdda)].2H2O (tddaH2 = trioxaundecanedioic acid)) were 
thermally stable and had the ability to swell in the presence of water. Generally, for 
the Ag(I)-Bioglues, as the amount of added Ag(I) ions decreased the degree of 
swelling increased. The surface morphology of the Bioglue without Ag(I) ions was 
very porous in comparison to the smooth surface of the Ag(I)-Bioglues. In tests using 
wood and pig skin, the adhesive properties of the Bioglues decreased with increasing 
amounts of added Ag(I) ions. The elasticity of the Bioglue also reduced upon 
incorporation of Ag(I) ions. Leaching of bioactive Ag(I) ions from AgNO3-Bioglue 
samples increased over time and equilibrium was reached after 55 h. Ag(I)-Bioglues 
were reduced to Ag(0) using sodium borohydride and sodium citrate, but there was 
no evidence of Ag(0) nanoparticle formation. 
Bioglue formulated without Ag(I) ions is readily colonized by microbes. The Ag(I)-
Bioglues inhibit the growth of the fungal pathogen, Candida albicans, and are even 
more potent against the bacterial species, Pseudomonas aeruginosa, Escherichia 
coli, Staphylococcus aureus and Methicillin-Resistant Staphylococcus aureus. S. 
aureus cells exposed to AgNO3 show a short-term increase in the activity of 
antioxidant enzymes, such as superoxide dismutase, catalase and, to a lesser extent, 
glutathione reductase, but this activity decreases as the cells lose viability. AgNO3 
also induces an increase in the amount of amino acid leakage from S. aureus cells, 
suggesting that Ag(I) ions affect membrane permeability. Proteomic analysis 
revealed that S. aureus cells were experiencing stress as a result of exposure to 
AgNO3, which causes an increase in the expression of virulent and essential 
metabolic proteins. 
These Ag(I)-Bioglues have the potential to offer significant antimicrobial protection 
if used in surgical wound closure. 
xv 
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1.0 Aims of the Project 
The aims of this study were (i) to synthesise a surgical Bioglue incorporating 
antimicrobially active Ag(I) ions in order to prevent the occurrence of nosocomial 
infections during surgery, and (ii) to determine the possible mode(s) of action of 
Ag(I) ions against the bacterium, Staphylococcus aureus.  
 
1.1 Introduction to Silver 
1.1.1 Silver 
The chemical symbol for silver, Ag, is derived from the Latin argentum, meaning 
shiny or glistening. Silver is found in the earth’s crust with an abundance of 0.07 
ppm.
1,2
 It has 2 main isotopes,
1
 
107
Ag and 
109
Ag with a natural abundance of 51.82% 
and 48.18%, respectively.
2
 Silver occurs as either an element in nature or in a 
combined state such as sulfidic ores, Ag2S (argentite),
3
 as horn silver (chlorargyrite) 
AgCl, and AgBr (bromargyrite).
4
 Silver is also produced as a by-product in the 
processing of ores, such as PbS (galena) and CuFeS2 (copper pyrite). When lead and 
copper are extracted from these ores the silver collects in the crude lead or copper 
where it can then be isolated and purified using electrolysis.
4
 Pure silver exists as a 
ductile and malleable metal (Fig. 1.1). 
 
Fig. 1.1: Metallic silver.
5
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1.1.2 Coordination chemistry of silver 
Silver has the electronic configuration, [Kr]4d
10
5s
1
. The energy difference between 
the filled d orbitals and the unfilled valence shell s orbital is relatively small and this 
allows for extensive hybridisation of the dz² and s orbitals (Fig 1.2). Initially, the 
electron pair in the dz² orbital occupies ψ1, which gives a circular region of relatively 
high electron density from which the ligands are repelled.
6
 The regions above and 
below this ring in which the electron density is relatively low, attracts ligands. By 
further mixing ψ2 with the pz orbital, two hybrid orbitals suitable for forming a pair 
of linear covalent bonds can be formed.
6
 
 
 
Fig. 1.2: The hybrid orbitals formed from (a) a dz² and an s orbital (Ψ1 and Ψ2), and 
(b) the hybrids from a Ψ2 and pz orbital. 
Ψ1 
 
 
Ψ2 
 
 
 
 
 
Ψ2 Pz 
(a) 
(b) 
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Silver ions can exist in four oxidation states: Ag(I), Ag(II), Ag(III) and Ag(IV), with 
Ag(I) being the most dominant.
2
 The most common coordination number for Ag(I) is 
two where the ligands are in a linear arrangement, e.g. [Ag(NH3)2]
+
.
4
  
An example of some of the other coordination geometries can be seen in the 
following complexes: [(Me2NC6H4PEt2)2AgI], where the metal has the coordination 
number three and is trigonal; [Ag(SCN)4]
3- 
is an example of a tetrahedral 
arrangement with a coordination number of four; [Ag(L)]
+2
, where L is an N5 
macrocyclic ligand, is a five-coordinate complex in a pentagonal pyramidal 
arrangement; AgCl which is an example of an octahedral, six-coordinate complex.
6
  
The Ag(II) ion is produced as an orange transient species, [Ag(H2O)6]
2+
, through 
oxidation of silver(I) salts with ozone in strongly acidic solutions.
2
 Silver(II) 
fluoride, AgF2, is obtained as a dark-brown solid by fluorination of AgF or other 
silver compounds at elevated temperatures.
6
 AgF2 is antiferromagnetic, with a 
magnetic moment well below that expected for a species with one unpaired 
electron.
2
 Silver(II) forms stable complexes with a variety of nitrogen donor ligands, 
such as pyridine, 2,2΄-bipyridyl, and 1,10-phenanthroline (Fig. 1.3). These are some 
examples of complexing agents which all from planar arrangements with the four N 
atoms around the Ag(II) ion.
6
  
 
 
Fig. 1.3: Structures of silver(II) complexes containing (a) pyridine, (b) 2,2΄-
bipyridyl, and (c) 1,10-phenanthroline. 
 
            (a)                                       (b)                                               (c) 
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Silver(III) is produced by the anodic oxidation of neutral aqueous solutions of 
AgClO4 or AgBF4, producing black, metallic lustrous crystals of Ag2O3 which 
contains square-planar Ag(III) centres.
2
 Silver monoxide, AgO, has been shown to 
contain both monovalent Ag(I) and trivalent Ag(III) in a linear and square-planar 
arrangement, respectively.
6
 AgO can be obtained by the oxidation of Ag2O with 
S2O8
2-
 in alkaline solution.
2
 Fluorination of a mixture of CsCl and AgCl under 
pressure yields the complex salt, Cs2[Ag
IV
F6], containing tetravalent silver(IV).
2
 
Due to its d
10 
outer electronic configuration, silver metal is borderline between the 
main group metals and the transition metals. Silver metal, Ag(0), is relatively 
unreactive, but can be oxidised to the biologically active Ag(I) ion under certain 
conditions. The reduction potential for the Ag
+
/Ag
0
 complex is given below: 
Ag
+
   +   e
-
                               Ag
0
         E
0
 = + 0.7996 V 
The reduction potential can vary when the Ag(I) ions are complexed. Generally, 
complexation lowers the redox potential and therefore the reducibility of silver ions.
7
 
For example, when the Ag(I) ion is complexed to two ammonia ligands, reduction to 
Ag(0) becomes more difficult, and when it is ligated with cyano ligands, reduction 
becomes even less viable. 
[Ag(NH3)2]
+
   +   e
-
                              Ag
0 
+ 2NH3         E
0
 = +0.37 V 
[Ag(CN)2]
- 
  +   e
-
                              Ag
0
 + 2CN
- 
       E
0
 = -0.31 V 
Ag(I) has four well characterised halides (Cl, Br, I) and all, except AgI, have a rock-
salt structure.
3
 The colour darkens from white to yellow and insolubility increases in 
the series Cl < Br < I.
6
 The fluoride is unique in forming hydrates such as 
AgF·4H2O, and these can be prepared by dissolving AgO in hydrofluoric acid and 
evaporating the solution until the solid crystallises. The rest of the halides can be 
prepared directly by addition of X
-
 to Ag
+
 solutions, such as aqueous AgNO3.
3
 The 
most important property of the halides, in particular AgBr, is their sensitivity to 
light, which is the basis for their use in photography.  
A photograph is a permanent record of an image formed on a light-sensitive surface 
which is coated with a silver halide dispersed in a gelatine support. The halide is 
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carefully precipitated to produce small uniform crystals or ''grains''.
3
 When the light-
sensitive layer is exposed to light, the silver bromide is photochemically 
decomposed, producing traces of colloidal Ag(0) metal.  
The main principle behind this process is that when a suitably energetic photon 
strikes a halide ion in a grain of silver halide, an outer electron from the halide is 
excited into the conduction band, through which it passes and is then able to reduce a 
Ag(I) ion:
4
  
X
-
   +   hv                                X   +   e
- 
                                    Ag
+ 
  +   e
-
                                 Ag
0
                                  
The resulting Ag(0) atoms are distributed in the silver bromide layer and the free 
bromine is bound to the gelatin. The more intense the light exposure the greater the 
number of Ag(0) grains are formed.
4
 The image is usually still invisible at this stage 
due to the relatively small amount of Ag(0) precipitated. This is called the latent 
image and it is then further developed using a reducing agent, such as hydroquinone, 
in the dark. The developer reduces the silver bromide to Ag(0).
4
 
                                      AgX                                 Ag   +   HX   
After this stage the image on the negative is fixed by dissolving away all the 
remaining AgBr to prevent its further reduction. This dissolution process requires the 
use of a complexing agent (ammonium or sodium thiosulphate being the most 
common) since the reaction goes to completion and both products are water-soluble.
3
 
AgX(s)  +   2Na2S2O3                               Na3[Ag(S2O3)2]   +  NaX 
 
 1.1.3 Silver nanotechnology 
Nanotechnology is one of the most rapidly growing areas in science.
8
 ‘Nano’ 
originates from the Greek meaning ‘dwarf’ and refers to the microscopic size that 
nanotechnology deals with.
9
 Nanoparticulate structures usually range from 1-100 nm 
in size.
10
 More than 800 products available on the market claim nanomaterial content 
and 30% of those are said to contain Ag(0) nanoparticles.
11
 Such silver-containing 
H
+ 
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products range from clothing, cosmetics, electronics, water disinfectants and 
washing detergent (Fig. 1.4).  
        
               (a)                              (b)                                   (c) 
Fig. 1.4: Nano Ag(0)-based products: (a) antibacterial leggings, (b) hair shampoo 
and (c) washing detergent.  
 
A broad range of synthetic methods for obtaining nanosilver(0) are available, with 
the most popular being the reduction of Ag(I) nitrate using sodium borohydride, 
citrate, glucose or ascorbate.
12
 Other methods include photochemical reduction, laser 
ablation, vacuum ion sputtering and microwave radiation.
9
 Metal(0) nanoparticles 
display unique optical properties, such as the presence of an absorption band in the 
visible region of the electromagnetic spectrum. The UV-Visible spectrum of Ag(0) 
nanoparticle suspension contained a band with λmax values in the range 400-500 
nm.
13
  
It has been suggested that the antimicrobial properties of Ag(0) nanoparticles are due 
to their ability to release Ag (I) ions as a result of particle oxidation.
8
 Oxidation may 
occur upon contact with moisture in the skin or wound exudate, and as a result the 
nanoparticles become ionised.
14
 Smaller Ag(0) particles have an overall greater 
surface area, and thus have a greater ability to release Ag(I) ions and cause a larger 
antimicrobial effect.
8
 As in the case of the Ag(I) ion, the exact mechanism of how 
Ag(0) nanoparticles interact with microorganisms is not yet fully understood. 
Proposed mechanisms suggest that Ag(0) nanoparticles i) release Ag(I) ions which in 
turn generate reactive oxygen species (ROS), ii) cause direct damage to cell 
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membranes and affect their permeability, iii) uptake of free Ag(I) ions is followed by 
disruption of ATP production and DNA replication (Fig. 1.5).
12
 
 
 
Fig. 1.5: Image depicting the proposed interaction of Ag(0) nanoparticles with 
bacteria.
12
 
 
Due to the increased use of Ag(0) materials, concerns have been raised about the 
effect of increased exposure to humans and also aquatic environments.
12
 Ag(0) 
nanoparticles may be released into the environment due to leaching from household 
products, washing of fabrics containing silver and washing detergents containing 
silver.
12
 This, in turn, can possibly endanger surrounding lakes and streams by 
disrupting aquatic organisms.
11
 Also, it has been suggested that frequent use of 
silver-based products may lead to increased cases of microbial resistance to the 
metal, equivalent to the emergence of antibiotic-resistant bacteria.
15
 It remains 
unclear whether the toxic effects are due to the Ag(0) nanoparticles, Ag(I) ions or a 
combination of both. The use of Ag(0) nanoparticles in biomedical and household 
applications have allowed for the development of new antimicrobial agents.
14
 
However, further research is needed to understand its mode of action and also any 
toxic side-effects.  
Introduction                                                                                                  Chapter 1                                                                                                  
8 
 
1.1.4 Biological activity of silver 
Silver is not an essential trace element in the body and it fulfils no physiological or 
biochemical role in any tissue, even though it interacts with key elements, such as 
zinc and calcium.
16
 The metal does not appear to be a cumulative poison.
16
 Low 
concentrations (2.3 µg/L) of silver have been found in the bloodstream and also in 
tissues of the liver and kidneys, which are the main routes for silver excretion.
17
 
Ag(I) is readily absorbed into the body with food, drink and by inhalation.
16
 Silver 
granules accumulate in the cytoplasm of phagocytic cells, hepatocytes and renal 
tubular epithelium bound in lysosomal vesicles, and are then released into bile ducts 
and urinary ducts for excretion.
18
 
Metallic Ag(0) readily ionises in the presence of body fluids and wound exudates to 
produce the biologically active Ag(I) ion, which binds strongly to electron donor 
atoms of biological molecules containing sulphydryl groups and other anionic 
ligands derived from deprotonated amino acid residues in proteins, cell membranes 
and tissue debris.
19
 The Ag(I) ion is highly active against a range of microorganisms 
through interactions with the cell wall, which result in conformational changes.
20
 
This allows the Ag(I) ion to penetrate cells causing cell leakage, denaturation and 
inactivation of proteins and essential enzymes, such as RNA- and DNA-ases, and 
ultimately leads to cell death.
21
  
The action of Ag(I) ion on the cell wall has been studied using the fungus, Candida 
albicans, and it has been shown to bind to cysteine residues of the enzyme, 
phosphomannose isomerise (PIM), and causing its inhibition.
22
 This enzyme plays 
an important role in cell wall biosynthesis
23
 and inhibition can lead to leakage of 
important nutrients from the cytoplasm, such as phosphates and succinates.
18
 The 
inhibitory action of the Ag(I) ion can be attributed to its strong binding affinity for 
thiol groups present in cell respiratory enzymes, its interaction with structural 
proteins and its binding with DNA bases which inhibits replication.
24
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1.1.5 Silver in healthcare 
The antimicrobial properties of silver have been known for many centuries. Silver 
containers were used to transport water to prevent contamination as far back as 
Babylonian times,
1
 and, more recently, Ag(I) ion was used aboard both the Russian 
MIR space station and on the NASA space shuttle to sterilise recycled drinking 
water.
15
 Ag(I) compounds were also exploited for their antimicrobial properties to 
treat tetanus and rheumatism in the 19
th
 century.
24
 One of the first publications on the 
use of silver in medicine was in the 1880s by Carl S.F. Credé, who introduced a 
simple technique of cleaning the eyes of newborn infants with a 2% w/v aqueous 
solution of silver nitrate for the treatment of ophthalmia neonatorum (ON) (neonatal 
conjunctivitis).
25
 This infection was mostly caused by the bacterium, Neisseria 
gonorrhoeae, which was transmitted from mother to infant during delivery. The 
AgNO3 treatment reduced the number of cases of ON from 30-35 cases per year to 
only one by the end of 1880 in Credé’s maternity hospital in Leipzig.25 Credé’s 
prophylaxis is still the ''gold standard'' in most parts of the world today, however, the 
concentration has been reduced to 1% w/v aqueous silver nitrate solution to lessen 
irritation.
25
 
With the advent of the penicillin antibiotics, interest in the use of silver salts or silver 
salt solutions disappeared around the time of the Second World War.
26
 A resurgence 
in the use of silver in the 1960s has been accredited to C.A Moyer, who popularised 
the use of silver with publications suggesting that 0.5% w/v silver nitrate solution 
should be used as an antiseptic agent to prevent invasive infection.
26,27
 This was the 
lowest concentration which was effective against bacteria in vitro and in vivo on 
burns, without being toxic to growing epidermal cells,
26
 and it was found to reduce 
mortality from 81% to 33%.
22
 
Silver sulphadiazine (SSD) (Fig. 1.6) was introduced onto the market in 1968 by 
Charles Fox to treat burn wounds infected with the bacterium, Pseudomonas 
aeruginosa. It has also shown to be effective against other bacteria such as 
Escherichia coli, Enterobacter cloacae, Proteus morganii, Staphylococcus aureus 
and also Staphylococcus epidermis.
28
 Silver sulphadiazine is formulated from silver 
nitrate and sodium sulphadiazine by substituting an Ag(I) ion for a H
+
 ion in the  
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Fig. 1.6:  Structure of silver sulphadiazine. 
 
sulphadiazine molecule.
24
 The resulting complex (SSD) is a white, fluffy solid that is 
essentially insoluble in water.
28
 In formulating SSD, Fox combined the antimicrobial 
properties of the Ag(I) ion with the antibacterial properties of the sulphonamide 
moiety. SSD has become one of the most popular antibiotics for topical treatments 
(Fig 1.7) in burn clinics due to its efficacy in treating P. aeruginosa infections. SSD 
acts as a reservoir of available Ag(I) ions in the wound
29
 and it is thought that its 
success is due to the slow, continuous release of Ag(I) ions in the presence of body 
secretions and burn wound exudates. A lot of the released Ag(I) ions bind to 
albumins and macroglobulins, leaving the remainder to provide the antimicrobial 
function.
28
 It has been suggested that the primary biocidal action of SSD is provided 
by the Ag(I) ion, while the sulfadiazine serves to prevent the formation of light-
sensitive colloidal Ag(0) which can cause discolouration of the skin.
30
 SSD is 
marketed under the names Silvadene® and Flammazine®. Some of the advantages 
of silver sulphadiazine include, no discolouration of the skin (unlike silver nitrate), 
and a slower release of the Ag(I) ion to give a longer lasting therapeutic effect. A 
wider range of antimicrobial efficacy has been reported when the Ag(I) ion or 
sulphadiazine are used in combination, rather than by the additive effects of just 
Ag(I) or sulphadiazine alone.
28
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Fig. 1.7: Image depicting the application of a cream containing silver sulphadiazine 
(SSD). 
 
Wound healing is a complex process, involving inflammation around the site of 
injury, angiogenesis, development of granulation tissue, repair of the connective 
tissue and epithelium and ultimately leading to a healed wound.
24
  Once a wound 
becomes infected this healing process is delayed. If a wound becomes infected with 
an antibiotic-resistant microorganism, this can further increase mortality in the 
patient and also increase the cost of the treatment.
31
 To overcome this, there are a 
wide variety of silver-based products, such as plasters and dressings, on the market 
(Fig. 1.8) for wound care and the treatment of burns. These dressings are designed to 
allow for the controlled release of Ag(I) ions into the wound, allowing the dressing 
to be changed less frequently, a procedure which can sometimes be painful to the 
patient.
27
 The dressings vary in their total Ag(I) ion content, technology and 
application, but they all work on the basis that the wound fluids and exudates trigger 
the release of the biologically active Ag(I) ion for bactericidal or fungicidal action, 
and with the ideal that metal ion release will continue for the life-span of the 
dressing.
18
 
In recent years, there has been a large increase in the number of silver-based 
products on the market, ranging from medical devices to household items. Examples 
include in-dwelling catheters, cardiac valves and prostheses, orthopaedic pins, dental 
devices, socks, toothbrushes, pyjamas, paints and washing machines (Fig. 1.9). 
Whether they are for hospital or domestic use, all of these products have the overall 
objective of preventing infection. 
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                        (a)                                            (b)                                          (c) 
Fig. 1.8: (a) Contreet Biatain silver adhesive foam dressing (b) Elastoplast plaster 
containing silver and (c) a range of silver-based products from Silverlon. 
 
 
 
                              
(a)                                         (b)                                          (c) 
Fig. 1.9: (a) Toothbrush incorporating silver (b) Marks and Spencer range of 
pyjamas incorporating a fine thread of silver metal into the fabric and (c) Johnstone’s 
antibacterial paint formulated using silver ion technology. 
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1.1.6 Argyria 
Argyria is one of the most widely publicised conditions associated with chronic 
silver exposure. The condition is usually associated with prolonged exposure to 
silver (especially colloidal silver, which usually contains metallic silver particles 
suspended in a solution with <10% ionised silver)
32
 either occupationally or 
therapeutically, which leads to an accumulation of silver in the blood and soft 
tissues.
16
 Light acts as a catalyst for the photo-reduction of Ag(I) to metallic Ag(0) 
which is then oxidised in the body to form silver selenide and silver sulphide, which 
are in turn, deposited in the connective tissues of the dermis and resulting in a 
permanent blue-grey colouration of the skin, buccal membranes, hair and nail bed 
(Fig. 1.10). In addition to these silver deposits, pigmentation can also result from 
silver stimulation of melanocytes, which increases melanin production.
33
 
Discolouration is more prominent in sun exposed areas due to the photo-reduction of 
the Ag(I) ion. Although cosmetically undesirable, argyria is not known to be life-
threatening.
19,34,35
 Fatalities in patients with argyria have been attributed to pre-
existing medical conditions.
19
 
          
Fig. 1.10: Rosemary Jacobs developed argyria due to the prolonged intake of 
colloidal silver.
36
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1.1.7 Silver resistance 
Resistance has been defined as the ability of an organism to survive and/or multiply 
under conditions that would destroy or inhibit the growth of other members of the 
strain, either on a temporary or a permanent basis.
37
 The widespread use of 
antibiotics has led to the emergence of antibiotic-resistant and even multi-drug 
resistant strains of microorganisms.
38
 Bacterial silver resistance is frequently 
encoded by genes located on plasmids, the most studied of which was isolated from 
a Salmonella species.
30
 
The first case of a silver-resistant bacterium was reported in the Massachusetts 
General Hospital in Boston, and it was isolated from burns patients who were treated 
with a 0.5% w/v silver nitrate solution.
39
 Persistent strains of S. typhimurium were 
identified and plasmid pMG101 was established as the molecular basis of silver 
resistance.
40,41
 The plasmid was 180 kb in size and belonged to the IncH1 
incompatibility group plasmids
42
 which are large, multiple antibiotic-resistant 
plasmids.
30,43
 The region of the plasmid which induced silver resistance also 
conferred resistance to mercury, tellurite, ampicillin, chloroamphenicol, tetracycline, 
sulphonamide and streptomycin.
40,43
 This region of pMG101 which was responsible 
for resistance was subsequently cloned and sequenced. The gene cluster for silver 
resistance contains 9 genes, 7 of which are named (silP, silA, silB, silC, silS, silR, 
silE) and 2 are referred to as open reading frames (orf105, orf96) (Fig. 1.11a).
15
 
Functions for the named genes were determined  on the basis of homologies to 
known genes for other metal resistances, and the two unnamed ORFs lack any 
homology (Fig. 1.11b).
43
  
With respect to Fig. 1.11a, beginning from the right is silE (Fig. 1.11 a), which 
encodes for a small periplasmic Ag(I)-binding protein and is 47% homologous to 
PcoE, which is involved in the E. coli copper-resistance system.
44
 SilE (Fig. 1.11 b) 
binds Ag(I) ions at the cell surface, thus protecting the cell from toxicity.
45
 SilE lacks 
cysteine residues, which are the primary metal cation ligands used in metal-binding 
proteins but it does have ten histidine residues which are used for metal-binding.
46
 
Upstream of silE is a presumed two component signal transduction pair, which is 
made up of silS, a membrane kinase sensor and silR, a transcriptional regulator
15
 and 
are thought to be involved in controlling mRNA transcription in silver resistance.
45
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Fig. 1.11:  (a) Silver resistant genes and (b) their proposed function.
15
 
 
The copper resistance Pco system also includes genes for a two-component 
regulator, pcoRS, which is also upstream from pcoE.
15
 The next four genes, silCBAP, 
are transcribed in the opposite direction. The silCBA genes determine a SilCBA 
complex which functions as a cation/proton antitransporter. The components of this 
proposed efflux system are silA, a large 1048-amino acid inner membrane 
proton/cation antiporter which exports Ag(I) ions from the cytoplasm, the 
cytoplasmic membrane or the periplasm across the outer membrane directly to the 
outside,
47
 in this case the membrane protein, SilC. 
15
 The third protein, SilB, is a 
membrane fusion protein which attaches into the inner membrane and connects the 
outer membrane protein, SilC.
46
 Finally, the silP gene is a 824 amino acid P-type 
ATPase which is thought to pump Ag(I) ions from the cell cytoplasm to the 
(a) 
(b) 
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periplasmic space.
15,48
 The exact mechanism of how this occurs is not fully 
understood but it has been suggested
15
 that the Ag(I) ion is sequestered by SilE, 
possibly followed by movement across the outer membrane by the SilABC complex.  
The widespread use of silver-containing products could lead to an increase in the 
emergence of resistant organisms, which would be unfavourable considering its 
prominent use for clinical and hygiene purposes. With the identification of the silver-
resistant determinant from S. typhimurium, this should make the identification of 
new resistant strains from other pathogens a much quicker process. 
 
1.2 Hydrogels 
1.2.1 General properties of hydrogels 
Hydrogels are three-dimensional, hydrophilic, polymeric networks which are capable 
of absorbing large amounts of water or biological fluids,
49
 making them an ideal 
candidate for biomedical applications.
50
 Hydrogels can be used as contact lenses, 
membranes, biosensors, material for artificial skin
49
 and also as barrier materials to 
regulate biological adhesions.
50
 
‘Reversible’ or ‘physical’ hydrogels refer to polymer networks which are held 
together by molecular entanglements and secondary forces such as ionic, hydrogen- 
bonding or hydrophobic interactions. Due to the occurrence of either molecular 
entanglement clusters, or hydrophobically- or ionically-associated domains, physical 
hydrogels are not homogeneous.
51
 Covalently-crosslinked networks give rise to 
‘permanent’ or ‘chemical’ hydrogels.51 As in the case of physical hydrogels, 
chemical hydrogels are also not homogeneous as they contain areas of low water 
swelling and high crosslink density.
51
  
Hydrogels can be either natural or synthetic polymers.
50
 Natural polymers have 
many advantages such as bioactivity, ability to present receptor-binding ligands to 
cells and some of these are susceptible to cell-triggered proteolytic degradation.
52
 
Examples of natural polymers include alginic acid (Fig. 1.12) and chitosan (Fig. 
1.13). Alginic acid is found in the cell walls and intracellular spaces of brown algae 
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and is a copolymer of (1-4) glycosidically-linked monomers of D-mannuronic acid 
and L-guluronic acid.
53
 Alginate polymers have been utilised in cartilage tissue 
engineering, surgical dressings
53
 and cell encapsulation matrix.
54
 Chitosan is derived 
from chitin, which is found in the exoskeleton of arthropods and is a linear 
polysaccharide made up of N-acetyl-D-glucosamine (acetylated subunit) and β-1,4-
linked D-glusosamine (deacetylated unit).
53
 Chitosan has found medical applications 
as a scaffold in tissue engineering,
54
 as a topical ocular application, and in 
implantation and injection.
55
  
 
Fig. 1.12: Structure of alginic acid. 
 
 
Fig. 1.13: Structure of chitosan. 
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Synthetic hydrogel polymers, in general, have more predictable properties and batch-
to-batch uniformity. Some examples of synthetic polymers include poly(vinyl 
alcohol) (PVA) and poly(ethylene glycol) (PEG) (Fig. 1.14). Both of these synthetic 
polymers have found applications in tissue engineering, with PVA being used for 
avascular tissue, and PEG has been used as a surface coating for biomaterials.
53
 
 
                           
                                       (a)                                                (b) 
Fig. 1.14: Structures of (a) poly(vinyl alcohol) and (b) poly(ethylene glycol). 
 
1.2.2 Swelling in hydrogels 
The hydrophilicity of hydrogels is due to the presence of hydroxyl, carboxyl and 
amine groups along the polymer backbone and side chains.
50
 The maximum amount 
of water a hydrogel can absorb is known as the equilibrium swelling capacity and 
depends on factors such as hydrogel structure, cross-link density, ionic content and 
hydrophilic content.
56
 Highly crosslinked hydrogels have a more tightly bound 
structure and therefore will swell less compared to the same hydrogel with a lower 
crosslinking density.
49
 Also, hydrogels which have hydrophilic groups will swell 
more than those containing hydrophobic groups. Hydrophobic groups collapse in the 
presence of water and so reduce their exposure to the water molecules.
49
 
Based on the nature of their side groups, hydrogels can be classified as either ionic or 
non-ionic.
50
 The driving force for swelling in non-ionic hydrogels can be analysed 
using the Flory-Rehner theory. The combination of thermodynamic and elasticity 
theories states that a crosslinked hydrogel placed in a fluid and allowed to equilibrate 
with its surroundings is subject to two opposing forces: the thermodynamic force of 
mixing and the retractive force of the polymer chains.
50
 At equilibrium, these two 
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forces are equal and the physical situation can be described in terms of the Gibbs 
free energy: 
∆Gtotal = ∆Gelastic + ∆Gmixing 
where ∆Gelastic is the contribution due to the elastic retractive forces developed inside 
the gel, and ∆Gmixing is due to the spontaneous mixing of the fluid molecules with the 
polymer chains and is a measure of the compatibility of the gel with the surrounding 
fluid.
49
 The presence of ionic moieties can make the theoretical treatment of swelling 
much more complex. Along with ∆Gelastic and ∆Gmixing, the ionic nature of the 
network also contributes to the total change in the Gibbs free energy:
57
  
∆Gtotal = ∆Gelastic + ∆Gmixing + ∆Gionic 
 
1.2.3 Stimuli-sensitive hydrogels 
1.2.3.1 pH-sensitive hydrogels 
The mechanism of pH-sensitive swelling involves the protonation of amine groups 
as a result of decreasing the pH, which can lead to chain repulsion
55
 and, as a result, 
the uptake of solvent is increased.
49
 In neutral hydrogels, the degree of swelling only 
depends on the chemical composition of the hydrogel.
50
 However, with ionic 
hydrogels swelling not only depends on the chemical composition but also on the pH 
of the surrounding fluid.
50
 If the hydrogel is classified as being anionic, it will 
deprotonate and swell to a greater extent when the external pH is higher than the pKa 
of the ionisable groups bonded onto the polymer chains. Cationic hydrogels, on the 
other hand, protonate and swell when the external pH is lower than the pKb value of 
the ionisable groups. 
 
1.2.3.2 Temperature-sensitive hydrogels 
Temperature-sensitive hydrogels have received much attention due to their ability to 
swell or de-swell as a result of a change in temperature of the surrounding fluid. 
Such hydrogels can be classified as either positive or negative temperature systems.
49
 
Negatively-thermosensitive hydrogels exhibit lower critical solution temperature 
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(LCST) behavior.
50
 They tend to shrink or collapse when the temperature is 
increased above the  LCST and swell when the temperature drops below the LCST.
50
 
Positively-thermosensitive hydrogels on the other hand have an upper critical 
solution temperature (UCST), and they swell at high temperature and shrink at lower 
temperatures.
50
 These systems are mostly based on poly(N-isopropylacrylamide) 
(PNIPAAm) which has a LCST of 32 °C.
50
 This hydrogel can exhibit a hydrophilic 
nature below the LCST and a hydrophobic nature above the LCST, and it has gained 
attention as a surface for cell culture systems,
49
 drug delivery and also tissue 
engineering.
57
  
1.3. Bioglue Formulation  
1.3.1 General properties of adhesives 
Skin is the first line of defence against microorganism invasion as it provides a 
protective barrier and has the ability to repair minor wounds with great efficacy. 
However, in circumstances when immediate cover of the wound is required to 
protect and accelerate wound healing,
54
 the application of surgical adhesives 
provides a convenient method for wound closure.
58
 Adhesives can be defined as 
glues which are able to bond tissues together, including a range of surfaces such as 
skin, muscle and blood vessels.
59
 Surgical adhesives provide many advantages over 
sutures and staples as they do not require a local anaesthetic and are therefore less 
time consuming.
60
 Adhesives are also less traumatic to the surrounding tissues, 
provide easy application, quality and strength of seal.
58
 Adhesives must provide 
sufficient mechanical resistance,
61
 allow satisfactory healing by holding joined 
tissues in close proximity and prevent the leakage of bodily fluids.
58
 There is 
currently a wide variety of medical adhesives available commercially and these can 
be separated into three categories: fibrin, cyanoacrylate and albumin/gluteraldehyde 
sealants.
59
 Each category of adhesive has advantages and disadvantages, and as a 
result will determine the procedure in which they will be used.  
Fibrin glues are biological glues which are composed of concentrated fibrinogen and 
thrombin which mimic the final stages of the blood clotting cascade.
62
 They can 
produce a fibrin clot which is biodegradable and can be resorbed within days to 
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weeks as part of the normal healing process.
63
 An example of commercial fibrin glue 
is Tisseel (Fig. 1.15). However, these fibrin glues are known to have weak tensile 
and adhesive strengths
58
 and so cannot be considered as a vascular adhesive.
64
 If 
commercial human plasma is used instead of the patient’s own plasma, this results in 
a multi-donor exposure for the patient
64
 and, if not screened properly, may lead to 
exposure to hepatitis or HIV.
58
  
 
Fig. 1.15: The commercial fibrin glue product, Tisseel. 
 
Cyanoacrylates are synthetic adhesives which polymerise upon contact with water or 
blood.
63
 Based on their chemical structure these glues can be further sub-divided into 
butyl or octyl cyanoacrylate.
59
 2-Octyl-cyanoacrylate is commercially available as 
Dermabond and is used for superficial wound closure (Fig. 1.16).
63
 Cyanoacrylate 
glues have been shown to have good tensile strength,
64
 however, one major issue 
with them is that their polymerisation is an exothermic reaction and this could lead to 
thermal injury in vascular applications.
64
  
             
                       (a)                                                         (b) 
Fig. 1.16: (a) Dermabond commercial product and (b) structure of the monomer used 
in making Dermabond. 
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Adhesives provide many advantages over sutures in that only a topical anaesthetic 
may be required, they are much faster to apply and they provide a water-resistant 
covering. Overall, adhesives provide a less traumatic experience for the patient. 
However, good wound management should not be overlooked for a quick repair as 
this may cause an increase in infection.
65
 The use of adhesives should be continued 
to expand the knowledge of their biodegradation, safety and delivery and should be 
used in conjunction with techniques which are already well established.
66
  
 
1.3.2 Properties of Bioglue 
Bioglue is a surgical adhesive, constituted from the protein bovine serum albumin 
(BSA) (45% w/v) and glutaraldehyde (GLA) (10% w/v) mixed in a 4:1 ratio.
67
 The 
glue provides a flexible, mechanical seal which is independent of the body’s own 
clotting mechanism.
68
 Bioglue has been found to provide good homeostasis, a 
decrease in blood loss and thus the number of transfusions,
67
 and is an effective 
tissue strengthener and adherent.
69
 Bioglue is applied using a sterile, reusable 
double-barrelled syringe delivery system (Fig. 1.17) in which the two components 
are kept separate prior to mixing. Mixing occurs in the attached single nozzle which 
can be replaced for subsequent applications.
69
 Once the two components are mixed, 
polymerisation occurs within 20-30 secs, with the Bioglue reaching full bonding 
strength in 2 min.
70
 
 
Fig. 1.17: Bioglue double-barrelled delivery system.
67
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1.3.3 General properties of a protein 
Proteins account for 50% of the dry weight of cells and are involved in many 
processes such as structural support, storage, transport, signalling from one part of 
the organism to another, movement and defence.
71
 Proteins are polymers of amino 
acids and are known as polypeptides. Amino acids contain a carboxylic acid and an 
amino functionality, the general structure of which is shown in Fig. 1.18 (R is the 
variable group). The sequence of amino acids determines the 3-D conformation, and 
this, in turn, establishes what function the protein will have. As a polypeptide chain 
is synthesised, the chain folds spontaneously to give the functional conformation of 
the protein. Proteins have four levels of structure, known as primary, secondary, 
tertiary and quaternary.  
 
Fig. 1.18: General structure of amino acids. 
 
1.3.3.1 Primary structure 
The primary structure is the unique sequence of amino acids which make up the 
protein and these amino acids are linked together by a peptide bond.  
 
1.3.3.2 Secondary structure 
Most proteins have regions of coiled or folded patterns along the polypeptide chain 
which contributes to the overall conformation. These folds or coils are mainly due to 
hydrogen-bonding interactions at regular intervals along the polypeptide chain. 
Examples of this would include the alpha (α) helix (Fig. 1.19) and the beta (β) 
pleated sheet (Fig. 1.20). The α-helix is a delicate coil which occurs in such a way 
that the peptide bonds are able to form hydrogen bonds between each other.
72
 The 
remaining components of the amino acids protrude from the helix at right angles, 
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which minimises steric interactions and has the overall effect of stabilising the 
structure.
72
 
                                        
 (a)                                                         (b) 
Fig. 1.19: (a) Ribbon structure of an α-helix and (b) an α-helix illustrating hydrogen-
bonding in a protein.
73
 
 
The β-pleated sheet is due to a layering of protein chains above and below the plane, 
giving the appearance of pleats.
74
 Hydrogen-bonding occurs between parts of the 
backbone in either a parallel or anti-parallel form, holding the structure together.
71
      
                                 
(a)                                                             (b) 
Fig. 1.20: (a) Ribbon structure of a β-pleated sheet and (b) a β-pleated sheet 
illustrating hydrogen-bonding in a protein.
73
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1.3.3.3 Tertiary structure 
The tertiary structure of a protein is due to contortions formed from bonding between 
side chains of the various amino acids and gives the overall 3-D structure of the 
protein (Fig. 1.21). As the residues interact, some will attract and others repel each 
other, which causes the protein to twist and turn until the most favourable 
conformation has been achieved. Many types of bonding contribute to the tertiary 
structure such as hydrophobic interactions, van der Waals forces, hydrogen-bonding 
and also disulfide bridges.  
 
Fig. 1.21:  Types of bonding which contribute to the tertiary structure.
71
 
 
1.3.3.4 Quaternary structure 
Quaternary structure arises when two or more polypeptide chains aggregate to form 
one functional macromolecule (Fig. 1.22). Ionic bonding plays an important role in 
quaternary structure as it involves interactions between the exterior surfaces of the 
protein.
72
 
 
 
Fig. 1.22: (a) Tertiary structure and (b) quaternary structure of proteins. 
(a) (b) 
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1.3.4 Bovine serum albumin 
Bovine serum albumin (BSA), which is homologous to human serum albumin 
(HSA), is a single polypeptide chain consisting of 585 amino acids in length.
75
 
Serum albumin (66.5 kDa) is one of the most abundant proteins in plasma (Fig. 
1.23).
76
 It is a versatile carrier protein involved in the transport of hormones, 
vitamins, fatty acids, xenobiotics, drugs and metabolites.
77
  Serum albumin accounts 
for 60% of the total protein in blood serum
78
 and has a typical concentration of 0.63 
mM.
79
 There are three domains in the protein (I, II and III), and each of these is 
divided into two subdomains, A and B.
80
  
1
H NMR data have suggested that serum 
albumin is a heart-shaped molecule (Fig. 1.23), made up of mainly helical domains 
(67%)
76
 and contains 17 disulphide bonds.
81
 The disulphide bridges ensure some 
rigidity within each subdomain, but they allow modifications in the shape and size of 
the serum albumin in response to changes in pH and other influences.
82
 Albumin 
contains one reduced cysteine residue (Cys
34
) which, due to the large amount of 
albumin in plasma, accounts for the largest fraction of free thiols in circulation.
83
 
Serum albumin is responsible for maintaining blood pH and contributes 80% to the 
colloidal osmotic pressure.
84
 
                 
(a)                                                                      (b)                                   
Fig. 1.23: (a) Ribbon structure of albumin
75
 and (b) space filled model of albumin.
84
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Many factors have been shown to affect the conformation of serum albumin such as 
heat, pH, organic solvents, detergents and pressure.
85
 Heat denaturation has been 
found to cause a partial loss of alpha-helical structure and an increase in beta sheet 
formation when the protein is heated above 65-70 °C.
86
 Serum albumin, when 
heated, goes through two structural stages. The first is reversible, whereas the second 
is irreversible.
86
 In the reversible stage, some of the alpha-helices are transformed 
into random coils. The conformational change can be reversed by simply restoring 
the original conditions.
87
 If the temperature is increased past the reversible stage, 
unfolding of the pocket around Cys
34
 occurs, causing it to be exposed.
86
 
Intramolecular disulphide bonds, which play an important role in maintaining the 
native structure, are broken and this allows for the formation of intermolecular 
disulphide bonds.
88
 As disulphide bonds are covalent bonds, this stage is irreversible. 
Serum albumin can undergo reversible conformational isomerisation as a result of 
changes in pH. There have been five isomeric forms identified with increasing pH, 
from expanded (E), to fast (F), normal (N), basic (B) and aged (A) forms.
89
 The N 
form is predominant in the pH range 3.5-7, the N-F transition occurs between pH 4.5 
and 4.0, the F form is produced when the pH is lowered abruptly below pH 4.0 and 
the E form occurs when the pH is below 3.0.
90
 During the N to F structural 
transition, a decrease is observed in the alpha-helical content from approximately 
51% to 44%.
91
 There are very little changes to the helical content during the F to E 
transition but an increase in intrinsic viscosity is observed.
74,91
 At pH 9.0, serum 
albumin changes conformation to the B form. If this pH is maintained for three days 
at a low ionic strength at 3 °C, the A isomerisation occurs.
74
  
One of the most outstanding properties of albumin is its ability to bind reversibly to a 
wide range of molecules such as bilirubin, hormones, drugs and ions.
85
 Albumin 
represents the main antioxidant in plasma and functions either by binding and 
carrying radical scavengers, or by sequestering transition metal ions with pro-oxidant 
activity.
92
 25% of Cys
34
 forms a disulphide bond with small sulphydryl compounds 
such as cysteine, homocysteine and glutathione.
83,93
 Albumin is able to scavenge 
hydroxyl radicals through the reduced Cys
34
 entity.
83
 Oxidation of Cys
34
 can lead to 
the formation of either the sulphinic (RSO2H) or sulphonic (RSO3H) acid form.
83,93
 
Sulphenic acid (RSOH) has been described as a central intermediate. Albumin is a 
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major nitric oxide carrier and this binding of NO can lead to covalent 
modifications.
92
  
As serum albumin has a high content of charged residues such as glutamine and 
lysine, this allows for strong interactions with anionic and cationic species (e.g. 
metal ions).
75
 Albumin has binding sites for a number of metal cations such as 
copper, nickel, calcium, manganese, zinc, cadmium, mercury, aluminium and 
cobalt.
93
 Four metal-binding sites have been identified for albumin. Cys
34
 is located 
in a hydrophobic pocket, which selectively binds hydrophobic complexes of heavy 
metals such as Pt
2+
 and Au
+
.
77
 Another binding site is found at the N-terminal, which 
is made up of the first three amino acid residues of the albumin sequence, Asp-Ala-
His.
94
 This site is also called the ATCUN (amino terminal Cu and Ni binding) which 
is suitable for binding metal ions that have a preference for square-planar 
coordination, and provides four N-donor atoms which include an imidazole nitrogen 
of His, the N-terminal amino group and two deprotonated backbone amide 
nitrogens.
95
 This is the primary binding site for the coordination of Cu
2+
 and Ni
2+
.
77
 
The third binding site has been located at the interface of domain I and domain II, 
with each domain providing two ligands: His
67
 and Asn
99
 from domain I, and His
247
 
and Asp
249
 from domain II. This site has been referred to as site A
95
 and also as 
MBS, a multi-binding site,
77
 and is the primary binding site for Zn
2+ 
and other metal 
dications such as Cu
2+
, Ni
2+
, Cd
2+
 and Co
2+ 
(Fig. 1.24).
77
 The last binding site has 
been referred to as site B, which is the primary binding site for Cd
2+
, but its location 
remains unknown.
77,95
 
Shahabadi et al
96
 recently reported the interaction of the Ag(I) complex, [Ag(2,9-
dmp)2](NO3) (dmp = 2,9-dimethyl-1,10-phenanthroline), with bovine serum albumin 
(BSA). It was postulated that interactions between the cationic Ag(I) complex and 
the biological macromolecule are attributable to hydrogen-bonding, electrostatic 
attractions and van der Waals forces.
96
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Fig. 1.24: (a) Proposed Zn
2+
 binding site in HSA. Ligand atoms (Nε of His67, Nδ of 
His
247
, amide oxygen of Asn
99
 and carbonyl oxygen of Asp
249
) for zinc binding are 
highlighted in yellow, domain I in red, domain II in blue and domain III in green.  
(b) overlay of the zinc binding site in the X-ray structure.
94
 
(a) 
(b) 
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1.3.5 Mechanism of protein crosslinking by glutaraldehyde 
Glutaraldehyde (GLA) (Fig. 1.25) is a linear, pale straw-coloured liquid, 5-carbon 
dialdehyde which is soluble in water, alcohol and general organic solvents.
97
 In its 
simplest form, GLA exists as a monomeric dialdehyde with molecular formula, 
CHO(CH2)3CHO (Fig 1.25a). GLA can also exist as a dimer, trimer and polymer 
(Fig. 1.25b).
98
  
 
(a) 
 
(b) 
Fig. 1.25: Structure of (a) monomeric forms of glutaraldehyde and (b) 
poly(glutaraldehyde). 
 
The reactivity of GLA towards proteins at neutral pH is due the presence of 
numerous functional groups in the proteins
97
 such as thiol, amine, phenol and 
imidazole. Crosslinking mainly occurs through reactions with the ε-amino groups of 
lysine residues.
99
 Many mechanisms have been proposed for the crosslinking effect 
of glutaraldehyde with these ε-amino groups due to the numerous molecular forms 
that GLA can adopt in aqueous solution, and this can lead to many possible reactions 
taking place.
97
 One possible reaction is that the aldehydes can form Schiff bases 
upon nucleophilic attack by the ε-amino groups of the lysine residues in the protein, 
resulting in the formation of an imine bond which is stabilised by conjugation 
(Scheme 1).
97
 Another possibility is that the crosslinking reaction proceeds by a 
Michael-type addition, involving the conjugate addition of protein amino groups to 
ethylenic double bonds of the α,β-unsaturated GLA oligomers (Scheme 2).97 The 
electrophile, which is the α,β-unsaturated carbonyl compound, accepts a pair of  
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Scheme 1: General mechanism for a Schiff base reaction.
100
 
 
 
Scheme 2: General mechanism for a Michael addition reaction using poly(GLA).
100
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electrons and is known as the Michael acceptor. The attacking nucleophile, which is 
the amine of the protein, donates a pair of electrons and is therefore the Michael 
donor.
100
 
It has been suggested that the products formed from the reaction between GLA and 
proteins can vary depending on the pH conditions. Under acidic or neutral 
conditions, glutaraldehyde can exist either as a mixture of monomers or as a polymer 
(Fig.1.26) which can form Schiff bases upon nucleophilic attack. However, Schiff 
bases formed under acidic conditions are inherently unstable.
97
 Under basic 
conditions, the α,β-unsaturated GLA oligomers can react with an amine to give two 
products, a Schiff base and a Michael addition product (Fig. 1.26), as already 
discussed. The mechanism by which protein crosslinking occurs is still not fully 
understood and depending on the form of GLA present, several reaction mechanisms 
could be operative at the same time.
97
 
 
  
Fig. 1.26: Products of 1) Schiff base and 2) Michael-type addition reactions of 
glutaraldehyde with proteins.
97
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1.3.6 Applications of Bioglue 
Bioglue is a relatively new adhesive which was approved by the US Food and Drug 
Administration (FDA) in 2001 for use as an adjunct in adult patients undergoing 
repair of the aorta, femoral and carotid arteries.
101,102
 Bioglue is used as an adjunct to 
reinforce, bond or seal tissue in vascular, thoracic and neurological procedures.
68
 As 
previously mentioned, Bioglue offers many advantages such as good homeostasis 
and the ability to reduce blood loss and consequently the number of transfusions. It 
has been found that Bioglue used in cardiac procedures actually strengthened aortic 
tissue at the site of anastomoses.
69
 The strengthening and hemostatic properties were 
able to control bleeding from very fragile tissues and it was also a versatile and 
reliable alternative to gelatin-resorcinol-formaldehyde (GRF) glue. Toxicity issues 
with GRF were raised due to the formaldehyde component of the glue
69
 which can 
be present at high concentrations (37%).
103
 There have also been many advantages to 
the use of Bioglue in nephron-sparing surgery carried out after tumour resection 
(Fig. 1.27), such as reducing the formation of urinary fistula, shorter operative times 
and also the warm ischemic time, which is the time between interruption and re-
establishment of the blood supply. The latter property has been one of the major 
disadvantages to the old technique of suturing.
67
  
 
Fig. 1.27: Bioglue applied to a dry tumour bed and protecting the surrounding tissue 
in the process.
67
 
 
Despite the many advantages Bioglue offers as an adjunct to suturing, there have 
been reports to the contrary. LeMaire et al
101
 found that direct contact between 
Bioglue and the phrenic nerve consistently caused nerve damage and paralysis of the 
diaphragm in their pig model. The use of an adhesive in cardiovascular operations in 
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neonates has the added requirement of allowing the vascular anastomoses to enlarge 
as the patient grows.
104
 Further studies carried out by LeMaire et al
104
 showed that 
Bioglue causes severe fibrosis surrounding the aorta, which is an excess of fibrous 
tissue resulting from inflammation, irritation or healing. This observation was then 
translated to suggest that Bioglue impairs vascular growth and also causes stricture 
(abnormal narrowing) when applied to cardiovascular anastomoses in four week old 
piglets, which are designed to mimic a paediatric patient.
104
 The cytotoxic effects of 
Bioglue on tissue of the lung, liver and aorta in rabbits was assessed by Fürst et al.
105
 
It was found that the glutaraldehyde component caused sensitivity to tissues of the 
lung and liver but no difference was observed in the tissue of the aorta. This 
corresponds with the fact that Bioglue was originally approved as an adjunct in adult 
patients undergoing repair of the aorta, femoral and carotid arteries.
101
  
Other conflicting reports regarding the use of Bioglue have been documented. For 
example, Ngaage et al
106
 suggested that the use of Bioglue results in an 
inflammatory process which lasts two years after initial application and may retard 
normal healing. Pasic et al
107
 suggest that Bioglue may produce a foreign body 
reaction as long as the glue is present. As the major component of Bioglue is 
albumin, it degrades by proteolysis and is resorbed slowly
108
 which may cause a 
prolonged inflammatory response.
107
 In contradiction to this, Yuen et al
109
 found that 
after two years the Bioglue was present unaltered, and not associated with any 
inflammatory, foreign body or allergic reactions or any local tissue toxicity. Using a 
sheep model, Hewitt et al
110
 observed only minimal and inconsistent inflammatory 
responses, and preliminary results also suggested minimal reactions in humans, two 
and nine months after an aortic repair. This is in contrast to the findings mentioned 
earlier by LeMaire et al.
104
 Gaberel et al
111
 observed that, over an eighteen month 
period, a substantial increase of 5.4% in surgical site infections (SSI) occurred when 
Bioglue was used, and that this returned to the normal rate of 1% when its use was 
discontinued. A wide variety of microorganisms were found to be responsible for 
infection and included: 17 Staphylococcus species, 9 Gram-negative species and 2 
Streptococcus species. It was suggested that Bioglue can be the cause of bacterial 
infection through two methods. Firstly, that bacteria can become trapped in the 
wound during surgery which is the main route of exposure in SSI. Secondly, it was 
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proposed that the inflammation response can prevent wound healing and may 
weaken the wound incision, causing it to separate. Once separation occurs, the skin 
microbial flora can enter the wound and migrate deeper into the tissue.
111
 Within this 
report, many other factors were considered to increase the rate of SSI such as the use 
of Neuropatch® (a synthetic graft) in combination with Bioglue, and also surgery 
duration time. The report set out to determine all risk factors causing SSI, and not 
just to prove if Bioglue was the main source. The authors even suggested caution in 
the interpretation of the results as the controls were not paired with known risk 
factors of SSI.
111
 
In the present study, microbial growth was observed on normal Bioglue samples 
prepared in the laboratory (Fig. 1.28). In this respect, one of the objectives of the 
present study was to incorporate a biocidal agent (namely Ag(I) ions) into the 
Bioglue formulation in an attempt to inhibit microbial growth. 
          
Fig. 1.28: Microbial growth (white) on Bioglue (golden coloured). 
 
Many of the negative findings associated with the use of Bioglue are advertised by 
the manufacturer’s, CryoLife®, as precautions to be taken into account before using 
Bioglue.
112
 Tissue adhesives have provided immense adjunct support in surgery and 
the issue regarding inflammation could be regarded as a typical foreign body 
response.
110
 However, these issues have highlighted the need for further long-term 
studies with respect to the use of Bioglue and to evaluate these effects.  
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1.4 Staphylococcus aureus 
Staphylococcus aureus is a Gram-positive, versatile bacterial pathogen (Fig. 1.29a) 
which has the ability to survive in nutrient-limiting and stressful conditions. These 
factors contribute to its infectious nature in a hospital environment, which can take 
place by direct contact with wounds, airborne carriage and contact with indwelling 
devices such as catheters.
113
 Approximately 30-50% of healthy individuals carry S. 
aureus, most commonly in the anterior nares (i.e. nose), with up to 10-20% of these 
individuals remaining persistently colonised.
114
  S. aureus has been identified as one 
of the  main pathogens associated with infections of the skin and soft tissue (40%)
115
 
(Fig. 1.29b), and it can lead to more serious diseases such as toxic shock syndrome 
(TSS), scalded skin syndrome (SSS) and also sepsis.
116
  
                                             
(a)                                                              (b) 
Fig. 1.29: (a) S. aureus cells (golden colour)
117
 and  (b) a leg ulcer infected with S. 
aureus.
118
 
 
S. aureus was first identified in the 1880s by Sir Alexander Ogston, and before the 
discovery of antibiotics for the treatment of such an infection, the mortality rate from 
an S. aureus infection was approximately 80%.
119
 Penicillin-resistant strains of S. 
aureus were first observed two years after the introduction of penicillin as a 
successful treatment. A new treatment of methicillin was introduced, but again, 
resistance was observed.
120
 In the UK alone, over 20,000 cases of S. aureus infection 
are reported each year, with half of these cases being antibiotic-resistant.
121
 Data 
collected as part of the European Antimicrobial Resistance Surveillance Network 
(EARS-Net), found that in Ireland there were 1,412 reported S. aureus infections 
identified by analysts working in 42 different microbiology laboratories in 2006.
122
 
Of these, 41.9% were found to be methicillin-resistant. This figure decreased by 
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2010 to 1,251 cases of S. aureus infections and of these, 24.4% showed emergence 
of resistance.
122
 Even though the overall trend shows that the incidence of resistance 
is decreasing, Ireland was ranked 9
th
 highest out of 28 countries in 2009 regarding 
the number of M.R.S.A. cases reported.
122
 The cost of treating M.R.S.A. infections in 
hospitals has been estimated to be €23 million annually and the need for more 
frequent after-care can add to this.
123
 This financial problem has contributed to the 
need for continuing research into the pathogenesis and mode of action of S. aureus in 
order to develop a diverse portfolio of complementary approaches to prevent the 
spectre of untreatable infections.
121
 
 
1.4.1 Pathogenesis of S. aureus 
Many factors contribute to the pathogenesis of S. aureus such as the presence of a 
capsule, the expression of adhesins, the secretion of various toxins and also 
immunomodulators (Fig. 1.30).
124
 The capsule is composed of capsular 
polysaccharides which aid S. aureus in the evasion of opsonophagocytosis.
121
 
Opsonophagocytosis is a process where white blood cells can efficiently consume 
bacteria that contain opsonin, which is an antibody or product of the complement 
activation in blood serum that causes bacteria or other foreign cells to become more 
susceptible to the action of phagocytes. This was suggested on the basis of findings 
that a reduced uptake by human neutrophils of bacterial cells containing a capsule 
occured in vitro.
125
 The capsule is composed of serotype 5, serotype 8 or serotype 
336. Serotypes 5 and 8 have been associated with increased virulence in animal 
infection models,
125
 and recent studies from the United States and the Netherlands 
have found that 92% and 82% of S. aureus isolates were either serotype 5 or serotype 
8, respectively.
126
  It can be seen that the presence of a capsule can effectively protect 
S. aureus by providing a barrier to help evade an immune response. The presence of 
teichoic acids, which is a shared feature of the cell wall and the membrane, also 
assists in the protection of S. aureus from a host immune response. Teichoic acids 
are composed of polyglycerol phosphate or polyribitol phosphate polymers coated 
with sugar substituents or esterified with D-alanyl groups, and it is the positively 
charged free amino moiety of the D-alanyl groups that neutralise the anionic 
properties imposed by the phosphate groups. This, in turn, protects S. aureus from 
 38 
 
 
 
Fig. 1.30: (a) Surface and secreted proteins of S. aureus, (b) and (c) are cross sections of cell envelope.
127
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attack by the cationic antimicrobial peptides (CAMPs) which are part of the host 
immune response.
121
 
Adherence is a critical first step in bacterial pathogenesis and is needed for 
colonizing a host. The process of adherence is usually carried out by adherence 
factors called adhesins, which are produced by bacteria and which recognise and 
bind to the host extracellular matrix.
128 
Adhesion is effected by several cell wall- 
associated proteins, known as microbial surface components, which recognise 
adhesive matrix molecules (MSCRAMMS).
121
 The best characterised of these are the 
fibronectin-binding proteins (FnBpA and FnBpB), the collagen-binding protein 
(Cna) and the fibrinogen-binding proteins clumping factor (ClfA and ClfB).
121
 The 
N-terminus of these binding proteins contains a signal sequence made up of about 40 
residues, followed by an A domain which is exposed to the bacterial surface and 
which contains a ligand binding region.
129
 The C-terminus contains the 
LeuProXThrGly (LPXTG) motif, which is cleaved by sortase and covalently link the 
adhesins to the bacterial cell peptidoglycan.
130
 Fibrinogen, and especially fibronectin, 
can be present as secreted or plasma membrane-associated molecules.
131
  FnBpA has 
been found to bind to extracellular matrix-associated fibronectin which, in turn, 
induces the clustering of fibronectin-bound integrin receptors (α5β1) which activates 
intracellular signalling.
128,132
 This clustering leads to focal adhesion kinase (FAK) 
activation, a protein tyrosine kinase which is engaged at an early stage to focal 
adhesions and which ultimately leads to actin-binding protein recruitment to the 
attachment site and promotes the internalisation of S. aureus.
133
 The collagen-
binding protein, Cna, mediates bacterial adherence to collagenous substrates and 
tissues. It has been found that the presence of Cna is sufficient and necessary for S. 
aureus cells to adhere to cartilage in vitro due to the fact that antibodies against Cna 
inhibit binding to collagen and also block adherence to cartilage.
134
 The N-terminal 
A domain of ClfA binds to the γ-chain of fibrinogen. If cells are densely packed in 
suspension, the γ-chain C-termini located at either end of the fibrinogen molecule 
can bind simultaneously to two ClfA molecules on two different bacterial cells, 
leading to clumping of cells.
125
 ClfA mediates bacterial attachment to plasma clots 
formed in vitro and also to plastic biomaterials which were exposed to canine and 
human blood for short-term conditioning, suggesting that it is an important factor in 
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wound and foreign body infection.
134
 Although attachment of the bacterial adhesins 
to the host cell is beneficial for bacterial colonization it can also stimulate an immune 
response.
135
  
Staphylococci are the main coloniser of in-dwelling devices such as catheters (Fig. 
1.31).
136
 After the device has been implanted in the patient, the surface is rapidly 
coated by host proteins such as fibronectin and fibrin, which are the main ligands that 
facilitate the binding of S. aureus.
137
 The bacteria then encase themselves in a 
hydrated matrix of polysaccharide and protein, which forms a slimy layer, known as 
a biofilm.
138
 Adhesion to the surface is a critical transition from free-floating 
planktonic cells to biofilm formation. Once attachment has taken place, the bacteria 
start to accumulate in mass and this results in a multi-layered cell structure.
139
 Once 
the biofilm aggregates and matures, clusters of cells break away from the film and 
distribute to distant sites which facilitates the spread of a biofilm-associated 
infection.
139
 Quorum sensing is a cell to cell signalling mechanism that allows the 
bacteria to control gene expression. The signals of quorum sensing systems are 
molecules called autoinducers (AIs) which are at a low concentration when the cell 
density is also low. Once a certain cell density is reached, AIs reach a threshold 
concentration and activate a transcription factor.
140
 This, in turn, regulates the 
expression of various genes, including virulence factors,
139
 and allows optimal 
expression which conserves energy and maximises their survival, to the disadvantage 
of the host. 
 
Fig. 1.31: SEM of S. aureus adhering to catheter pieces placed in tissue cages. 
Microcolonies (arrow) of S. aureus were found attached to the catheter.
141
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S. aureus produces a wide variety of cytotoxins which have potent effects on the 
cells of the host immune system.
142
 Some examples of these include hemolysin (α, β, 
γ, δ), leukocidin, toxic shock syndrome toxin-1 and also enterotoxins. The ability of 
a bacterial protein toxin to cross a cellular membrane is an important function in 
order to allow access to the host’s cytosolic molecular targets. Alpha-hemolysin is 
one of the main pore-forming toxins of S. aureus. Monomers are secreted which 
attach to the membrane of a host cell, where a cylindrical heptamer is formed with β-
strands from each monomer contributing to the formation of a β-barrel which spans 
across the membrane (Fig. 1.32).
125
 Once this occurs, a 1-2 nm pore forms which 
allows for the rapid efflux of K
+
 and influx of Na
+
, Ca
+
 and other small molecular 
weight molecules into the target cell.
142
 Osmotic swelling ultimately results in 
rupture due to a breakdown in cell integrity and thus allowing greater vascular 
permeability.
142
 The overall structure of the pore was found to be in the shape of a 
mushroom, which is divided into three domains: the cap, rim and stem (Fig. 1.32).
143
 
The cap domain is mainly hydrophilic and, with the rim domain, projects from the 
extracellular surface of the membrane and forms the core of the protein.
143
 A 
prominent feature of the core is the amino latch
144
 which is formed when the N-
terminal extremity detaches from each monomer and interacts with the next two 
protein subunits at the entrance of the pore.
143
 The stem domain is formed by the 14-
strand, anti-parallel β-barrel, which defines the transmembrane portion of the pore 
(channel).
144
  
 
Fig. 1.32: Ribbon representation of the α-hemolysin heptamer (a) with cap, rim and 
stem domains labelled and (b) depiction of the membrane pore (channel).
144
 
(a) (b) 
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Leukotoxins target leukocytes and are made up of two subunits, S and F components, 
named as such because of their relative elution positions on an ion exchange 
column.
142,145
 Leukotoxins are secreted separately and assemble into hexameric or 
heptameric oligomers in the membrane of leukocytes.
125
 Leukotoxins include γ-
hemolysin and Panton-Valentine leukocidin (PVL). γ-Hemolysin is made by 
virtually every strain of S. aureus, while PVL is made by only 2-3% of strains.
138
 
The two components of PVL are LukS-PV and LukF-PV, with LukS-PV initiating 
binding on the leukocyte membrane, where it dimerises with LukF-PV. This is 
followed by the alternate binding of LukF-PV and LukS-PV components until the 
heptamer is formed.
146
 Binding of PVL results in the activation of the target cell by 
the opening of calcium ion channels, and this can lead to the production of 
interleukins and other inflammatory mediators.
147
 PVL has been associated with skin 
infections such as furunculosis
148
 and also necrotising pneumonia.
149
 Necrotising 
pneumonia is characterised by high fever, hypotension, leucopenia and multilobular 
alveolar infiltrates which usually progress into abscesses.
147
 Histopathological 
studies have shown the presence of necrotic lesions of the tracheal mucosa and 
alveolar septa and numerous clusters of Gram-positive cocci have been observed. 
The production of interleukins and inflammatory mediators is most likely the cause 
of local vasodilation and also the progression to acute respiratory distress 
syndrome.
147
 S. aureus secretes toxins which can act as superantigens and also 
induce vomiting (an emetic response) when ingested.
148
 Examples of these include 
Toxic Shock Syndrome Toxin-1 (TSST-1) and Staphylococcal enterotoxins.
142
 
TSST-1 is associated with Toxic Shock Syndrome (TSS), an acute and potentially 
fatal illness, which is characterised by a high fever, rash, desquamation of the skin 
one to two weeks after onset, hypotension and involvement of three or more organ 
systems.
138,142
 Superantigens have the ability to bind to the exterior surface of the 
major histocompatibility complex II (MHC) molecules on the surface of antigen-
presenting cells and link them to the T-cell receptors which are on the surface of the 
T-cell.
148
 In normal antigen processing, proteins which have been endocytosed are 
degraded within the cell by enzymes and are presented via the inner groove of the 
MHC class II molecule on the outside surface so they can be recognised by the T-
cell, activating an immune response (Fig. 1.33).
150
 In this case, binding occurs  
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Fig. 1.33: An illustration of the interaction of a normal antigen (left) and a 
superantigen (right) with a T-cell and MHC class II on an antigen presenting cell.
150
  
 
without MHC class II having to present to the T-cell receptor.
148
 The expression of 
superantigens during an infection prevents a normal immune response. Antigen-
specific T cells fail to proliferate antigens which are presented normally by MHC 
class II.
125
 This results in immunosuppression due to the failure to induce an 
appropriate immune response and a lack of immunological memory
125
 which, in 
turn, prevents the production of antibodies to the superantigen toxin which is 
characteristic to TSS patients.
125
 TSS is usually classified into two categories: 
menstrual TSS (MTSS) and non-menstrual TSS (NMTSS).
138
 MTSS has been 
associated with the use of tampons which are thought to introduce oxygen into the 
normally anaerobic vagina, an environment which is required for TSST-1 
production.
138
  NMTSS can occur in men, women and children and is associated 
with localised infections of surgical wounds, abscesses, lacerations, furuncles (a hair 
follicle infection) and burns.
150
  
Staphylococcus enterotoxins (SEs) have been implicated in outbreaks of food 
poisoning, which is known as staphylococcal food poisoning (SFP). This usually 
results from the ingestion of SEs on food contaminated by S. aureus.
142
 SFP is 
characterised by nausea, vomiting, abdominal pain and diarrhea
151
 and usually 
resolves within 24-48 h.
142
 There are a variety of SEs, ranging from SEA-SEE and 
SEG-SEJ, with SEA and SED being the most common enterotoxins responsible for 
food poisoning in the US (77.8% and 37.5% of all outbreaks, respectively).
151
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Antibodies to one SE will not necessarily provide immunity to SFP due to the 
multiple SEs capable of causing disease.
142
 
In conclusion, it can be seen that the pathogenesis of S. aureus is attributed to the 
numerous secreted and cell-surface-associated virulence factors which promote the 
success of an infection. However, once S. aureus breaches the skin and mucous 
surfaces, the organism has to deal with the hosts’ immune system. 
 
1.4.2 Host immune response 
The immune system is made up of two defense mechanisms: the innate immune 
response and the adaptive or specific immune response. The innate immune response 
is the host’s first line of defense against invading pathogens and consists of 
macrophages, neutrophils, natural killer cells and dendritic cells. The main functions 
of the innate immune system are: to recruit cytokines to the site of infection and 
inflammation; to activate the complement cascade to identify bacteria; to remove 
foreign organisms from the body and to activate the adaptive immune response by 
antigen presentation. The adaptive immune system has the ability to remember 
certain pathogens and recognise them in the event of a repeated exposure to that 
pathogen. This leads to immunological memory, which results in a more effective 
and faster process to eliminate pathogens.  
The skin forms the first line of defence against the invasion of microbial pathogens. 
The uppermost layer, the corneal layer, is composed of dead keratinocytes which 
provide the physical barrier of the skin. These cells contain antimicrobial peptides 
such as defensins, which can be induced in response to infection.
152
 Beneath this 
layer are the granular, spinous and basal layers which are made up of keratinocytes 
which express pattern recognition receptors (PRRs) that, in turn, recognise the 
pathogen-associated molecular patterns (PAMPs) of invading microorganisms.
152
 
Each PAMP is recognised by a specific, toll-like receptor (TLR) which can be found 
extra- and intra-cellularly and are produced in response to pathogens. TLRs allows 
for the activation of phagocytes and tissue dendritic cells to respond to pathogens by 
releasing chemokines and cytokines.
153
 The interaction of TLRs with their specific 
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PAMP results in the activation of the nuclear transcription factor, kappa (NF-κB),154 
which causes  translocation to the nucleus and, in turn, activates inflammatory target 
genes, including those which encode for cytokines, cytokine receptors, adhesion 
molecules, stress-associated proteins and also defensins.
155
  
A characteristic of an S. aureus infection is the formation of a neutrophil abscess, 
which is necessary for bacterial clearance.
152
 Neutrophils are key innate immune 
cells which express many PRRs, and it is through these receptors that neutrophils 
first detect S. aureus. TLR2 is considered to be the main PRR for Gram-positive 
bacteria, as lipoteichoic acids signal through this receptor.
156
 The recruitment of 
neutrophils is governed by pro-inflammatory mediators such as cytokines 
(Interleukin-1, IL-1 and tumour necrosis factor alpha, TNF-α) and chemokines 
(CXCL-1 and CXCL2).
156
 Cytokines are proteins which can be induced, and are 
produced on stimulation of white blood cells and are therefore necessary for a host 
immune response.
157
 Once neutrophils encounter S. aureus, phagocytosis occurs 
which is followed by an oxidative burst to facilitate bacterial killing. This process 
involves the generation of reactive oxygen species (ROS) such as superoxide, 
hydrogen peroxide and also hypochlorous acid, which mediate bacterial killing. 
Despite this, the numerous virulence factors associated with S. aureus provide a 
means of avoiding recognition and phagocytosis by neutrophils, which is 
advantageous to the organism.
156
 
 
1.4.3 S. aureus antibiotic resistance 
The phenomenon of antibiotic resistance stimulated research into trying to firstly 
understand the mechanisms behind it and, secondly, in doing this, to produce novel 
therapeutic agents to keep one step ahead of the organism by providing a wide range 
of treatments. 
Antibiotic resistance was first reported in 1942, two years after the introduction of 
penicillin for the treatment of S. aureus infections.
120
 One mechanism of resistance is 
the production of enzymes which inactivate the antibiotic either by hydrolysis or the 
formation of inactive derivatives.
158
 Penicillin is inactivated by the enzyme β-
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lactamase, a serine protease that hydrolyses the β-lactam ring.127 With the 
introduction of methicillin, a penicillinase-resistant penicillin, resistance was once 
again observed due to the acquisition by the bacterium of the staphylococcal cassette 
chromosome (SCCmec).
159
 SCCmec is a 21-67 kilo base (kb) fragment of DNA 
which carries the mec gene complex which encodes for β-lactam resistance.159 The 
mecA gene codes for the 78 kDa penicillin-binding protein, 2a (PBP2a), a 
transpeptidase which catalyses the formation of cross-bridges in bacterial cell 
peptidoglycan.
159
 In susceptible cells, β-lactam antibiotics bind to PBPs present in 
the S. aureus cell wall, causing disruption of the synthesis of the peptidoglycan layer 
and resulting in cell death.
120
 In M.R.S.A., however, PBP2a is present, preventing the 
binding of β-lactam antibiotics. The growth of M.R.S.A. is observed as the 
peptidoglycan layer synthesis is not disrupted.
120
 Another mechanism adopted by 
organisms is target alteration. This process involves the alteration of cellular targets 
by either mutation or enzymatic modification, which reduces the affinity of the target 
for the antibiotic.
158
 Lastly, another proposed mechanism is the removal of 
antibiotics from the organisms by efflux systems.
160
 Bacterial efflux pumps are 
responsible for the removal of toxins produced by the cell itself and also the efflux of 
toxic compounds that the cell encounters, such as antibiotics.
160
 Some examples of 
efflux pumps for S. aureus are the quaternary ammonium compounds (QAC) efflux 
system which encodes the genes qacA-D, with qacC and qacD being identical to the 
ebr gene which encodes resistance to ethidium bromide and which explains why 
resistance to QAC is often observed with ethidium bromide resistance.
37
 Another 
efflux pump associated with S. aureus is NorA, which is responsible for resistance to 
fluoroquinolones.
161
 The ability of S. aureus to adapt to and evolve resistance against 
a range of antibiotics makes the treatment of infections limited and causes added 
expense to the healthcare system.  
 
1.4.4 Treatment of S. aureus 
The appearance of resistance in S. aureus to various treatments only reinforces the 
importance of research into novel therapies. One suggestion has been to target the 
auto-inducing peptides used in quorum sensing by synthesizing analogues to 
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compete with these autoinducing peptides. This will, in turn, prevent any cell-cell 
signalling from occurring.
162
  
 
Although the structure of the S. aureus cell is quite complex it provides many 
cellular targets for drug intervention.
121
 One suggested avenue would be to inactivate 
the genes that esterify teichoic acids with D-alanine as this would result in the 
mutants becoming sensitive to cationic, antimicrobial peptides (CAMPs) which are 
part of the innate immune response causing the production of defensins that protect 
the skin from invading organisms.
163
 Another area that could act as a potential target 
is the peptidoglycan of the cell wall.
121
 Peptidoglycan is made up of a pentaglycine 
bridge which is required for structural integrity. Lysostaphin has been used due to its 
ability to cleave the pentaglycine cross-bridges in the cell wall. This has been very 
successful in the prevention and eradication of S. aureus colonization of both inert 
materials such as catheters and also living tissue.
164
 As mentioned earlier, Cna which 
is a collagen-binding protein, ClfA which is a fibrinogen-binding protein clumping 
factor and FnbpB, a fibronectin-binding protein, provided promising results when 
used as vaccines in rodent models. The binding proteins had the ability to reduce the 
severity of symptoms caused by the bacteria and reduced the mortality rates by 2-6 
fold.
165-167
 
Many silver-based dressings have been used in the treatment of S. aureus. Edwards-
Jones
168
 found that nano Ag(0) dressings (Acticoat and Acticoat Absorbent) provided 
an effective barrier, by preventing the penetration of  M.R.S.A. through the dressing. 
This, in turn, prevents the spread of M.R.S.A. from the wound surface to the 
surrounding area.
168
 Rattanaruengsrikul et al
169
 found that a Ag(0)-nanoparticle 
loaded gelatin hydrogel pad was more effective against S. aureus, E. coli and P. 
aeruginosa than the neat gelatin hydrogel.  
S. aureus has been shown to be a very versatile, colonizing pathogen and has been 
isolated from both hospital and community acquired infections. The consequences of 
an S. aureus infection can be detrimental to the host, with 4% of cases each year 
being fatal.
121
 This is especially the case when resistance emerges, as has been found 
in the case of M.R.S.A. and other resistant strains of S. aureus. As the main coloniser 
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of wounds and a major problem for burn patients, patients with open wounds and in-
dwelling catheters, it is essential to gain an understanding to the mode of action of S. 
aureus in order to have new therapeutic options available when resistance eventually 
emerges. As this has occurred with the introduction of the first method of treatment 
using penicillin, and has continued with the introduction of each new antibiotic, such 
as methicillin and vancomycin, it is vital to continue in the search for novel 
treatments, whether it is in the form of prophylactic or therapeutic agents. 
 
1.5 Other Microorganisms Used in this Study 
1.5.1 Escherichia coli 
E. coli is a Gram-negative, rod-shaped bacterium (Fig. 1.34) which is found mainly 
in the lower intestinal tract. Harmless strains are part of the normal flora of the gut 
and can even benefit the host with the production of vitamin K and also by 
preventing pathogenic bacteria from establishing in the host’s intestine. Despite this, 
there are some strains of E. coli, namely O157, which are pathogenic and are known 
to cause disease.
170
 E. coli O157 has the potential to be life-threatening, with the US 
Centre for Disease Control estimating that it accounts for at least 20,000 cases of 
infection and 250 deaths per year in the USA alone.
170
  
                 
Fig. 1.34: E. coli cells. 
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1.5.2 Pseudomonas aeruginosa 
P. aeruginosa is also a Gram-negative bacterium (Fig. 1.35a) which has the ability to 
cause a range of infections in both a community and hospital environment. In the 
community, the bacterium has been known to cause folliculitis (Fig. 1.35b) and also 
green nail or hot foot syndromes, usually caused by exposure to contaminated hot 
tubs or swimming pools.
171
 This opportunistic pathogen is a leading cause of 
nosocomial infections and also contributes to chronic lung infections of cystic 
fibrosis patients.
172
 A US National Healthcare Safety Network listed P. aeruginosa 
as the sixth most frequently occurring bacterial pathogen, the second most important 
pathogen in ventilator-associated pneumonia and also the sixth leading cause of 
catheter-related, bloodstream infections.
171
  
                                                                                              
   (a)                                                                (b) 
Fig. 1.35: (a) P. aeruginosa cells and (b) P. aeruginosa folliculitis infection. 
 
1.5.3 Candida albicans 
The Candida genus of yeast consists of many species of which C. albicans is a 
member. C. albicans is a dimorphic yeast (Fig. 1.36a) and is carried unknowingly by 
humans on the epithelial surfaces of the mouth, gastro-intestinal tract (GI tract), 
vagina and skin. In healthy individuals they are harmless, but in individuals with an 
impaired immune system the organism can overgrow and cause harm. For this 
reason it is known as an opportunistic pathogen.
173
 When C. albicans has overcome 
the host’s immune system it can lead to a number of infections, which are either 
superficial or systemic.
174
 Superficial infections affect the skin, mucous membranes 
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of the oral cavity (Oropharyngeal Candidosis, oral thrush) (Fig. 1.36b) and the 
vagina (Vulvovaginal Candidosis, thrush), while systemic infections occur when the 
C. albicans cells penetrate through the outer layers of the skin and mucosal surfaces 
and enter the bloodstream causing Candidaemia.
175
 
 
                
                       (a)                                                       (b) 
Fig. 1.36: (a) C. albicans cells and (b) an oral C. albicans infection 
 
1.6 Previous Research from laboratory 
Previous work within our group at N.U.I. Maynooth has focused on the antimicrobial 
effects of Ag(I) complexes incorporating ligands such as 1,10-phenanthroline (phen), 
1,10-phenanthroline-5,6-dione, imidazoles and salicylates (Fig. 1.37).
176-179
  It was 
found that Ag(I) complexes incorporating 1-10-phenanthroline e.g. 
([Ag2(phen)3(mal)].2H2O) (malH2 = malonic acid) damage mitochondrial function 
and also inhibit cytochrome biosynthesis, which leads to a decrease in cellular 
ergosterol content. The imidazole/salicylates complex ([Ag2(imH)4](salH)2 ((imH)4 = 
imadazole, (salH)2 = salicylic acid) was found to be 47 times more potent than the 
marketed drug, ketoconazole, against the fungal pathogen C. albicans.
179
 A range of 
Ag(I)-coumarin complexes were also synthesised and it was found that they had the 
ability to disrupt fungal respiration, leading to an increase in cell membrane 
permeability, loss of cytochrome c, which triggers an apoptotic response within the 
cell and can lead to DNA cleavage.
180
 The effect of AgClO4 on C. albicans was also 
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assessed. The activation of two stress response pathways (Cap1p and Hog1p) was 
observed, indicating that the cells were experiencing oxidative stress as a result of 
exposure to the Ag(I) ion.
174
 
 
 
 
 
 
Fig. 1.37: Structures of (a) 1,10-phenanthroline, (b) 1,10-phenanthroline-5,6-dione, 
(c) imidazole, (d) salicylic acid and (e) coumarin. 
 
(a) (b) (c) 
(d) (e) 
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2.1 Instrumentation 
Bioglue samples for subjection to atomic absorption, infrared spectroscopy, 
differential scanning calorimetry and scanning electron microscopy analysis were 
pre-dried at room temperature under high vacuum (approx. 8 h) until a constant mass 
was obtained. 
Infrared (IR) spectra were obtained on a Perkin Elmer System 2000 FT IR 
spectrometer and were recorded in the range of 4,000-370 cm
-1
. Solid samples were 
ground with an excess of anhydrous KBr and liquid samples were placed between 
two NaCl plates. 
1
H NMR spectra were recorded on a Bruker Avance 300 MHz spectrometer at a 
probe temperature of 25 ˚C using D2O and with tetramethylsilane (TMS) as an 
internal standard. 
Differential Scanning Calorimetry (DSC) measurements were carried out using a 
Perkin Elmer Pyris 6 DSC. The parameters for the first experiment were; hold for 1 
min at 25 °C, heat from 25-50 °C at 3 °C/min, cool from 50-30 °C at 3 °C/min, hold 
for 1 min at 30 °C, and this was repeated three times. The parameters for the second 
experiment were; hold for 1 min at 25 °C, heat from 25-50 °C at 3°/min, cool from 
50-37 °C at 3 °/min, hold at 37 °C for 3 h, cool from 37-30 °C and hold for 1 min at 
30 °C.  
Atomic Absorption Spectrometry (AAS) was performed using a Perkin Elmer 
AAnalyst 200 and calibration plots were obtained using AgNO3 (99.99% purity).  
Tensile testing was performed on a LLOYD Instruments LRX instrument and the 
data were analysed using the NEXYGEN software package. The parameters used for 
tensile testing of the pre-measured pieces of wood were; general purpose, pull to 
break, preload; 1 N, speed; 20 mm/min, gauge length; 20 mm, area; 5 mm x 3 mm, 
break; load drops to 5%. The parameters used for tensile testing of the pre-measured 
pieces of pig skin were; general purpose, pull to break, preload; 1 N, speed; 20 
mm/min, gauge length; 40 mm, area; 25 mm x 5 mm, break; load drops to 5%.  
Microanalytical data were obtained using a Flash EA 1112 series CHN Analyser.  
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Mass spectrometry for the determination of molecular weight of the [Ag2(3,6,9-
tdda)] (tddaH2 = trioxaundecanedioic acid) samples was carried out on an Agilent 
Technologies 6210 Time of Flight LC/MS mass spectrometer. An Agilent 
Technologies 6340 Ion Trap LC/MS spectrometer was used for proteomic analysis. 
Scanning Electron Microscopy was carried out on a Hitachi S-3200 N Scanning 
Electron Microscope, using Au sputtering. 
All electrochemical work was completed using the CH Instruments Electrochemical 
Workstation. Analysis of data was carried out using chi760c program. 
All worktops and benches were washed down with 70% (v/v) ethanol prior to use. 
Sterilisation of all growth media and materials required for aseptic techniques was 
achieved by autoclaving in either a TOMY SX-500 E autoclave at 121 °C and 15 
lb/sq.in or in a Dixons ST2228 autoclave at 121 ˚C and 18 lb/sq.in for 20 min. Any 
solutions that were not suitable for autoclaving were filter-sterilised using 0.22 µM 
Millipore membrane filters (Sarstedt, Nümbrecht, Germany). All cultures were 
autoclaved prior to final disposal.  
A Bio-Tek Synergy HT spectrophotometer was used at λ=540 nm for the anti-fungal 
and anti-bacterial susceptibility testing, and at λ=450 nm for the superoxide 
dismutase assay. A Cary IE UV-Visible spectrophotometer was used at λ=340 nm 
for the glutathione reductase assay. A Unicam UV500 UV-Visible 
spectrophotometer was used for UV-Visible analysis of Ag(0)-Bioglue supernatants 
in the range 190-900 nm. The OD600nm of an overnight bacterial culture was 
determined using a Biophotometer, Eppendorf spectrophometer.  
Centrifugation was carried out on either a Beckmann GS-6 Centrifuge or on an 
Eppendorf 5417R centrifuge when a controlled temperature was required.  A Heto 
DNA Mini vacuum centrifuge was used during mass spectrometry preparation. 
Sonication was performed using either a Bandelin Sonopuls HD 2200 sonicator 
probe to disrupt external proteins for SDS-PAGE electrophoresis or in a Fisher 
Scientific FB 15050 sonicator bath as part of protein preparation for mass 
spectrometry analysis.  
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Iso-electric focusing was performed on an Ettan IPGphor II, supplied by Amersham 
Biosciences, NJ, USA.  
SDS-PAGE gels were cast on the Bio-Rad PROTEAN II casting unit and were 
electrophoresed on the Bio-Rad PROTEAN PLUS Dodeca cell system. 
RNA quality was measured using a Mason Technology nanodrop 1000 
spectrophotometer. 
Polymerase chain reactions (PCR) were carried out on an Eppendorf Mastercycler 
PCR instrument. 
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2.2 Theoretical Background and Specific Instrumental Techniques 
2.2.1 Tensile Testing 
The mechanical behaviour of an adhesive is one of its most fundamental properties. 
Such behaviour can be assessed by having the test sample clamped at each end with 
one end being fixed, whilst a hydraulic piston applies a gradual upward load until the 
sample breaks apart (Fig. 2.1).
181
  
     
                                       (a)                                             (b) 
Fig. 2.1: (a) LLOYD Instruments LRX tensile testing machine and (b) set-up of 
clamping system. 
 
There are a number of mechanical testing protocols such as tensile, compression and 
shear. Tensile stress measurements provide information on the resistance of a 
material to stretching forces, whereas compression stress measurements indicate the 
resistance of a material to ‘squashing’ forces. Shear stress measures the resistance to 
‘push and pull’ forces.182  
Tensile testing gives an insight into the tensile strength, stress-strain behaviour and 
Young’s modulus of the material being tested. The tensile strength is the force that a 
material can be subjected to before failure. The degree by which a material will 
Clamp with 
gradual 
upward load 
applied 
Test specimen 
Fixed clamp 
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strain depends on the stress being imposed, and this stress (σ) is defined as the load 
(F) per unit area (A): 
182,183
 
σ = F / A  (Pascal, Pa) 
The strain (ε) is the amount of deformation per unit length of the material as a 
function of the load being applied: 
ε = ∆L / Lo 
where ∆L is the amount of elongation (mm2) and Lo is the original length (mm
2
). 
The Young’s modulus, or the modulus of elasticity (E), is calculated as the slope of a 
linear stress vs strain graph. In the linear region, the line obeys Hooke’s law, where 
the ratio of stress to strain is a constant: 
E = σ / ε    (Pascal, Pa) 
The modulus of elasticity refers to the stiffness of a material but only in the linear 
region. If the load is removed within this region the specimen will return to its 
original condition. However, if the load remains, the curve is no longer linear and so 
Hooke’s law does not apply.183 
 
2.2.2 Differential Scanning Calorimetry 
Differential scanning calorimetry (DSC) is a thermoanalytical technique which 
measures a physical property of a material as a function of temperature.
182
 The 
process involves measuring the energy needed to maintain an almost zero 
temperature difference between a sample and an inert reference material in an 
assembly where the two materials are subjected to the same heating conditions 
(Fig.2.2).
184
 The sample holder is commonly an aluminium pan, and the reference 
material is either an empty pan or a pan containing an inert material such as 
anhydrous alumina.
181
 A constant flow of nitrogen gas is maintained over the 
samples to create a reproducible and dry atmosphere, and it also eliminates air 
oxidation of the samples from occurring at high temperatures. 
185
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Fig. 2.2: Schematic representation of a DSC assembly.
186
 
 
The DSC profile for a typical polymer is shown in Fig. 2.3. The shift in baseline at 
the starting transient can be calculated as the heat capacity, Cp.
185
 After further 
heating the sample goes through a small endothermic event which is the glass 
transition, Tg. Above the glass transition phase, the polymer is more mobile and has 
gained enough energy to move into an ordered arrangement.
186
 This is the 
crystallisation phase and is observed as an exothermic event in the DSC profile. The 
crystallisation temperature, Tc, is the lowest point of this peak and the area of the 
peak is the latent energy of crystallisation of the material.
186
 Further heating results 
in another phase transition, melting. Upon melting, the crystals begin to move more 
freely and lose their ordered arrangement. This is observed as an endothermic event. 
The melting temperature, Tm, is the highest point of the peak and the area of the peak 
is the latent heat of melting.
186
   
 
Fig. 2.3: DSC profile for a typical polymer sample.
185
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2.2.3
 
Proteomics 
Proteomics is the study of the proteome which is described as the set of proteins 
encoded by the genome.
187
 As 1-dimensional electrophoresis separates proteins on 
the basis of molecular weight, 2-dimensional electrophoresis is used in proteomic 
analysis as it provides comprehensive resolution of complex protein mixtures.  
Proteins carry positive, negative or zero net charges depending on the pH of the 
solution.
188
 Each protein has a specific isoelectric point (pI) where the net charge is 
zero, and it is this property which is exploited for first dimension isoelectric focusing 
(IEF) which separates proteins based on their pI.
189
 This is achieved by introducing 
the immobilised pH gradient (IPG) strip containing the protein to a pH gradient 
using carrier ampholytes and then applying an electric potential difference across the 
strip (Fig. 2.4). During electrophoresis, the net charge on the protein will determine 
which direction the protein will migrate; at a pH value below the pI the protein will 
migrate towards the cathode and at a pH value above its pI, it will travel towards the 
anode.
188
 Following IEF, strips must be equilibrated to ensure that the proteins are 
denatured, and this allows for efficient separation based on molecular weight.
190
 
Dithiothreitol (DTT) is used to reduce inter- and intra-disulphide bonds in proteins, 
whereas iodoacetamide (IAA) is used as an alkylating agent to prevent the 
reformation of these bonds by alkylating the sulphur atoms.
190
 Once the strips are 
equilibrated, they are ready for separation in the second dimension.  
 
Fig. 2.4: Isoelectric focusing experimental assembly. 
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Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) separates 
proteins based on their molecular weight and makes up the second dimension. 
Polyacrylamide gel is the main medium for protein electrophoresis and it can be cast 
in a multi-chamber gel casting unit (Fig. 2.5 (a)). The polyacrylamide gel is prepared 
using acrylamide, bisacrylamide and SDS with the polymerization reaction being 
aided by ammonium persulfate (APS) and N,N,N’,N’-tetramethylethylenediamine 
(TEMED). APS acts as a catalyst, TEMED is used to form the free radicals needed 
for polymerisation
191
 and bisacrylamide functions as a cross-linker in the gel.
190
 
TEMED accelerates the decomposition of persulphate molecules into sulphate free 
radicals, which in turn initiates the polymerisation.
191
 The IPG strip containing the 
isoelectrically focused proteins is then placed in contact with the SDS-PAGE gel, 
which is then covered with agarose sealing solution containing added bromophenol 
blue to act as a tracking dye. The electric current in the electrophoresis cell (Fig. 2.5 
(b)) is carried by the ions in the running buffer. Smaller molecular weight proteins 
migrate through the gel faster, with the larger molecular weight proteins remaining 
near the top of the gel. Gels are subsequently stained to visualise protein spots, 
excised and digested for mass spectrometry analysis. 
                        
(a)                                                           (b) 
Fig. 2.5: SDS-PAGE (a) multi-chamber gel casting unit and (b) electrophoresis 
apparatus. 
 
2.2.4 Electrochemistry 
A three-electrode electrochemical assembly was used (Fig. 2.6). The working 
electrode was a glassy carbon (GC) with a diameter of 2 mm, the auxiliary or counter 
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electrode was a platinum wire and the reference electrode was a saturated calomel 
electrode (SCE). The working electrode is the electrode at which the analyte is 
oxidised or reduced.
192
 The counter electrode provides a pathway for current to flow 
in the electrochemical cell without passing significant current through the reference 
electrode.
193
 Platinum is the most commonly used counter electrode due to its 
inertness and the speed at which most electrode reactions occur at its surface.
193
 The 
SCE works using the calomel redox couple and therefore contains chloride ions. To 
prevent the precipitation of AgCl, the SCE electrode was separated from the test 
solution and placed in a separate cell with filter paper as a salt-bridge circuit 
connection. The SCE is a half cell composed of mercurous chloride (Hg2Cl2, 
calomel) in contact with mercury metal. The half reaction is described by;
194
  
 
 
Fig. 2.6: Electrochemical cell assembly. 
 
All electrode reactions are conducted using a non-reactive supporting electrolyte.
192
 
The electrolyte, NaNO3, is a salt added in excess to the analyte solution and is the 
principal source of electrically conducting ionic species and has a concentration of at 
least 100 times that of the electroactive species.
195
 
Metal deposition involves a constant potential being applied to the GC working 
electrode causing the reduction of the Ag(I) ions in the sample and their deposition as 
Ag(0) on the GC electrode surface.
192
 The electrode is maintained at this potential for 
60 s, followed by an anodic stripping. In anodic stripping, the working electrode 
Auxiliary Electrode 
Working Electrode Electrolyte 
Reference 
Electrode 
Salt Bridge 
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behaves as a cathode during the deposition step and as an anode during the stripping 
step, where the analyte is being oxidised back to its original form (Ag(0) → Ag(I)).192 
Following deposition, the potential of the electrode is increased linearly to more 
positive values (to oxidise deposited Ag(0) back to Ag(I) ions), while the current in the 
cell is recorded as a function of time or potential.
192
 Linear sweep voltammetry (LSV) 
involves the sweeping of the electrode potential between the limits Ei and Et at a known 
sweep rate, v, before stopping the potential sweep.
196
 A typical LSV response curve can 
be seen in Fig. 2.7. The scan begins at a potential more positive of E
0' 
for the reduction, 
when only non-faradaic current flows.
197
 Once the electrode potential reaches E
0' 
the 
reduction begins
 
and current starts to flow.
197
 As the potential becomes more 
negative, analyte flux to the surface increases, resulting in a current increase.
197
 As 
the potential proceeds past E
0'
, the surface concentration drops almost to zero, mass 
transfer to the surface reaches a maximum and then declines once depletion sets in. 
This results in a peaked current-potential curve (Fig. 2.7).
197
  
 
                                    (a)                                              (b) 
Fig. 2.7: (a) Linear potential sweep or ramp starting at Ei  and (b) resulting i-E 
curve.
197
 
The oxidation/reduction of silver is a reversible 1e
-
 process, 
 
and so the Nernst equation can be used to derive the expression:
198
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E1/2 = E
0'
 + RT/nF ln C*Ag+ 
Where C*Ag+ is the Ag(I) ion concentration, E1/2 is the half-wave potential, R is the 
gas constant (8.314 J K−1 mol−1), T is temperature in K, n is the stoichiometric 
number of electrons involved in the process, F is the Faraday constant (96,485 C 
mol
-1
).  
Therefore, the half-wave reaction is expected to shift 60 mV with every ten-fold 
dilution of the Ag(I) ion.
198
 In the present experiments, at relatively high 
concentrations of Ag(I) ions the behaviour followed this prediction. However, at 
lower Ag(I) ion concentrations, multiple-peaked curves were observed (Fig. 2.8). 
 
   
                                       (a)                                                    (b) 
Fig. 2.8: An example of multiple-peaked curves in Ag(I) ion analysis as found by (a) 
Perone et al
198
 and (b) in the present study.  
 
2.2.4.1 Experimental set-up 
Cyclic voltammetry was performed on a standard silver nitrate solution (4.5 x 10
-4
 
M) with the potential swept between 0.06 and -0.10 V, at a scan rate of 0.02 V/s. A 
reduction potential of 0.04 V was chosen for all silver deposition experiments. Silver 
was stripped from the electrode surface using linear sweep voltammetry (LSV), 
swept over the potential range of 0.2 to 1.0 V. A constant potential of 0.9 V was 
applied to ensure that all the silver was removed from the electrode and returned to 
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the solution. The electrode was removed, washed with deionised water and then 
polished with 0.05 µm alumina paste before the next measurement was recorded. 
 
Calculation of Ag(I) concentration 
1) Using peak height  
Ip: 1.5190 x 10
-7
 
Divide by deposition time (60 s): 2.5317x 10
-9
 
Divide by slope (2.6899e-3): 9.4116 x 10
-7
 [Ag
+
/M] 
 
2) Using charge  
Have to calculate charge first: Integrate the area under the curve using 
chi760c program (dataproc, integration), use cursor to find values on the right 
and left of curve and subtract these values from each other (left from right). 
Left: 9.440 x 10
-8
, Right: 1.1940 x 10
-6
, Charge: 1.0966 x 10
-6
 
Divide by deposition time (60 s): 1.827 x 10
-8
 
Divide by slope (5.6780 x 10
-3
): 3.2187 x 10
-6
 [Ag
+
/M] 
 
2.2.5 Atomic absorption 
Pre-weighed Ag(I)-Bioglue samples were ashed in a ceramic crucible over a Bunsen 
burner and the residue dissolved in aqueous nitric acid (20 mls, 50% (v/v)). The acid 
solutions of the samples were gravity filtered once the solution had cooled. The 
filtrates were placed in a 250 cm
3
 volumetric flask and made up to the mark using 
distilled water. From this stock solution, a 1 in 25 dilution was carried out and the 
Ag
+1
 content measured against a standard curve using known concentrations of 
AgNO3.  
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Calculation of Ag(I) content 
Weight of sample: 50 mg       Absorbance: 0.088 mg/L 
50mg in 250 ml of water: 50 / 0.25 = 200 mg/L 
 Divide by second dilution factor: 200 / 25 = 8 mg/L (theoretical conc. of sample) 
% Ag(I): actual/theoretical * 100 
Therefore: 0.088/8.00 * 100 = 1.1% 
 
2.3 Chemicals, Yeast and Bacterial Strains 
 
Starting material chemicals and assay kits were obtained from the commercial 
suppliers listed below. These chemicals were used without further purification. 
Table 2.1: Commercial suppliers  
Chemical Supplier 
Agarose Melford labs, Ltd. Ipswich, England 
Alumina paste 
Logitech Ltd., Erskine Ferry Rd., Old Kilpatrick, 
Glasgow, G60 5EU, Scotland. 
Bacteriological peptone Difco Labs. Le Pont de Claix, France 
Bovine serum albumin Sigma-Aldrich Chemical Company, St. Louis, USA 
Bradford reagent Bio-Rad, Munich, Germany 
CHAPS Sigma-Aldrich Chemical Company, St. Louis, USA 
Deoxyribonuclease I (AMP-
D1) kit 
Invitrogen, CA, USA 
Dithiothreitol (DTT) Sigma-Aldrich Chemical Company, St. Louis, USA 
D-Glucose Sigma-Aldrich Chemical Company, St. Louis, USA 
Glass vials 
Agilent Technologies UK Limited, Lakeside, 
Cheadle Royal Business Park, Stockport, Cheshire 
SK8 3GR 
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Glutaraldehyde Sigma-Aldrich Chemical Company, St. Louis, USA 
Immobiline™ DryStrip GE Healthcare Bio-Sciences AB, Uppsala, Sweden 
IPG buffer pH 3-10 GE Healthcare Bio-Sciences AB, Uppsala, Sweden 
Nutrient agar Oxoid Ltd., Basingstoke, Hampshire, England 
Nutrient broth Oxoid Ltd., Basingstoke, Hampshire, England 
RNA protect bacteria reagent 
Qiagen, Fleming way, Crawley, West Sussex, RH10       
9NQ 
RNeasy Minikit 
Qiagen, Fleming way, Crawley, West Sussex, RH10       
9NQ 
Silver nitrate (99.0%) Sigma-Aldrich Chemical Company, St. Louis, USA 
Silver nitrate (99.9999%) Sigma-Aldrich Chemical Company, St. Louis, USA 
Spin filters Corning Incorporated, Corning, NY, 14831 
Superoxide Dismutase Assay 
kit 
Sigma-Aldrich Chemical Company, St. Louis, USA 
Superscript III First-Strand 
Synthesis System 
Invitrogen, CA, USA 
3,6,9-Trioxaundecanedioic 
acid 
Sigma-Aldrich Chemical Company, St. Louis, USA 
Thiourea Sigma-Aldrich Chemical Company, St. Louis, USA 
Triton-X 100 Sigma-Aldrich Chemical Company, St. Louis, USA 
Trypsin Promega, Madison, WI, USA 
Urea Sigma-Aldrich Chemical Company, St. Louis, USA 
Yeast extract Oxoid Ltd., Basingstoke, Hampshire, England 
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The yeast and bacterial strains used in this study are shown in Table 2.2. 
Table 2.2: Microbial strains used in this study.  
Microbial Strain Origin Reference 
Candida albicans 
10231 
American Type Culture Collection 
(ATCC), 
Marassas, VA, USA 
ATCC 
Pseudomonas aeruginosa 
10145 
American Type Culture Collection 
(ATCC), 
Marassas, VA, USA 
ATCC 
Pseudomonas aeruginosa 
27853 
American Type Culture Collection 
(ATCC), 
Marassas, VA, USA 
ATCC 
Escherichia coli 
Gastro-intestinal tract infection, 
St. James’s Hospital, Dublin 
Clinical 
Isolate 
Staphylococcus aureus 
Urinary tract infection, 
St. James’s Hospital, Dublin 
Clinical 
Isolate 
Methicillin-resistant 
Staphylococcus aureus 
(M.R.S.A.) 
American Type Culture Collection 
(ATCC), 
Marassas, VA, USA 
ATCC 
 
 
 
 
 
 
 
 
Experimental                                                                                                                             Chapter 2 
67 
 
2.4 Buffers 
Lambert’s breaks buffer  
 KCl                                                     10.0 mM 
 NaCl                 3.0 mM 
 MgCl2                 4.0 mM 
 PIPES                                                 10.0 mM 
 
Glutathione Assay Buffer 
 EDTA                                                 1.0 mM 
 K2HPO4                                              100.0 mM 
 pH 7.5                                             
 
Ninhydrin Solution 
 Ninhydrin                                           0.37 g  
 Ethanol                                               100 mls 
 
Iso-Electric Focusing (IEF) Buffer  
 Urea                                                    8.0 M           
 Triton-X 100                                      1% (v/v) 
 CHAPS                                               4% (w/v) 
 Tris-HCl                                             10.0 mM 
 Thiourea                                              2.0 M 
 Dithiothreitol (DTT)                           65.0 mM 
 IPG buffer pH 3-10                            0.8% (v/v) 
 
Reducing Buffer for Equilibration 
 Glycerol                                              30% (v/v) 
 SDS                                                     2% (w/v) 
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 Urea                                                    6.0 M (w/v) 
 Tris HCl                                              50.0 mM (w/v)                                               
 Dithiothreitol (DTT)                          2% 
 pH 6.8 
 
Alkylation buffer for Equilibration 
 Glycerol                                              30% (v/v) 
 SDS                                                     2% (w/v) 
 Urea                                                    6.0 M (w/v) 
 Tris HCl                                              50.0 mM (w/v)                                               
 Iodoacetamide (IAA)                          2.5% 
 pH 6.8 
 
Solutions and buffers used in 1- and 2- dimensional electrophoresis are listed below. 
Stacking Gel Buffer 
 Tris-HCl                                              0.5 M 
  pH 6.8 
 
Separating Gel Buffer 
 Tris-HCl                                             1.5 M 
 pH 8.8 
 
10X Running Buffer 
 Tris-HCl                                             20 mM 
 Glycine                                               200 mM 
 SDS                                                    0.1% (w/v) 
Running buffer was diluted to 1X prior to running gels. pH 8.9 
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Ammonium Persulphate (APS) 
 APS                                                    10% (w/v) in distilled water 
 
Sodium Dodecyl Sulphate (SDS) 
 SDS                                                    10% (w/v) in distilled water 
 
Sample Buffer (10X) 
 0.5M Tris-HCl                                    1 ml, pH 6.8 
 Glycerol                                              1.6 ml 
 10% SDS                                            1.6 ml 
 β-Mercaptoethanol                             0.4 ml 
 0.5% (w/v) Bromophenol Blue          0.4 ml 
 Distilled H2O                                      3 ml 
 
Coomassie Staining Solution 
 Brilliant Blue                                      0.2% (w/v) 
 Methanol                                            45%  (v/v)                            
 Acetic Acid                                        10% (v/v) 
 Distilled H2O                                      44.8 % (v/v) 
 
Destain Solution 
 Acetic Acid                                         10% (v/v) 
 Methanol                                             20% (v/v) 
 Distilled H2O                                      70% (v/v) 
 
 
Colloidal Fixing Solution 
 Ethanol                                                50% (v/v) 
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 Phosphoric Acid                                 3% (v/v) 
 Distilled H2O                                      47% (v/v) 
 
Colloidal Coomassie Staining Solution 
 Methanol                                             34% (v/v) 
 Phosphoric Acid                                 3% (v/v) 
 Ammonium Sulphate                         17% (w/v) 
 Serva Blue                                          ≈ 0.4 g 
 Distilled H2O                                      46% (v/v) 
 
2.5% Polyacrylamide Stacking Gel 
 Distilled H2O                                      3.4  ml 
 Acrylamide                                         0.83 ml 
 0.5M Tris-HCl                                    0.63 ml 
 10% (w/v) SDS                                   0.05 ml 
 10% (w/v) APS                                   0.05 ml 
 TEMED                                              0.005 ml 
 
12.5% Polyacrylamide Separating Gel 
 1.5M Tris-HCl                                    3 ml 
 Distilled H2O                                      3.8 ml 
 Acrylamide                                         5 ml 
 10% (w/v) SDS                                   0.12 ml 
 10% (w/v) APS                                   0.075 ml 
 TEMED                                              0.003 ml 
 
Agarose Sealing Solution 
 Agarose                                              1% (w/v) 
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 Bromophenol Blue                             0.5 % (w/v) 
 1X Running Buffer                            100 ml 
 
Y1 buffer 
 Sorbitol                                          1 M 
 EDTA                                            0.1 M (pH 7.4) 
 β-mercaptoethanol                          0.1% (v/v) 
 Zymolase                                        0.125 g/sample 
 
10X FA gel buffer 
 MOPS                                            200 mM 
 Sodium acetate                               50 mM 
 EDTA                                            10 mM,  pH 7 
A 1/10 dilution of this was made for 1X running buffer 
 
cNDA synthesis master mix 
 10X RT buffer                                 2 µl (supplied) 
 25 mM MgCl2                                 4 µl 
 0.1 M DTT                                      2µl 
 RNaseOUT                                     1 µl (supplied) 
 
 
 
Experimental                                                                                                                             Chapter 2 
72 
 
2.5 IR spectra of starting materials 
 
2.5.1 IR spectrum of bovine serum albumin (BSA) (KBr) 
 
 
 
 
2.5.2 IR spectrum of gluteraldehyde (GLA) (thin film between NaCl plates) 
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2.5.3 IR spectrum of 3,6,9-trioxaundecandioic acid (3,6,9-tddaH2) (thin film 
between NaCl plates) 
 
 
 
 
2.5.4 IR spectrum of AgNO3 (KBr) 
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2.6 UV-Vis Spectra of Starting Materials 
 
2.6.1 UV-Vis spectrum of bovine serum albumin (BSA) solution (1.5 x 10
-3
 M) 
 
 
 
2.6.2 UV-Vis spectrum of glutaraldehyde (GLA) solution (1.1 M) 
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2.6.3 UV-Vis spectrum of AgNO3 (0.05 M) 
 
 
 
 
2.6.4 UV-Vis spectrum of sodium borohydride (NaBH4) (0.01 M) 
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2.6.5 UV-Vis spectrum of sodium citrate (0.04 M) 
 
 
 
All reactions involving Ag(I) ions were conducted in the dark. All Ag(I)-containing 
samples were stored in the absence of light. 
2.7 Synthesis of Silver(I) Complex of 3,6,9-Trioxaundecanedioic 
Acid (3,6,9-tddaH2) 
2.7.1 Determination of the concentration of the supplied solution of 3,6,9-
trioxaundecanedioic acid (3,6,9-tddaH2) using standardised NaOH 
Sodium hydroxide (2.00 g, 50.00 mmoles) was weighed out accurately and dissolved 
in distilled water (100.0 mls). This solution was transferred to a 500 ml volumetric 
flask and made up to the mark. Oxalic acid (COOH)2  (2.25 g, 25.00 mmoles) was 
weighed out accurately and dissolved in distilled water (100.0 mls). This solution 
was transferred to a 250 ml volumetric flask and made up to the mark to give a 
standard solution of oxalic acid. This standard (COOH)2 solution was titrated against 
the NaOH solution using phenolphthalein indicator. The titration was carried out 
three times in order to obtain reproducible results and establish the concentration of 
the NaOH solution (0.098 M). The NaOH solution was then titrated against the 
supplied 3,6,9-trioxaundecanedioic acid solution (2.00 g, 9.00 mmoles) using 
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phenolphthalein as the indicator. Again, three titrations were carried out to obtain 
reproducible results and to establish the concentration of the 3,6,9-tddaH2 solution 
(0.08 M).  
 
2.7.2 Synthesis of [Ag2(3,6,9-tdda)].2H2O using a known concentration of 3,6,9-
tddaH2, NaOH and AgNO3 
Using the values calculated from the titrations in Section 2.4.1, 3,6,9-tddaH2 (1.48 g, 
6.66 mmoles) was added to ice-cold H2O (10.0 mls). NaOH (0.098 M) and AgNO3 
(2.00 g, 11.77 mmoles) along with 3,6,9-tddaH2, were added to a conical flask on ice 
and left stirring in the dark for 4 h. This suspension was filtered using a glass frit and 
the brown solid was washed with ice-cold water, ethanol and ether. The solid was 
dried under high vacuum and stored in the absence of light.  
Yield: 1.04 g (36.4%) 
 
2.7.3 Synthesis of silver(I) complex [Ag2(3,6,9-tdda)].2H2O from the potassium 
salt K2(3,6,9-tdda) and AgNO3 
Potassium hydroxide (0.90 g, 16.04 mmoles) was weighed out accurately and 
dissolved in distilled water (10.0 mls) and the solution was then cooled on ice. 3,6,9-
TddaH2 (1.20 g, 5.41 mmoles) was made up to 10.0 mls and stirred on ice. To this 
stirred solution, the aqueous KOH solution was added until pH=7 (monitored using a 
pH meter). The solution was transferred to a 25 ml volumetric flask and made up to 
the mark using distilled water to give a stock solution of K2(3,6,9-tdda) (1.6 M). The 
stock solution of K2(3,6,9-tdda) (3.0 mls, 0.2 M) was transferred to a conical flask 
containing distilled water (20.0 mls). To this stirred solution, a solution of AgNO3 
(0.15 g, 0.88 mmoles) in distilled water (2.0 mls) was added drop-wise. The solution 
was allowed to stir in the dark for 4 h. Acetone (50.0 mls) was added and the mixture 
allowed to stir for a further 1 h. The resulting suspension was filtered using a glass 
frit and the pinkish-white solid was washed with ice-cold water, acetone and ether. 
The solid was dried under high vacuum and stored in the absence of light. 
Yield: 0.139 g (72.8%) 
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[Ag2(3,6,9-tdda)].2H2O Calc. Molecular Weight: 471.95 g mol
-1
 
Mass Spectrometry Found: (245.06, 3,6,9-tddaH2 + Na
+
), (434.87, 436.87, 438.87 
[Ag2(3,6,9-tdda)]
+
)
 
g mol
-1
 (see Appendix I) 
Anal. Calc.: H, 2.56; C, 20.36; Ag, 45.71% (C8H16O10Ag2) 
Anal. Found: H, 2.50; C, 20.34; Ag, 45.48% 
Solubility: soluble in hot H2O and hot DMSO 
IR (KBr):  3425 (O-H), 2896 (C-H), 1614 asym (O-C-O), 1406 sym (O-C-O), 1116 (C-
O-C) cm
-1
 
1
H NMR (D2O, ppm): 3.81 (s, 4H), 3.56 (s, 8H) 
 
IR (KBr): [Ag2(3,6,9-tdda)].2H2O 
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1
H NMR (D2O, ppm): 3,6,9-tddaH2 
 
 
 
   
1
H NMR (D2O, ppm): [Ag2(3,6,9-tdda)].2H2O 
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2.8 Synthesis of Bioglue 
2.8.1 Preparation of bovine serum albumin/glutaraldehyde Bioglue  
Bovine serum albumin (BSA) (0.50 g, 7.46 x 10
-3
 mmoles) was added to distilled 
water (2.0 mls) and the mixture vortexed until all the solid had dissolved. A stock 
solution of glutaraldehyde (GLA) (0.11 g, 1.09 mmoles) was prepared in distilled 
water (1 ml). The GLA solution (0.25 mls) was slowly added by a 1 ml pipette to the 
BSA solution. The mixture was vortexed briefly and after approximately 2 min the 
golden-coloured, gel-like Bioglue formed. The sample was dried under high vacuum 
to a constant weight. 
Yield: 0.49 g 
IR (KBr): 3435 (N-H, O-H), 2862 (C-H), 1647 (C=O), 1534 (N-H), 1446 (C-H) cm
-1 
IR (KBr): Bovine Serum Albumin/Glutaraldehyde Bioglue 
     
 
 
2.9 Synthesis of Ag(I)-Containing Bioglues 
2.9.1 Preparation of bovine serum albumin/glutaraldehyde Bioglue 
encapsulating various amounts of added AgNO3   
The general procedure for the preparation of a Bioglue encapsulating AgNO3 (0.10 
g) is outlined below. 
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 BSA (0.50 g, 7.46 x 10
-3
 mmoles) was added to distilled water (1.0 ml) and 
vortexed until the solid had dissolved. A stock solution of GLA (0.11 g, 1.09 
mmoles) was prepared in distilled water (1.0 ml). Silver nitrate (1.00 g, 5.89 
mmoles) was dissolved in water (10.0 mls). Solutions of GLA (0.25 mls) and 
AgNO3 (1.0 ml) were mixed in a test-tube and then added slowly to the BSA 
solution. The mixture was vortexed briefly. The gel-like Bioglue did not form. The 
mixture was originally white in colour turning orange as the reaction progressed. The 
sample was dried under high vacuum to a constant weight and stored in the absence 
of light. 
Yield: 0.57 g 
Ag(I)-Bioglues containing varying weights of added AgNO3 (0.01-0.0001 g) were 
prepared using the same method. These preparations resulted in the formation of an 
orange to golden-coloured gel with a sticky consistency. 
IR (KBr): 3408 (N-H, O-H), 2875 (C-H), 1656 (C=O), 1536 (N-H), 1439 (C-H), cm
-1
 
 
IR (KBr): Bovine Serum Albumin/Glutaraldehyde Bioglue Encapsulating AgNO3 
(0.10 g) 
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2.9.2 Preparation of bovine serum albumin/glutaraldehyde Bioglue 
encapsulating various amounts of the disilver(I) salt of 3,6,9-
trioxaundecanedioic acid [Ag2(3,6,9-tdda)].2H2O 
The general procedure for the preparation of a Bioglue encapsulating [Ag2(3,6,9-
tdda)].2H2O (0.010 g) is outlined below. 
 BSA (0.50 g, 7.46 x 10
-3
 mmoles) was added to distilled water (1.0 ml) and 
vortexed until the solid was dissolved. A stock solution of GLA (0.11 g, 1.09 
mmoles) was prepared in distilled water (1.0 ml). A stock solution [Ag2(3,6,9-
tdda)].2H2O  (0.10 g,  0.21
 
mmoles) was dissolved in water (10.0 mls) with heat. 
Solutions of GLA (0.25 mls) and [Ag2(3,6,9-tdda)].2H2O (1.0 ml) were mixed in a 
test-tube and were slowly added to the BSA solution. The mixture was vortexed 
briefly and after approximately 2 min the gel-like Bioglue formed. The sample was 
dried under high vacuum to a constant weight and was stored in the absence of light. 
Yield: 0.51 g 
Ag(I)-Bioglues containing varying weights of added [Ag2(3,6,9-tdda)].2H2O (0.001-
0.00001 g) were prepared using the same method. These preparations resulted in the 
formation of an orange to golden-coloured gel with a sticky consistency. 
IR (KBr):  3415 (N-H, O-H), 2867 (C-H), 1652 (C=O), 1539 (N-H), 1443 (C-H) cm
-1 
 
IR (KBr): Bovine Serum Albumin/Glutaraldehyde Bioglue Encapsulating 
[Ag2(3,6,9-tdda)].2H2O (0.01 g). 
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2.10 Bioglue Swelling Studies 
A similar procedure to that used by Butler et al,
199
 who prepared a gel (already 
hydrated to some extent), and after allowing to stand for 16 h, then proceeded to 
conduct swelling measurements by placing pre-hydrated gels in either aqueous acid 
or aqueous base (pH range 1-12) and measuring the swelling ratio (r). It should be 
noted that their swelling measurements were not conducted starting from a pre-
hydrated polymer sample.
199
 In the current experiments, a freshly made, partially 
hydrated Bioglue was used as a starting point for the swelling studies. Each Bioglue 
sample was made in triplicate (Section 2.8.1, 2.9.1 and 2.9.2) and allowed to stand 
overnight. Before proceeding with the swelling measurements, the initial weight of 
the sample was recorded. Each sample was placed in a beaker containing water (25 
mls) and the beaker was then placed into a water bath to maintain a constant 
temperature (25 °C). At each time point, the Bioglue sample was removed from the 
beaker, pat dried using filter paper and weighed before being returned to the beaker. 
Every 3 h the water volume was restored to 25 mls. This process was repeated until 
an equilibrium mass was achieved. The swelling ratio (r), was determined using the 
following equation:
199
 
r = (mf-mi/mi) × 100% 
where mf is the final mass and mi is the initial mass. 
 
2.11 Synthesis of Ag(0) Nanoparticles 
2.11.1 Reduction of Bioglue samples with and without added AgNO3 using 
sodium borohydride 
NaBH4 (0.95 g, 25.01 mmoles) was weighed out and made up to 250 mls with 
deionised water in a clean, dry volumetric flask to give a 0.1 M solution. The flask 
was inverted with caution due to the production of H2. A 1:10 dilution of this 
solution was made to give a 0.01 M solution. A further 1 in 10 dilution was made to 
yield a 0.001 M solution of NaBH4. The three separate NaBH4 solutions (45 mls) 
were each poured into a falcon tube. The Bioglue samples, without Ag(I) ions 
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(Section 2.8.1) and with added AgNO3 (0.01 g) (Section 2.9.1), were prepared in 
triplicate and left for 1 h in the relevant NaBH4 reducing solution. The liquid was 
decanted off and the Bioglue samples were washed three times with deionised water.  
 
2.11.2 Reduction of Bioglue samples, with and without added AgNO3, using 
sodium citrate 
Bioglue samples, without Ag(I) ions (Section 2.8.1) and with added AgNO3 (0.01 g) 
(Section 2.9.1), were prepared in triplicate. The Bioglues were placed in beakers 
containing the relevant solvent (25 mls) and then treated under the following three 
different experimental conditions: i) water and exposed to light, ii) sodium citrate 
solution (1%, w/v) and light, and iii) sodium citrate solution (1%, w/v) only (stored 
in the dark). The samples were kept at 25 °C and left for 1 week.  
 
2.11.3 Reduction of Ag(I)
 
to Ag(0) using sodium citrate 
A procedure similar to that used by Liu et al
200
 was employed for the production of 
Ag(0) nanoparticles. AgNO3 (0.031 g, 0.185 mmoles) was added to deionised water 
(175 ml) and the resulting solution was heated to 100 °C. To this hot, stirred solution 
was added, drop-wise, an aqueous solution of sodium citrate (4 mls, 1% w/v) and the 
mixture allowed to stir for 35 min. After cooling to room temperature, deionised 
water (200 mls) was added to yield a suspension of 10
-4
 g/ml Ag(0) nanoparticles. 
The yellow/green suspension was preserved in the dark at 4 °C.  
UV-Vis of suspension ( λmax): 424 nm 
 
2.11.4 Interaction of Bioglue (without Ag(I) ions) with an Ag(0) nanoparticle 
suspension 
The Bioglue samples, without Ag(I) ions (Section 2.8.1), were prepared in triplicate 
and were placed in beakers containing a diluted Ag(0) nanoparticle suspension 
(Section 2.11.3) (66 mls made up to 100 mls with deionised water) and left to stand 
for 120 h in the dark. A control experiment was conducted by placing the Bioglue 
Experimental                                                                                                                             Chapter 2 
85 
 
samples in deionised water only (100 mls) and leaving to stand for 120 h. The UV-
Visible spectra of the Ag(0) nanoparticle suspension and deionised water were 
recorded initially, every hour up to 12 h and then every 24 h until the end of the 
experiment.  
 
2.12 UV-Vis Studies of Bioglue Supernatant 
Each Bioglue sample (with and without Ag(I) ions) was placed in a falcon tube 
containing deionised water (45 mls) and left to stand for 1 week. The supernatant 
was centrifuged at 78 x g for 30 min and the UV-Visible absorption was recorded to 
determine if Ag(0) nanoparticles were present. Deionised water was used as a blank.  
 
2.13 Fungal and Bacterial Growth Media 
2.13.1 Media for culturing yeast 
Yeast Extract Peptone Dextrose (YEPD) 
YEPD media was prepared using yeast extract (2% (w/v)), bacteriological peptone 
(2% (w/v)) and D-glucose (1% (w/v)) in distilled water, and the mixture was 
autoclaved and stored at 4 ˚C until further use.  
To make YEPD agar plates, agar (2% (w/v)) was added to the medium, autoclaved 
and poured into sterile petri dishes and stored at 4 ˚C until further use.  
 
2.13.2 Media for culturing bacteria 
Nutrient Broth 
Nutrient broth (13 g/L) was prepared in distilled water and autoclaved prior to use. 
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Nutrient Agar 
Nutrient agar (28 g/L) was prepared in distilled water, autoclaved, poured into sterile 
petri dishes and stored at 4 ˚C for further use.  
 
2.14 Fungal and Bacterial Culture Conditions 
2.14.1 Fungal culture conditions 
All parent yeast stocks were kept in a sterile mixture of 50% (v/v) glycerol and 50% 
YEPD media (v/v) at -70 ˚C for long-term storage. Yeast strains were grown on 
YEPD agar plates at 37 ˚C for 24 h and kept at 4 ˚C for short-term storage. Working 
stocks of the yeast were routinely sub-cultured onto fresh agar plates every 4-6 
weeks. For liquid culturing, yeast strains were cultured overnight in a fully aerated 
conical flask in an orbital shaker at 37 ˚C and 200 rpm using YEPD as the medium.  
 
2.14.2 Bacterial culture conditions 
All parent bacterial stocks were kept in a sterile mixture of 50% (v/v) glycerol and 
50% nutrient broth media (v/v) at -70 ˚C for long-term storage. Bacterial strains were 
grown on nutrient agar plates at 37 ˚C for 24 h and kept at 4 ˚C for short-term 
storage. Working stocks of the bacteria were routinely sub-cultured onto fresh agar 
plates every 4-6 weeks. For liquid culturing, bacterial strains were cultured overnight 
in a fully aerated conical flask in an orbital shaker at 37 ˚C and 200 rpm using 
nutrient broth as the medium.  
 
2.15 Determination of Fungal and Bacterial Cell Density 
2.15.1 Determination of fungal cell density 
Dilutions (1:20) of overnight yeast liquid cultures in YEPD medium were added to a 
haemocytometer (Neubauer) and cells were counted using a light microscope at a 
magnification of x 100. 
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2.15.2 Determination of bacterial cell density 
The OD600nm of an overnight bacterial culture was determined using a 
spectrophometer.  
 
2.16 Disk Diffusion Assay 
2.16.1 Anti-fungal disk diffusion assay 
Liquid cultures were grown in YEPD medium to the stationary phase (approximately 
1x10
8
 cells cm
-3
) overnight at 37 
o
C and in a shaking incubator at 200 rpm in YEPD 
medium. Cells were counted as described in Section 2.15.1. The culture was diluted 
in YEPD medium to yield a cell suspension that contained 1x10
6
 cells cm
-3
.  The 
culture (100 µl) was spread over a YEPD agar plate and placed in an incubator at 37 
˚C for 1 h. The solid test sample was placed on the plate, and the plates were then 
incubated for 24 h at 37 
o
C. The zones of inhibition were measured and 
photographically recorded. This was obtained by measuring the area of the sample 
and the area of the sample plus the zone of inhibition. The area of the sample was 
then subtracted from the area of the sample plus the zone of inhibition to give the 
area of the zone of inhibition (mm
2
). This procedure was repeated on three separate 
occasions. 
 
2.16.2 Anti-bacterial disk diffusion assay 
All bacterial strains were taken from nutrient agar plates and were cultured to the 
stationary phase (OD600nm of 2) overnight at 37 ˚C with shaking at 200 rpm in 
nutrient broth. The OD600nm of the overnight cultures was determined as described in 
Section 2.15.2. The culture was diluted with nutrient broth to yield a cell suspension 
with an OD600nm of 0.1. The culture (100 µl) was spread over a nutrient agar plate 
and placed in an incubator at 37 ˚C for 1 h. The solid test sample was placed onto the 
plate, which was then incubated for 24 h at 37 
o
C. The zones of inhibition were 
measured and photographically recorded as described in Section 2.16.1. This 
procedure was repeated on three separate occasions. 
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2.17 Anti-Fungal and Anti-Bacterial Susceptibility Testing 
2.17.1 Anti-fungal susceptibility testing 
Cultures were grown to the stationary phase (approximately 1x10
8
 cells cm
-3
) 
overnight at 37 
o
C and shaking at 200 rpm in YEPD medium. Cells were counted as 
described in Section 2.15.1. The culture was diluted in YEPD medium to yield a cell 
suspension that contained 5x10
6
 cells cm
-3
. To each well of a 96–well round-
bottomed plate, fresh YEPD medium (100 µl) was added. A stock suspension of 
compound (100 µl, 200 µg/ml) to be tested was prepared, added to each well 
(starting at the last column), and a serial dilution was carried out across the plate to 
the third column to give a concentration range of 0.195-100 µg/ml. Finally, yeast 
culture (100 µl, 5x106 cells cm-3) was added to each well apart from the first two 
columns. The plates were incubated at 30 ˚C overnight and the OD540nm of the plates 
was determined spectrophotometrically using a microplate reader. All micro-
dilutions were performed on three separate occasions and the results analysed using 
Excel ©.  
 
2.17.2 Anti-bacterial susceptibility testing 
Bacterial strains were taken from nutrient agar plates and were cultured to the 
stationary phase (OD600nm of 2) overnight at 37 ˚C with shaking at 200 rpm in 
nutrient broth. The OD600nm of the overnight cultures was determined as described in 
Section 2.15.2. The culture was diluted to yield a cell suspension with an OD600nm of 
0.1 in nutrient broth. To each well of a 96–well round-bottomed plate, fresh nutrient 
broth medium (100 µl) was added. A stock suspension of compound (100 µl, 200 
µg/ml) to be tested was prepared, added to each well (starting at the last column), 
and a serial dilution was carried out across the plate to the third column to give a 
concentration range of 0.195-100 µg/ml. Finally, bacterial culture (100 µl, OD600nm 
0.1) was added to each well apart from the first two columns. The plates were 
incubated at 37 ˚C overnight and the OD540nm of the plates was determined 
spectrophotometrically using a microplate reader. All micro-dilutions were 
performed on three separate occasions and the results analysed using Excel ©. 
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The MIC80 (Minimum Inhibitory Concentration) of any given compound was taken 
to signify the concentration of compound that would inhibit the growth of that 
microorganism by 80%.  
 
2.18 Whole Cell Protein Extraction  
 Liquid nutrient broth medium (100 ml) was inoculated with a loopful of bacterial 
culture, previously aseptically taken from a fresh culture plate, and grown to 
stationary phase (OD600nm ≈ 2). Silver nitrate (MIC80 3.0 µg/ml) was added and the 
cultures were grown for 1, 2 or 4 h. Cells were harvested by centrifugation for 10 
min at 1814 x g and the cell pellet was washed twice with sterile phosphate buffered 
saline (PBS). Cells were re-suspended in Lambert’s breaks buffer (2.0 mls). In 
addition, protease inhibitors, at a concentration of 10 µg/ml, were used (Leupeptin, 
Pepstatin A, Aprotinin and N-α-p-tosyl-L-lysine chloromethylketone hydrochloride 
(TLCK)). Two methods were employed to extract protein from S. aureus cells. 
 1) Cell suspensions were sonicated with two 10 sec blasts using a soniprobe 
sonicator to dislodge cell wall proteins. The suspension was then centrifuged at 239 
x g for 4 min at 4 ˚C and the supernatant retained. Protein concentration was 
determined using the Bradford reagent. 
2) Acid-washed glass beads (w/v) were added to the mixture and vortexed on ice for 
5 min. The suspension was then centrifuged for 5 min at 454 x g and the resulting 
supernatant was centrifuged at 239 x g for 4 min at 4 ˚C. Protein concentration in the 
supernatant was determined using the Bradford reagent. 
 
2.19 Enzymatic Assays 
2.19.1 Glutathione reductase (GLR) assay 
This assay is conducted as described by Foster and Hess
201
 and is based upon the 
reduction of glutathione (GSSG) by NADPH in the presence of glutathione reductase 
(GLR).  
Experimental                                                                                                                             Chapter 2 
90 
 
NADPH + H
+ + GSSG → NADP+ + 2GSH 
The reaction is monitored by a reduction in the absorption band for NADPH at 
λ=340 nm with the extinction co-efficient (ε) of 6.22 mM-1cm-1. After exposure of S. 
aureus cells to AgNO3 over given time periods the cells were then lysed (Section 
2.18) and centrifuged at 17,949 x g for 30 min at 4 ˚C. The supernatant was then 
used immediately after extraction. Into a 1 ml quartz cuvette was added oxidised 
glutathione (GSSG) (500 µl, 2.0 mM), glutathione assay buffer (400 µl), protein (50 
µl, 1 µg/µl) and NADPH (50 µl, 2.0 mM). The reference assay blank contained 
oxidised glutathione (GSSG) (500 µl, 2.0 mM), assay buffer (450 µl) and NADPH 
(50 µl, 2.0 mM). The contents of the cuvette was mixed by gentle inversion and the 
absorbance monitored at λ=340 nm. After each reading, the cuvette containing the 
protein was emptied and washed with molecular biology grade absolute ethanol and 
then with the assay buffer before a new protein sample was added. The GLR activity 
was calculated as follows: 
 
GLR Activity (units/ml) =     
 
 
2.19.2 Superoxide dismutase (SOD) assay 
SOD activity of S. aureus cells treated with AgNO3 was determined using the SOD 
Assay kit. The SOD activity was measured using the WST-1 tetrazolium salt, 2-(4-
iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulphphenyl)-2H-tetrazolium monosodium 
salt, which  produces a formazan dye upon reaction with a superoxide anion (O2
-.
) 
(Scheme 1).  
 
 
 
(Rate of change of sample-Rate of change of blank) 
    (6.22 mM
-1
cm
-1
 x Concentration of protein) 
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Scheme 1: Reaction scheme for the detection of SOD activity. 
 
Freshly extracted S. aureus protein (20 µl) was used for the determination of SOD 
activity which was carried out using the supplied buffers according to the 
manufacturer’s instructions (Table 2.3). The SOD activity was determined at λ=450 
nm using a microplate reader and the activity was calculated using the following 
equation: 
 
SOD Activity (inhibition rate %) = 
  
 
 
 
 
[(Ablank1 – Ablank3) – (Asample - Ablank2)]  X 100 
                     (Ablank1 – Ablank3) 
XO 
SOD 
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Table 2.3: Composition of sample, blank 1, blank 2 and blank 3 solutions. 
 Sample 
(µl) 
blank 1 
(µl) 
blank2 
(µl) 
blank 3 
(µl) 
Sample Solution 20   20   
H2O  20   20  
WST Working Solution 
(supplied) 
200  200  200  200  
Dilution Buffer (supplied)   20  20  
Enzyme Working Solution 
(supplied) 
20  20    
 
 
2.19.3 Catalase (CAT) assay 
Fresh protein extracts were prepared as described in Section 2.18. Protein extract 
(100 µl, 250 µg/ml) was added to H2O2 (1.8 ml, 17 mM) in a sterile tube. The 
mixture was mixed well by pipetting and left at room temperature for 15 min. After 
this time, the suspension was centrifuged at 10,000 x g for 1 min to stop the reaction. 
The supernatant was removed and placed in a clean quartz cuvette. The absorbance 
at λ=240 nm was obtained. A blank consisted of 17 mM H2O2. 
 
2.19.4 Amino acid leakage assay 
Amino acid leakage of AgNO3-treated S. aureus cells was determined using the 
ninhydrin calorimetric assay.
202
 Proteins contain free amino groups on the alpha-
carbon which can react with ninhydrin to produce a blue-purple product known as 
Ruhemann’s purple (Scheme 2).203 Amino acids that contain a secondary amino 
group can also react with ninhydrin but in this case, the product is yellow. 
Experimental                                                                                                                             Chapter 2 
93 
 
                             
 
Scheme 2: Reaction scheme to depict the detection of free amino groups using the 
ninhydrin calorimetric assay.
203
 
Overnight cultures of S. aureus (5 ml) were sub-cultured into fresh nutrient broth 
media and then grown to exponential phase (6 h). Cells were harvested by 
centrifugation (1814 x g, 5 min), washed twice in PBS and the pellet then  
resuspended in deionised H2O and either DMSO (10% (v/v), positive control) or 
AgNO3 (3 µg/ml, test compound) and incubated at 37 ˚C and 200 rpm for a further 1, 
2 or 4 h.  
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The amino acid concentration was determined by the ninhydrin calorimetric assay in 
which aspartic acid and glutamic acid were used as standards (Fig. 2.8). A ninhydrin 
solution (250 µl) was added to each sample (1.0 ml) and heated at 95 ˚C for 8 min. 
After the samples were allowed to cool, the absorbance at λ=570 nm was recorded. 
A standard curve was plotted of absorbance Vs concentration (µg/ml) of aspartic 
acid and glutamic acid. The concentration of the test sample was found using the 
equation of the line; y = mx + c. 
 
y = mx + c
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Fig. 2.8: Standard curve of amino acid concentration using aspartic acid and 
glutamic acid as references. 
 
2.20 RNA Extraction 
2.20.1 Preparation of RNase-free buffers and equipment 
All glassware was autoclaved twice prior to use so as to reduce RNase 
contamination. Diethyl pyrocarbonate (DEPC), at a concentration of 1% (v/v), was 
used to treat the water. The mixture was left to stir overnight and it was then 
incubated for a minimum of 4 h at 37 °C prior to sterilisation. This DEPC-treated 
Experimental                                                                                                                             Chapter 2 
95 
 
water was then used for the preparation of all buffers needed for the RNA extraction. 
All bottle lids, O-rings and magnetic stirrers were soaked in DEPC water overnight 
and autoclaved before use. All chemicals were weighed out without the use of a 
spatula. Gloves were worn at all times and changed frequently. Pipette tips were 
taken from freshly-opened bags and autoclaved twice before use.  
 
2.20.2 RNA extraction using the Qiagen RNeasy® minikit 
Cultures of S. aureus cells were grown overnight, sub-cultured (10 mls) in fresh 
nutrient broth media (50 mls) and grown to exponential phase at 37 °C for 3-4 h. 
AgNO3 (3.0 µg/ml) was added and incubated further for relevant timepoints. At each 
timepoint, cells were harvested by centrifugation at 1814 x g for 5 min. The 
supernatant was removed and cells were then resuspended in fresh Y1 buffer (1.5 
mls) and placed in an incubator (37 °C, 200 rpm) for 20 min to generate 
spheroplasts. The cell suspension was centrifuged at 300 x g for 5 min and the 
supernatant then carefully removed. Buffer RLT (350 µl, supplied) was added and 
the mixture then vortexed to lyse the spheroplasts. Ethanol (350 µl, 70% (v/v)) was 
added and the mixture inverted gently. The lysate was transferred to an RNeasy Mini 
spin column placed in a 2 ml collection tube (supplied) and centrifuged for 15 sec at 
8000 x g. The flow-through was discarded. Buffer RW1 (700µl, supplied) was added 
to the RNeasy spin column and the mixture centrifuged for 15 sec at 8000 x g to 
wash the spin column membrane. The RNeasy spin column was placed into a new 2 
ml collection tube and Buffer RPE (500 µl, supplied) was added. This was then 
centrifuged for 15 sec at 8000 x g to wash the spin column membrane. The flow-
through was discarded. Buffer RPE (500 µl, supplied) was added to the spin column, 
and centrifuged for 2 min at 8000 x g to wash the spin column membrane. The 
RNeasy spin column was placed in a new collection tube (1.5 ml, supplied) and 
RNase-free water (40 µl) was added and centrifuged for 1 min at 8000 x g to elute 
the RNA. This step was repeated with a further 20 µl of RNase-free water and the 
final solution was aliquoted and stored at -70 °C. Extracted RNA was quantified 
spectrophotometrically at 260/280 nm. 
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2.20.3 RNA extraction using Qiagen RNeasy® minikit with RNAprotect 
bacteria reagent 
Two volumes of RNAprotect bacteria reagent (1000 µl) was added to one volume of 
bacterial culture (500 µl) in an eppendorf tube (2 ml) and mixed by vortexing for 5 
sec and then incubated at room temperature for 5 min. The suspension was then 
centrifuged for 10 min at 5000 x g. The supernatant was discarded and the pellet was 
resuspended in TE buffer (100 µl, supplied) containing lysozyme and Proteinase K 
(10-20 µl) and the mixture then vortexed for 10 sec. The solution was incubated at 
room temperature for 10 min, with vortexing every 2 min. RLT buffer (700 µl, 
supplied) was added to the solution and this was then vortexed vigorously for 5-10 
sec. The suspension was transferred to a safe-lock tube (2 ml) containing acid-
washed glass beads. The cells were disrupted by vortexing on ice for 5 min, followed 
by centrifugation for 10 min at a maximum speed of 20,000 x g. The supernatant was 
transferred into a new tube and ethanol (590 µl, 80%) was added. The mixture was 
agitated well by pipetting. The lysate was transferred to an RNeasy Mini spin 
column placed in a collection tube (2 ml, supplied) and then centrifuged for 15 sec at 
8000 x g. The flow-through was discarded. Buffer RW1 (700µl, supplied) was added 
to the RNeasy spin column and the mixture centrifuged for 15 sec at 8000 x g in 
order to wash the spin column membrane. The RNeasy spin column was then placed 
into a new collection tube (2 ml) and Buffer RPE (500 µl, supplied) was added, 
followed by centrifugation for 15 sec at 8000 x g so as to wash the spin column 
membrane. The flow-through was discarded. Buffer RPE (500 µl, supplied) was 
added to the spin column and the mixture was centrifuged for 2 min at 8000 x g in 
order to wash the spin column membrane. The RNeasy spin column was placed in a 
new collection tube (1.5 ml, supplied) and RNase-free water (30 µl) was added and 
this was then centrifuged for 1 min at 8000 x g to elute the RNA. This step was 
repeated with a further 20 µl of RNase-free water and the final suspension was 
aliquoted and stored at -70 °C. Extracted RNA was quantified 
spectrophotometrically at 260/280 nm.  
 
Experimental                                                                                                                             Chapter 2 
97 
 
2.20.4 RNA extraction using TRI-reagent 
RNA was isolated from exponentially growing bacterial cells. Aliquots of stationary 
phase S. aureus cultures were grown to exponential phase at 37 °C for 4 h. Cells 
were treated with an MIC80 value of AgNO3 (3.0 µg/ml) for 1 h. RNA extractions 
were carried out after relevant timepoint. Cells were harvested by centrifugation at 
12,000 x g for 10 min at 4 °C. To the pellet, TRI-reagent (3.0 mls) and glass beads 
(0.5 g) were added. The mixture was vortexed vigorously and then incubated at room 
temperature for 15 min. The mixture was the distributed into sterile 1.5 ml tubes and 
centrifuged at 12,000 x g for 10 min at 4 °C. The pellets were discarded and 
chloroform (200 µl) was added to the supernatant. This mixture was vortexed 
vigorously and left to stand at room temperature for 10 min. It was subsequently 
centrifuged at 12,000 x g for 10 min at 4 °C in order to cause separation into two 
layers. The top layer was retained and to this 2-proponal (500 µl) was added. The 
tube was inverted several times and left to stand at room temperature for 10 min. The 
solution was centrifuged at 12,000 x g for 10 min at 4 °C. The supernatant was 
discarded. The pellet was washed with molecular grade ethanol (50 µl, 75% (v/v)) 
and the suspension then centrifuged at 7500 x g for 5 min at 4°C. The supernatant 
was removed, and the resulting pellet was allowed to air-dry before being 
resuspended in RNase-free water. The suspension was aliquoted and either stored at 
-70 °C or used immediately. Extracted RNA was quantified spectrophotometrically 
at 260/280 nm.  
 
2.20.5 DNase treatment of RNA 
In order to remove any contaminating DNA within the sample, DNase treatment was 
performed using a Deoxyribonuclease I (AMP-D1) kit.  Reaction buffer (10 X, 1 µl, 
provided) and DNase I (1 µl, 1 unit/µl) were added to RNA (4 µg) and the sample 
was incubated at room temperature for 15 min. The enzyme activity was stopped by 
adding stop solution (1 µl, 50 mM EDTA, provided). Samples were then heated to 
70 °C for 10 min and cooled on ice.  
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2.20.6 RNA electrophoresis 
Prior to use, the gel rig was washed with hydrogen peroxide (2% v/v), rinsed with 
DEPC water and allowed to air-dry. RNA was visualised by running the extraction 
products on an agarose gel (1% (w/v)). Once the gel was hand-hot, formaldehyde 
was added (1.8 µl, 37% (v/v)) along with ethidium bromide (1 µl, 10 mg/ml) before 
pouring the gel. Prior to running, the gel was equilibrated in 1X FA running buffer 
for at least 30 min. RNA (4 µl) was added to 6X loading dye (1 µl) and formamide 
(6 µl) and the mixture then heated to 60 °C for 10-15 min before loading into the 
wells of the gel. The gel was run at 6 V/cm in 1X FA buffer. The gel was visualised 
using Syngene Geneflash.  
 
2.20.7 cDNA synthesis  
cDNA was synthesised using the Superscript III First-Strand Synthesis System for 
RT-PCR kit. RNA concentration was determined, and all samples contained equal 
amounts of RNA prior to cDNA synthesis. RNA was added to an RNA- and DNA-
free tube and RNA-free water was added to bring the volume up to 8 µl. To this 
mixture, dNTP mix (1 µl, 10 mM, provided) and oligoDT’s (1 µl, 50 µM, provided) 
were added. The solution was incubated at 65 °C for 5 min and then placed on ice 
for at least 1 min. A master mix was prepared according to the number of reactions 
required and 9 µl of this mix was added to each of the RNA/primer mixes. The 
combination was mixed gently, incubated at 42 °C for 2 min and held on ice. 
Superscript III RT (1 µl, 200 U/µl, provided) was added to each reaction tube and 
the mixture incubated as follows: 42 °C for 50 min, 70 °C for 5 min, and the mixture 
was then held on ice. To each tube, RNaseH (1 µl, supplied) was added and this was 
further incubated at 37 °C for 20 min. cDNA was aliquoted and stored at -20 °C.  
 
2.20.8 Polymerase chain reaction (PCR) 
Primers were dissolved in molecular grade water to give a stock solution of 100 µM 
and this was subsequently diluted to give a 10 µM working solution. Each PCR 
reaction tube (20 µl volume) contained cDNA (1 µg/µl), 10 X LA buffer (2 µl), 
DMSO (0.4 µl, molecular grade), dNTP mix (1 µl, 10 mM, promega), water (14.6 
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µl, molecular grade), forward primer (0.4 µl) (Table 2.3), reverse primer (0.4 µl) 
(Table 2.3) and AccuTaq™ LA DNA polymerase (0.2 µl). Solutions were mixed by 
pipetting and then immediately placed in the thermal cycler.  
 
Table 2.3: Primers and RT-PCR cycle conditions. 
 
 
2.20.9 PCR product visualisation and quantification 
The PCR product (4 µl) was run on a 1% agarose gel as detailed in Section 2.20.6. 
 
2.20.10 Genomic DNA extraction 
Cultures (50 ml) were grown to stationary phase overnight and harvested by 
centrifugation for 5 min at 1814 x g. The supernatant was discarded and the pellet 
was washed twice with PBS followed by EDTA (10 mM, pH 8). The pellet was then 
kept on ice for the remainder of the protocol. The pellet was resuspended in 
spheroplasting buffer (4 ml) along with acid-washed glass beads (5 g) and then the 
mixture was vortexed on ice for 5 min. Cells were harvested by centrifugation at 
Gene Primer Sequence 5'-3' 
PCR Cycle 
Conditions 
DNA 
Gyrase
204
 
gyrA-F TGCTGAGTTAATGGAGGATATTG 95 °C 5 min, [95 °C 
30 sec, 50 °C 45 sec, 
68 °C 45 sec] x 35 
cycles, 68 °C 7 min. 
gyrA-R CACGTGTAATACCACTCTTACC 
Superoxide 
Dismutase 
A
205
 
SodA-F 
CATAACACTTATGTWACTAAATTA
AA 
95 °C 5 min, [95 °C 
1 min, 55 °C 1 min, 
68 °C 1 min] x 30 
cycles, 68 °C 10 min. 
SodA-R ATCTAAAGAACCCCATTGTTC 
Superoxide 
Dismutase 
M
206
 
SodM-F TTAATTCTCTTTAAAAGCGGGAAA 95 °C 5 min, [95 °C 
1 min, 62 °C 1 min, 
68 °C 1 min] x 30 
cycles, 68 °C 10 min. SodM-R 
GGGACATTCATCAACTTTTATCAG 
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2056 x g for 5 min at 4 °C. Cells were resuspended in lysing buffer (4 mls), SDS 
(10%) and proteinase K (100 µl, 30 µg/µl). This combination was mixed by pipetting 
and then incubated at 65 °C for 30 min. An equal volume (4 mls) of phenol-
chloroform-isoamyl alcohol mixture (25:24:1) was added and the mixture vortexed 
vigorously for 5 min on ice. The mixture was centrifuged at 17,400 x g for 15 min at 
4 °C. The upper layer was transferred to a new tube and an equivalent volume of 
chloroform-isoamyl alcohol (24:1) was added and subsequently mixed by inversion. 
The mixture was centrifuged as before. The upper layer was transferred to a new 
tube and washing repeated until no white interphase layer remained. Two volumes of 
ice-cold ethanol (95% (v/v)) was added and the sample precipitated overnight at –20 
°C. The sample was centrifuged as before. The recovered DNA pellet was washed 
with ice-cold ethanol (70% (v/v)). The ethanol was decanted off and the pellets 
allowed to air-dry. The pellets were resuspended in sterile water (4 mls) containing 
RNase (150 µl, 1 mg/µl) and then incubated at 37 °C for 30 min. Ice-cold ethanol (8 
mls, 95% (v/v)) and ammonium acetate solution (3 M, pH 5.2) was added and the 
mixture stored at -20 °C overnight. The mixture was centrifuged as before and the 
pellet allowed to air-dry. The sample was resuspended in sterile distilled water (200 
µl), aliquoted and stored at -20 °C. 
 
2.21 SDS-PAGE Gel Electrophoresis 
2.21.1 One-dimensional SDS-PAGE electrophoresis 
Protein extraction was carried out as outlined in Section 2.18. Protein was 
precipitated by adding three times the volume of ice-cold acetone and storing the 
suspension at -20 ˚C overnight. The precipitated protein was collected by 
centrifugation (17,949 x g for 30 min at 4 ˚C). The acetone was removed and the 
pellet allowed to air-dry. Pellets were resuspended in 5X sample buffer (1 in 2 
dilution of 10X sample buffer) and boiled for 2-3 min at 95 ˚C. Samples were loaded 
into the wells of a 12.5% separating gel with a 2.5% stacking gel, and immersed in 
1X running buffer. The gels were electrophoresed initially at 80 V followed by 120 
V once the protein had moved sufficiently through the gel. Protein bands were 
Experimental                                                                                                                             Chapter 2 
101 
 
revealed using either Coomassie or colloidal Coomassie staining solution, and 
destained using either destain or deionised water. 
 
2.21.2 Two-dimensional SDS-PAGE electrophoresis 
Protein extraction was carried out as outlined in Section 2.18. Protein was 
precipitated by adding three times the volume of ice-cold acetone and storing the 
suspensions at -20 ˚C overnight. The precipitated protein was collected by 
centrifugation (17,949 x g for 30 min at 4 ˚C). The acetone was removed and the 
pellet allowed to air-dry. Released proteins were resuspended in IEF buffer (250 µl) 
along with DTT (10 mmol), ampholytes (0.8%) and a few grains of molecular grade 
bromophenol blue.  The solution was applied to a 13 cm Immobiline™ DryStrip pH 
3-10, covered with pulse-1 cover fluid and iso-electric focusing was performed on an 
Ettan IPGphor II system using the following program: 
1. Step         100 V         2 h 
2. Step         500 V        1.5 h 
3. Step         1000V       1 h 
4. Step         2000 V      1 h 
5. Step         4000 V      1 h 
6. Step         6000 V      2 h 
7. Step         8000 V      3 h 
8. Step         500 V        4 h 
9. Step         8000 V      3 h 
Following iso-electric focusing, strips were equilibrated in reducing buffer for 10 
min followed by equilibration in alkylation buffer for 10 min. Strips were placed on 
top of homogenous 12.5% SDS-PAGE gels. SDS-PAGE standards, low range, were 
boiled for 5 min in 2X sample buffer and loaded near to the positive end of the strip. 
Strips were overlaid with hand-warm agarose sealing solution. The gels were 
electrophoresed at 6 °C using a cooling system for 20 h at 100 V or until the 
bromophenol indication layer was at the bottom of the gel. Gels were fixed using a 
colloidal fixing solution for a minimum of 3 h and then washed three times with 
Experimental                                                                                                                             Chapter 2 
102 
 
deionised water before staining with colloidal staining solution for a period of 
several days. Gels were washed with deionised water to destain.  
Protein was extracted on three separate occasions and gels were produced in 
triplicate per treatment and scanned on a HP Scanjet 5400C. 
 
2.22 LC/MS Mass Spectrometry 
The following procedures were adapted from the work of Shevchenko et al:
207
  
 
2.22.1 Destaining gel pieces 
Gels were washed twice in sterile water and protein spots of interest were removed 
and placed in sterile Eppendorf tubes containing a 1:1 (v/v) solution of ammonium 
bicarbonate (100.0 mM) : acetonitrile (100 µl) and incubated for 30 min with 
occasional vortexing. The liquid layer was removed and acetonitrile (500 µl) was 
added and left until the gel pieces became white and reduced in size. The liquid layer 
was again removed and the gel plugs were used in the next preparation step. 
 
2.22.2 In-gel digestion  
In-gel digestion was carried out using sequencing grade modified trypsin. A trypsin 
solution was prepared by adding ammonium bicarbonate (100 µl, 10 mM) containing 
acetonitrile (10% (v/v)) to the trypsin powder. This solution was aliquoted in 10 µl 
volumes into separate tubes. To one of these aliquots, ammonium bicarbonate (500 
µl, 50 mM) was added. Approximately 40 µl of this resulting solution was added to 
each gel plug and the tubes were held at 4 ˚C for a minimum of 30 min. Gel pieces 
were held at 37 ˚C overnight.  
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2.22.3 Extraction of peptide digestion products 
The trypsin solution was removed to another tube and extraction buffer (100 µl) was 
added to each tube and these were then incubated for 15 min at 37 ˚C in a shaker. 
This solution was removed and added to the tube containing the previously collected 
trypsin solution. The combined solutions were dried in a vacuum centrifuge 
overnight and stored at -20 ˚C. 
 
2.22.4 LC/MS mass spectrometry 
Dried peptides were resuspended in aqueous formic acid solution (20 µl, 0.1% (v/v)). 
The resuspended peptides were placed in a sonicator bath for 2 min and then 
centrifuged at 10,621 x g for 15 min at 4 ˚C. Samples were then centrifuged through 
spin filters for 2 min at 425 x g, transferred to sterile glass vials and analysed using 
BSA as external standards. The mass lists were generated using the search 
programme http://www.matrixscience.com and a Blast search was then carried out 
using the http://expasy.org/sprot/ search programme. 
 
2.23 Statistical analysis 
All experiments were performed on three separate occasions. Multiple comparisons 
of means were analysed using Fisher’s least significant different test using PROC 
GLM of the SAS 9.1 statistical model. Differences were deemed significant with p ≤ 
0.05.
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3.1 [Ag2(3,6,9-tdda)].2H2O 
[Ag2(3,6,9-tdda)].2H2O was synthesised using two different methods. The first, 
using a known concentration of 3,6,9-trioxaundecanedioic acid (3,6,9-tddaH2) and 
NaOH, gave a product yield of 36% and the second, using the potassium salt, 
K2(3,6,9-tdda), gave a yield of 73%. The complex was soluble in hot H2O and hot 
DMSO. 
The IR spectrum of 3,6,9-tddaH2 (Section 2.5.3) showed a broad O-H band (3444 
cm
-1
)
 
and a  characteristic C=O band for the carboxylic acid function (1736 cm
-1
). 
Upon formation of the silver salt, [Ag2(3,6,9-tdda)].2H2O, bands corresponding to 
asymmetric (ʋ(OCO)asym) and symmetric (ʋ(OCO)sym) stretches were observed (1612 cm
-
1
 and 1406 cm
-1
, respectively) (Section 2.7.3). The separation between these two 
bands (Δ(OCO) = 206 cm
-1
) suggests an ionic interaction between the tdda
2-
 anion and 
the metals (Fig. 3.1).
208
 
 
 
 
Fig. 3.1: Proposed structure for [Ag2(3,6,9-tdda)].2H2O 
 
The 
1
H NMR spectrum of [(Ag2(3,6,9-tdda)].2H2O (Section 2.7.3) contained two 
singlets at 3.81 and 3.56 ppm (integral ratio 1:2), corresponding to the methylene 
groups of the tdda
2-
 anion. The peak at 3.81 ppm corresponds to the CH2 moieties 
close to the carboxylate function, whilst the peak at 3.56 ppm for the CH2 moieties 
located between the ether oxygen atoms. As a consequence of the Ag(I) ions, these 
two peaks are shifted upfield compared to the free acid (4.13 and 3.65 ppm, 
respectively). 
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3.2 Characterisation of Bioglue Prepared in the Absence and in the 
Presence of Ag(I) Ions 
3.2.1 Infrared spectroscopy 
Bioglues (without added Ag(I) ions) were made by reacting BSA with GLA in a 4:1 
ratio. The IR spectrum of BSA (Section 2.5.1) shows an intense band at 3312 cm
-1
 
which arises from the O-H and N-H stretching vibrations and also hydrogen-bonding 
interactions.
209
 The IR spectrum of the supplied aqueous GLA (Section 2.5.2) shows 
a characteristic aldehyde band ʋ(C=O) (1715 cm
-1
) and, a broad band associated with 
the ʋ(O-H) vibration (3424 cm
-1
). Upon reacting GLA with BSA, the GLA aldehyde 
ʋ(C=O) band disappears (Section 2.8.1) suggesting that crosslinking had occurred. It 
was noted that the IR spectrum of Bioglue closely resembled that of BSA. 
Bioglues incorporating AgNO3 and [Ag2(3,6,9-tdda)].2H2O were synthesised in 
triplicate using BSA, GLA and varying amounts of either AgNO3 or [Ag2(3,6,9-
tdda)].2H2O. Again, the IR spectra of these Ag(I)-Bioglues were very similar in 
appearance to those of the BSA and Bioglue without added Ag(I). Ag(I) 
incorporation was further confirmed using atomic absorption spectroscopy (AAS) 
and Energy dispersive X-ray spectroscopy (EDX). 
Reproducible Ag(I)-Bioglue formulations were obtained based on IR, atomic 
absorption, differential scanning calorimetry, scanning electron microscopy, swelling 
and drying studies, tensile testing and leaching studies. The BSA/GLA combination 
containing the highest quantity of added AgNO3 (0.1 g) failed to produce a hydrogel 
(Fig. 3.2a), unlike the hydrogels formed using lower amounts of added Ag(I) ions 
(Fig. 3.2b-e). Thus, swelling studies were not carried out on the AgNO3 (0.1 g) 
sample. In addition, the product obtained using the highest amount of AgNO3 (0.1 g) 
failed to adhere to the wooden test pieces used to assess the glue-like properties of 
the Bioglues. The failure to form a hydrogel upon addition of AgNO3 (0.1 g) may be 
due to the over-loading of the sample with Ag(I) ions, resulting in a product that is 
so extensively crosslinked with metal ions that most of the sites available for 
hydrogen-bonding molecules were effectively blocked. 
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                                                         (a)                                                   (b)                                                   (c) 
                                              
                                                           (d)                                                (e)                                                    (f) 
Fig. 3.2: Images of Bioglues prepared using (a) no Ag(I) ions, varying amounts of added AgNO3: (b) 0.1 g, (c) 0.01 g, (d) 0.0001 g, [Ag2(3,6,9-
tdda)].2H2O (e) 0.01 g and (f) 0.00001 g. 
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3.2.2 Silver content 
AAS was carried out to determine homogeneity of Ag(I) ions in the Ag(I)-Bioglues. 
Each Ag(I)-Bioglue sample was synthesised on three separate occasions and three 
separate portions of each sample were then analysed for % silver content (a total of 
nine readings per sample). Ag(I)-Bioglue formulated using the highest amount of 
added AgNO3 (0.1 g) and the theoretical amount of silver content in this sample was 
10.05%. The Ag(I)-Bioglue formulated with the lowest amount of added AgNO3 
(0.0001 g) had a theoretical amount of silver of 0.01%. It was also found that the 
Ag(I)-Bioglue made with the highest quantity of added [Ag2(3,6,9-tdda)].2H2O (0.01 
g) had a theoretical silver content of 0.84%, whereas the lowest (0.00001 g) had an 
expected silver content of 8.6 x 10
-4
%. For AgNO3, the % Ag detected in the Ag(I)-
Bioglue followed a stepwise reduction, corresponding to the decreased amount of 
added silver salt (0.1 g to 0.01 g added AgNO3). However, this trend was not 
observed for the remaining formulations of AgNO3-Bioglues or for the [Ag2(3,6,9-
tdda)].2H2O-Bioglues (Appendix II). This may be due to regions of these polymers 
having more silver content than others and resulting in a non-homogeneous 
distribution of the metal ion throughout the bulk sample.  
 
3.2.3 Thermal analysis 
Differential scanning calorimetry, a thermoanalytical technique which shows if a 
sample undergoes a temperature-induced physical transformation (e.g. a phase 
transition), was conducted on BSA (Fig. 3.3a-c), AgNO3 (Fig. 3.4a), [Ag2(3,6,9-
tdda)].2H2O (Fig. 3.4b), AgNO3-Bioglues (Fig. 3.5b), [Ag2(3,6,9-tdda)].2H2O-
Bioglues (Fig. 3.5c) and a Bioglue made in the absence of any added Ag(I) salt (Fig. 
3.5a). The DSC profile of the BSA protein alone (25-400 °C) showed two 
endothermic events at 72.70 °C and at 220.69 °C. Farahnaky et al
210
 also reported 
two endothermic events for five commercial BSA samples which occurred between 
35-60 °C and between 90-180 °C (Fig. 3.6).  These researchers suggested that as the 
endothermic peak in the low temperature range is displaced by > 50 °C from the high 
temperature endotherm, this did not indicate that the peaks represented denaturation  
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Fig. 3.3: DSC thermograms of (a) BSA (25-400 °C with increments of 50 
°C), (b) BSA (25-50 °C with increments of 5 °C), (c) BSA (held at 37 °C 
with increments of 5 °C). 
(a) 
(b) 
(c) 
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(a) 
 
(b) 
Fig. 3.4: DSC thermograms (25-400 °C with increments of 50 °C) of (a) 
AgNO3 and (b) [Ag2(3,6,9-tdda)].2H2O. 
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Fig. 3.5: DSC thermograms of Bioglue containing (a) no added Ag(I) ions, (b) added 
AgNO3 (0.01 g) and (c) added [Ag2(3,6,9-tdda)].2H2O (0.01 g). Samples were heated 
from [25 °C → 50 °C → 30 °C with increments of 5 °C] and the cycle began again 
at 25 °C.  
(a) 
(b) 
(c) 
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Fig. 3.6: DSC profiles of commercial BSA samples.
210
 
1- BSA from Sigma (cat. No. A-7906) 
2- BSA from Sigma (cat. No. A-0281) 
3- BSA from ACROS (cat. No. 13473-0100) 
4- BSA from Sigma (cat. No. A-2153) 
5- BSA from Sigma (cat. No A-7906) 
Moisture contents (% w/w) for BSA samples 1-5; 12.1, 8.6, 6.6, 5.1, and 3.7%, 
respectively (wet basis). 
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of the protein. Michnik et al
211
 also reported a Tm value of 70.1 °C although they did 
not observe  a second endothermic peak due to the fact that a much smaller 
temperature range (20-100 °C) was used in their test. In the present studies, the DSC 
profile of BSA was also recorded over the temperature ranges 25-400 °C, 25-50 °C, 
and holding at 37 °C for 3 h, in order to determine the stability of the protein on its 
own (Fig. 3.3 (b and c)). No phase transitions were detected under these conditions.  
The DSC thermogram of AgNO3 (Fig. 3.4a) shows an endothermic event which is in 
relation to the melting of the compound (peak maximum 210.12 °C). This correlates 
to the literature value of 212 °C.
212
 The DSC profile of [Ag2(3,6,9-tdda)].2H2O (Fig. 
3.5b) showed a melting endothermic peak (211.49 °C) followed by an exothermic 
event in the range of 220-240 °C (peak maximum 238.84 °C). Logvinenko et al
213
 
observed a large exothermic event for silver(I) acetate, CH3COOAg, between 170-
280 °C. The authors postulated that this peak corresponds to decomposition of the 
carboxylate ligand and formation of metallic silver suggesting that the following 
reaction had taken place:
214
 
2CH3COOAg                     2Ag
0
 + CH3CO2H + CO2 + H2 + C 
To establish the DSC profile of vacuum dried Bioglue samples, the solids were 
heated from 25-50 ˚C, cooled back down to 30 ˚C and cycled again at [25 °C → 50 
°C → 30 °C] etc. (without delay) a further two times (Fig. 3.5). The DSC profiles 
remained unchanged across the three cycles, suggesting that the Bioglues prepared in 
the absence and in the presence of added silver salt did not degrade within this 
temperature window. The IR spectrum of the samples were also recorded after they 
had been subjected to DSC scanning to further determine if the Bioglue samples 
were unchanged after the heating protocol (Fig. 3.7). No obvious changes in the IR 
spectral profiles of the Bioglue samples were evident suggesting that major structural 
changes did not occur upon heating to 50 °C (three times).  
As an extension of these experiments, Bioglue samples were again heated to 50 ˚C 
but this time cooled to 37˚C and held at the latter temperature for 3 hrs. The 
reasoning behind this experiment was to assess if the Bioglue samples remained 
unaltered at body temperature for a prolonged time (Fig. 3.8). No phase transitions  
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                                            (a)                                                    (b)                                                    (c) 
                   
                                              (d)                                                        (e)                                                  (f)  
Fig. 3.7:  Infrared spectra of (a) Bioglue with no added Ag(I) ions, (b) Bioglue with no added Ag(I) ions after DSC (cycled 3 times to 25-50 °C), 
(c) Bioglue with no added Ag(I) ions after DSC (held at 37 °C for 3 hours), (d) Bioglue with added AgNO3 (0.01 g), (e) Bioglue with added 
AgNO3 (0.01 g) after DSC (cycled 3 times to 25-50 °C) and (f) Bioglue with added AgNO3 (0.01 g) after DSC (held at 37 °C for 3 hours).
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Fig. 3.8: DSC scans of Bioglues containing (a) no added Ag(I) ions, (b) added 
AgNO3 (0.01 g) and (c) added [Ag2(3,6,9-tdda)].2H2O (0.01 g). Samples were 
heated from 25-50 °C with increments of 5 °C, cooled back down to 37 °C, held at 
this temperature for three hours, and then cooled to 30 °C. 
(a) 
(b) 
(c) 
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were observed and the IR spectra remained unaltered (Fig. 3.7 (c and f)). These 
observations confirmed the thermal stability of the Bioglues at 37 °C over a 3 h 
period. 
 
3.2.4 Surface morphologies 
The surface morphology of the Bioglues was analysed using SEM in order to detect 
if any structural changes occurred when Ag(I) ions were included in the Bioglue 
formulation (Fig. 3.9). Bioglue without added AgNO3 had a porous surface (Fig. 
3.9a). This contrasted with the Bioglue containing added AgNO3 (0.1 g), which 
appeared to have a rough surface (Fig. 3.9b). A ten-fold decrease in the amount of 
added AgNO3 (0.01 g) gave a Ag(I)-Bioglue with a very smooth surface (Fig. 3.9c). 
At the lowest quantity of added AgNO3 (0.0001 g) (Fig. 3.9d), the surface begins to 
appear porous once more and, unsurprisingly, resembles that of a Bioglue without 
added AgNO3 (Fig. 3.9a).   
Energy dispersive X-ray spectroscopy (EDX) was performed on the Bioglues to 
provide a qualitative elemental analysis of the sample (Fig. 3.10a). Three bands were 
observed between 2.98 and 3.35 KeV which are assigned to the Lα, Lβ1 and Lβ2 lines, 
respectively, of silver.
215
 Gold was also detected as this metal was used to sputter 
coat the samples prior to SEM and EDX analysis. 
 
3.2.5 Swelling studies 
Hydrogels by their nature are three-dimensional, cross-linked polymeric networks 
which have the ability to swell in water, and also in buffered or physiological 
solutions.
216,217
 Swelling studies were carried out on the current Bioglue hydrogels in 
order to determine the maximum amount of water that the samples could absorb 
(Section 2.10) (Fig. 3.11 and 3.12).  The swelling ratio was determined using the 
following equation:
199
 
r = (mf - mi / mi) × 100% 
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(a)                                                         (b)                  
 
                         (c)                                                      (d) 
Fig. 3.9: SEM images of Bioglues (a) with no added AgNO3, (b) added AgNO3 (0.1 
g), (c) with added AgNO3 (0.01 g) and (d) added AgNO3 (0.0001 g). 
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(a)                                                                                                    
                           
(b) 
Fig. 3.10: (a) SEM image of Bioglue prepared with the highest amount of added 
AgNO3 (0.1 g) and (b) the corresponding EDX spectrum. 
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                                            (a)                                                                 (b)                                                               (c) 
Fig. 3.11: Images depicting Biolue with no added Ag(I) ions at various stages of swelling studies (a) 0 h, (b) 24 h and (c) 120 h. 
 
6 cm 
8 cm 8 cm 
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                                          (a)                                                                   (b)                                                               (c) 
Fig. 3.12: Images depicting Bioglue with added [Ag2(3,6,9-tdda)].2H2O (0.01 g) at various stages of swelling studies (a) 0 h, (b) 24 h and (c) 
120 h. Images of the Bioglue with added AgNO3 (0.01g) over the same time period were very similar to those for the [Ag2(3,6,9-tdda)].2H2O 
Bioglue. 
8 cm 8 cm 8 cm 
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where r is the swelling ratio, mf is the final mass of the hydrogel after swelling and 
mi is the initial mass of the hydrogel sample. The Bioglue sample without Ag(I) ions 
reached a maximum weight (908% weight increase) after 48 h. The Bioglue 
containing added AgNO3 (0.01 g) had a 117% weight increase over the same time 
period (Fig. 3.13). 
Generally, for the AgNO3-Bioglues, as the amount of added Ag(I) ions decreased the 
swelling ratio increased. A similar trend was also seen for the [Ag2(3,6,9-
tdda)].2H2O-Bioglues (Fig. 3.14), where at the highest quantity of added [Ag2(3,6,9-
tdda)].2H2O (0.01 g) a 271% weight increase was observed, and at the lowest 
amount (0.00001 g) the weight increase was 945% after 48 h. Increasing the amount 
of added Ag(I) ion considerably reduces hydrogel swelling and also leads to a 
product whose glue-like adhesive properties are dramatically lessened. The structure 
of the Bioglue with the highest amount of added [Ag2(3,6,9-tdda)].2H2O (0.01 g) is 
more rigid and retains its shape throughout the swelling studies (Fig. 3.12) in 
comparison to the Bioglue with little or no added Ag(I) ions (Fig. 3.11). This was 
also found for the AgNO3-Bioglue (image not shown). Deen et al
218
 found a similar 
trend for a poly(N-acryloyl-N'-ethylpiperazine) hydrogel, in which the swelling ratio 
decreased in the presence of added Ni
2+
 ions. It was postulated that in the presence of 
the metal ion competition occurs between protonation and the formation of a metal-
ligand complex which act as physical crosslinks within the gel network and thereby 
affects the elastic modulus of the gel which, in turn, reduces the swelling ratio.
218
 
Katime and Rodriguez
219
 also found that increasing the amount of metal ion (Cu
2+
) in 
a poly(acrylic acid-co-itaconic acid) hydrogel resulted in a decrease in the swelling 
of the hydrogel. 
It was also found that the Bioglue (without added AgNO3) degraded over the 120 h, 
and in particular after 24 h (Fig. 3.13), whereas the Ag(I)-Bioglues with the lower 
amounts of added AgNO3 (0.001 g and 0.0001 g) started to degrade after 48 h. This 
may be due to hydrolysis of the imine bond and explains why breakdown of the 
Bioglue was observed.  
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Fig. 3.13: Swelling studies for a Bioglue without added Ag(I) ions and for a series of AgNO3-Bioglues (added AgNO3 0.01-0.0001 g). The 
experiments were repeated three times.  
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Fig. 3.14: Swelling studies for a series of Bioglues with [Ag2(3,6,9-tdda)].2H2O (0.01-0.00001 g). The experiments were repeated three times.  
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3.2.6 Mechanical testing 
Mechanical testing studies were conducted in order to determine the tensile 
properties of the various Bioglues. The first series of tensile tests were carried out 
using strips of wood where Bioglue samples (15 µl) were applied to one surface of 
the wood before overlapping by 10 mm with the second piece of wood (Fig. 
3.15a).
220
 Samples of wood stuck together with Bioglue were left to stand overnight 
at room temperature before tensile testing was carried out. It was found that the 
maximum load required to break the test pieces was 136.25 ± 5.39 N for the Bioglue 
without added Ag(I) ions. The force decreased to 112.71 ± 10.56 N for the Ag(I)-
Bioglue with the lowest amount of added AgNO3 (0.0001 g), and a further decrease 
occurred for the Bioglue with the highest quantity of added AgNO3 (0.01 g) (78.82 ± 
6.86 N) (Fig. 3.16a).  
The Young’s modulus, which is an assessment of the stiffness of an elastic material, 
was also determined for the Bioglues (Fig. 3.17a). Bioglue without added Ag(I) ions 
had a Young’s modulus of 293.46 ± 24.69 MPa. For the Bioglue containing the 
highest amount of added AgNO3 (0.01 g) the Young’s modulus was 334.47 ± 46.87 
MPa and 269.65 ± 18.05 MPa for the Bioglue containing the lowest amount of added 
AgNO3 (0.0001 g). These results imply that the presence of Ag(I) ions in the 
Bioglues does not alter the stiffness of the Bioglue.  
Tensile testing was repeated using Bioglue bonded pig skin as this matrix has a close 
resemblance to human skin.
221
 Initially, the majority of the fat layer was removed 
from the pig skin using a sterile scalpel. The second series of tensile tests were 
carried out using pig skin where Bioglue samples (100 µl) were applied to one 
surface of the skin before overlapping by 10 mm with the second piece of skin (Fig. 
3.15b).
221
 The sample was placed in a static incubator at 37 °C overnight to mimic 
body temperature before the tensile testing was carried out. The maximum load 
required to break apart the pieces of skin was 6.80 ± 1.22 N for the Bioglue without 
added AgNO3, and this value decreased to 4.39 ± 0.38 N for the Bioglue with the 
highest amount of added AgNO3 (0.01 g) (Fig. 3.16b). As the amount of AgNO3 in 
the Bioglue decreased, the maximum load required for skin detachment also 
decreased. This contrasts with the results obtained with the glued wood pieces,
Chemical synthesis and characterisation                                                                             Chapter 3                                                                  
124 
 
                          
(a) 
              
(b) 
Fig. 3.15: Dimensions of (a) wood and (b) pig skin used in the present 
study. 
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(a) 
 
 
(b) 
Fig. 3.16: Maximum load (N) required to break samples stuck together with Bioglue 
formulated with and without added AgNO3: (a) bonded pieces of wood and (b) 
bonded pieces pig skin. 
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(a)                                         
                                                               
 
(b) 
Fig. 3.17: Young’s modulus (MPa) for samples stuck together with Bioglue samples 
formulated with and without added AgNO3: (a) bonded pieces of wood and (b) 
bonded pieces of pig skin. 
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where the maximum load increased as the amount of added AgNO3 decreased. The 
observed difference in the tensile testing trends between the wood and pig skin may 
be due to the fact that the wood is more porous than the pig skin and that the Bioglue 
seeps into the pores and creates a stronger bond between the glue and the material 
with the greatest porosity. This may also explain why the maximum load at the point 
of break was different for the wood and the pig skin. The difference in the elasticity 
of the material can be seen clearly in Fig. 3.17. Young’s modulus for the pig skin 
adhered by Bioglue was found to be 0.85 ± 0.32 MPa for the Bioglue without added 
AgNO3 and 0.20 ± 0.02 MPa for the Bioglue with the highest amount of added 
AgNO3 (0.01 g) (Fig. 3.17b). At the lowest amounts of added AgNO3 (0.0001 g) a 
small decrease in the Young’s modulus was seen (0.16 ± 0.03 MPa). Subsequent 
increases in the amounts of added AgNO3, (up to 0.01 g) did not cause significant 
further decreases in Young’s modulus suggesting that increasing the amount of 
added AgNO3 did not affect the elasticity of the Bioglue. In comparing the Bioglue 
without added Ag(I) ions a clear difference can be seen suggesting that the 
incorporation of Ag(I) ions into the Bioglue formulation does effect the elasticity of 
the Bioglue.  
Issues concerning the effect that the elasticity of Bioglue may have on surrounding 
tissues have previously been raised. De Somer et al
64
 used Bioglue and Tissucol 
Duo, a fibrin sealant, as controls in the comparison of the mechanical and chemical 
characteristics of an autologous glue. These researchers found that, in elasticity 
testing experiments, the maximum loads required to break apart the test pieces 
(aluminum blocks with a surface area of 25 cm
2
 smeared
 
with an even application of 
glue (2.1 ml)) were 322 ± 104 N for Bioglue and 144 ± 66 N for the canine 
autologous glue. Bioglue, in comparison to other adhesives, was found to be a rigid 
glue (relatively inelastic). Azadani et al
222
 found that the Young’s modulus of 
Bioglue was nearly 60 times greater than Crosseal, a fibrin sealant, and 30 times 
greater than Tisseel, another fibrin sealant and CoSeal, a synthetic glue consisting of 
polyethylene glycol macromers. For the successful use of a tissue adhesive, product 
limitations must be understood in order that the correct adhesive is chosen for a 
given circumstance. 
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(a) 
 
(b) 
Fig. 3.18: Image depicting point of break for Bioglue-adhered surfaces without 
Ag(I) ions (a) wood and (b) pig skin. 
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3.2.7 Ag(I) leaching studies 
Electrochemical analysis was carried out to determine the amount of Ag(I) ions that 
leached from AgNO3-Bioglue samples over time. The dry mass of the AgNO3-
Bioglue (formulated using 0.01 g AgNO3) was 0.50 g and contained 5.88 x 10
-5
 
moles of Ag(I) ions. A portion (0.10 g, containing 1.17 x 10
-5
 moles Ag(I) ions) of 
this sample was used in the electrochemical cell that was employed in the leaching 
experiments. The supporting electrolyte (60 mls) was added to the cell and the 
amount of leached Ag(I) ions was determined at time intervals for up to 55 h (Fig. 
3.19(a)). Over the first 10 h, there was rapid leaching of Ag(I) ions from the Bioglue 
into the supporting electrolyte. Leaching then slowed down and appeared to reach an 
equilibrium concentration value (ca. 6 x 10
-5
 M (Ag(I)). At the 55 h timepoint, 
approximately 30% of the original amount of Ag(I) ions in the Bioglue had leached 
into the supporting electrolyte. This experiment was carried out on two separate 
preparations of the AgNO3-Bioglue (0.01 g AgNO3) (see Appendix III Fig. 1 and 2) 
and it was found that there was a variance in the total amounts of Ag(I) ions leached 
from these two samples. This implies that there is not a homogenous distribution of 
the metal ion throughout the samples (as confirmed by earlier AA analysis of the 
samples). This electrochemical experiment was repeated for a AgNO3-Bioglue a 
lower amount of added AgNO3 (0.001 g) (contained 5.58 x 10
-6
 moles Ag(I) ions). A 
portion of this sample (0.1 g, containing 1.17 x 10
-6
 moles Ag(I) ions) was used in 
the leaching experiments. As with the previous sample, the supporting electrolyte 
(60 mls) was added to the cell and the amount of Ag(I) ions leached from the sample 
was monitored for up to 55 h (Fig. 3.19(b). Again, it was found that an equilibrium 
concentration value was reached after 55 h (ca. 6.5 x 10
-6
 M Ag(I) ions) and this 
corresponded to approximately 30% of the original amount of Ag(I) ions in the 
Bioglue sample. 
These studies are important as they provide vital information on the rate at which 
Ag(I) ions leach from the samples and establish an antimicrobial environment. It can 
be seen from the graphs (Fig. 3.19) that the rate at which Ag(I) ions leach from the 
AgNO3-Bioglues reach an equilibrium by 55-65 h. As most patients come into 
contact with microorganisms within the first few hours of admission to hospital and   
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              (a) 
                                              
                (b) 
Fig. 3.19: Concentration of leached Ag(I) ions from AgNO3-Bioglues (a) with 0.01 g 
added AgNO3 and (b) with 0.001 g added AgNO3. 
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infections become evident after 48 h,
223
 the use of these AgNO3-Bioglues may 
prevent such infections from occurring. 
 
3.3 Reduction of Bioglues and the Synthesis of Ag(0) Nanoparticles 
Aqueous solutions of two different reducing agents (sodium borohydride and sodium 
citrate) were used in an attempt to reduce the Ag(I) ion within the AgNO3-Bioglue 
(0.01 g added AgNO3) to Ag(0). It should be noted that sodium borohydride also has 
the ability to reduce imine functionalities formed upon the production of Bioglue 
from BSA and GLA. The Bioglue changed colour, from a golden-yellow to either a 
dark-brown or orange upon reduction with NaBH4 (0.1 M and 0.01 M solutions, 
respectively) (Fig. 3.20) suggesting that the following chemical reaction had taken 
place:  
2Ag
+
 + 2NaBH4 + 6H2O                2Ag
0 
+ 7H2 + 2Na
+
 + 2B(OH)3 
Hydrogen gas may also be given off upon the reaction of sodium borohydride with 
water:  
NaBH4 + 4H2O                  NaB(OH)4 + 4H2 
Bioglue without Ag(I) ions was also exposed to NaBH4 solutions (0.1 M, 0.01 M and 
0.001 M) and it was found that the Bioglue remained its usual golden-yellow colour.  
Mohan et al
224
 also found a colour change, (colourless to brown) for a AgNO3-
poly(acrylamide) hydrogel with aqueous NaBH4 (0.1 M). In the present studies, UV-
vis spectroscopy (Fig. 3.21) was carried out on the reaction supernatant of the 
reduced AgNO3-Bioglue (0.01 g) to establish if nanoparticulate Ag(0) was present. 
The presence of a band with λmax = 276 nm suggesting that Ag(0) nanoparticles were 
not present in the supernatant (suspension of Ag(0) nanoparticles are expected to 
have a band with λmax = 400-500 nm).
224
  
The surface morphology of the NaBH4 reduced AgNO3-Bioglue was analysed by 
SEM and it was found to be smooth in some areas but porous in others (Fig. 3.22). 
The hollow pores may be a result of escaping H2 produced upon NaBH4 reduction. 
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Silver detected by EDX studies showed three lines between 2.98 and 3.35 KeV (Lα, 
Lβ1 and Lβ2 lines of silver).
215
 Although Ag(0) nanoparticles were not detected either 
in the reaction supernatant or on the outer surface of the reduced Bioglue, it is still 
likely that Ag(0) nanoparticles (or micro-particles) were trapped within the Bioglue 
matrix (as suggested by the colour change of the reduced Bioglues shown in Fig. 
3.20b).  
 
 
 
 
 
Fig. 3.20: Images depicting colours of AgNO3-Bioglues (0.01 g AgNO3) (a) before 
and (b) after reduction with (i) NaBH4 (0.1 M), (ii) NaBH4 (0.01 M) and (iii) NaBH4 
(0.001 M). 
(i) 
(ii) (iii) 
(a) 
(b) 
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 Fig. 3.21: UV-Vis spectrum of supernatant of NaBH4 reduced AgNO3-Bioglue (0.01 
g AgNO3). 
 
       
 
Fig. 3.22: Series of SEM images of different magnification for an AgNO3-Bioglue 
(0.01 g AgNO3) following reduction with aqueous NaBH4 (0.01 M). 
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In a series of separate experiments, aqueous solutions of sodium citrate were 
employed in an attempt to reduce the AgNO3-Bioglue (0.01 g of added AgNO3). 
Three different experiments were performed (Section 2.11.2) in which the AgNO3-
Bioglue samples were exposed to either sodium citrate solution (1%, w/v) alone or to 
sodium citrate solution (1% w/v) + light, or to just light only. The reaction of sodium 
citrate and Ag
+
 is given by the following equation:
225
 
4Ag
+ 
+ C6H5O7Na3 + 2H2O → 4Ag
0
 + C6H5O7H3 + 3Na
+ 
+ H
+
 + O2 
The UV-vis spectra of the resulting supernatants from the three experiments outlined 
above showed only a peak with λmax = 276 nm (Fig. 3.23), again suggesting that 
Ag(0) nanoparticles were not present in the supernatant. The surface morphology of 
the reduced Bioglues were analysed by SEM (Fig. 3.24). The surface morphology 
was very smooth in comparison to the NaBH4-reduced Bioglues. Silver was detected 
by EDX. Although Ag(0) nanoparticles were not detected in the supernatant or on 
the solid surface, it is again possible that Ag(0) nanoparticles (or micro-particles) 
were trapped within the matrix of the treated AgNO3-Bioglue.  
                                                                             
 
Fig. 3.23: UV-Vis spectrum of supernatant of reduced AgNO3-Bioglue (0.01 g) with 
(a) sodium citrate (1%, w/v), (b) sodium citrate (1%, w/v) + light and (c) light only. 
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Fig. 3.24: SEM images of reduced AgNO3-Bioglue (0.01 g) with (a) sodium citrate 
(1%, w/v), (b) sodium citrate (1%, w/v) + light and (c) light only. 
 
A number of experiments were conducted to investigate if a Bioglue (without added 
Ag(I) ions) would absorb Ag(0) nanoparticles from a reformed suspension of Ag(0) 
nanoparticles (Section 2.11.4). In the first instance, a suspension of Ag(0) 
nanoparticles was prepared using the established protocol
200
 of reducing aqueous 
AgNO3 with an aqueous solution of sodium citrate (1% w/v). The UV-visible 
spectrum of the resulting yellow/green suspension showed a broad band with λmax = 
424 nm, characteristic of Ag(0) nanoparticle formation (Fig. 3.25a).
200
 A Bioglue 
without added Ag(I) ions was prepared (in triplicate) and exposed to the previously 
synthesised Ag(0) nanoparticulate suspension for 120 h to allow sufficient time for 
any Ag(0) particles to diffuse into the Bioglue matrix. As there was no significant 
change in the absorption value of the 424 nm band after this time period (Fig. 3.25b) 
it was concluded that there had been no uptake of Ag(0) nanoparticles by the 
Bioglue. 
(a) (b) 
(c) 
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Fig. 3.25: (a) UV-Vis spectrum of Ag(0) nanoparticle suspension. The silver 
nanoparticles were prepared by reducing AgNO3 (0.0314 g, 0.185 mmoles) with 
sodium citrate (1%, w/v) and (b) UV-Vis spectra of Bioglue (without added AgNO3) 
in Ag(0) nanoparticle suspension. Black–6 h, green–24 h red–48 h, blue–120 h. 
 
SEM and EDX were carried out on the Bioglue following exposure to the silver 
nanoparticles. The surface morphology of the Bioglue was found to be very porous 
(Fig. 3.26) which may explain why a decrease in the intensity of the UV-Vis spectra 
was not observed as the nanoparticles could diffuse easily in and also back out of the 
Bioglue. EDX did not detect any silver present in the Bioglue (Fig. 3.27).  
(a) 
(b) 
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Fig. 3.26: SEM images of Bioglue without added AgNO3 following immersion for 
120 h in a Ag(0) nanoparticle suspension. 
.                                       
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(a)                                                                                       
 
(b) 
Fig. 3.27: (a) SEM image of Bioglue prepared in the absence of added AgNO3 and 
(b) the corresponding EDX spectrum. 
 
In correlation with the swelling studies, it was also found, Bioglue (without added 
AgNO3) degraded over the 120 h period, and in particular after 24 h (Fig. 3.28). This 
was evident by the large increase in the 276 nm band over this time period which 
corresponds to the formation of BSA through hydrolysis of the imine bond in the 
Bioglue 
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Fig. 3.28: UV-Vis absorption spectra of Bioglue (in the absence of Ag(I) ions) in 
deionised water over 120 h. Red-1 h, green-6 h, dark blue-12 h, light blue-24 h, pink-
48 h, yellow-72 h, black (dashed)-96 h, red (dashed)-120 h. 
 
3.4 Conclusion 
Bioglues prepared in the absence and in the presence of a silver salt (up to 0.01 g of 
added AgNO3 and [Ag2(3,6,9-tdda)].2H2O appear to be stable at temperatures up to 
50 °C, have the ability to swell in a moist environment, have good adherence 
properties and Ag(I) ions progressively leach from the dried AgNO3-Bioglues. 
AgNO3-Bioglues are readily reduced by borohydride and citrate ions but Ag(0) 
nanoparticles are not formed. The properties of the Bioglues are important for 
medicinal purposes. Although the mechanical strength is lower in the Bioglues with 
added Ag(I) ions this may be a worthwhile compromise if the presence of Ag(I) ion 
over a 60 h period may seriously reduce or even totally inhibit any pathogenic 
microbial growth.  
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4.0 Introduction 
The results presented in this Chapter aimed to determine the antimicrobial activity of 
AgNO3- and [Ag2(3,6,9-tdda)].2H2O-Bioglues against a range of Gram-negative and 
Gram-positive bacteria such as Escherichia coli, Pseudomonas aeruginosa, 
Staphylococcus aureus, Methicillin-Resistant Staphylococcus aureus (M.R.S.A.) and 
also the fungal pathogen, Candida albicans.  
 
4.1 Antimicrobial disk diffusion assay with Ag(I)-containing 
Bioglues 
The aim of these experiments was to determine the activity of the Ag(I)-containing 
Bioglues made using AgNO3 and [Ag2(3,6,9-tdda)].2H2O, against a range of Gram-
negative (P. aeruginosa strains 27853, 10145 and E. coli) and Gram-positive 
bacteria (S. aureus (Fig. 4.1a) and M.R.S.A.) and also the fungal pathogen, C. 
albicans (Fig. 4.1b). The disk diffusion assay was carried out (Sections 2.16.1 and 
2.16.2). After 24 h incubation at 37 °C, the area of the zone of inhibition (ZOI) (Fig. 
4.1c) was measured. The ZOI data are summarised in Table 4.1 and Figs. 4.2 and 
4.3.  
Against the fungal pathogen, C. albicans, only direct inhibition (inhibition directly 
underneath the sample only, no ZOI detected) was observed for the Ag(I)-Bioglues. 
Only at the highest amount of added AgNO3 (0.1 g) was a ZOI observed (100 mm
2
). 
Against the bacterial species, increasing the quantity of AgNO3 in the formulation 
caused a progressive increase in the ZOI. In general, activity is greatest against 
Gram-negative bacteria and least against the resistant, Gram-positive strain, M.R.S.A. 
Percival et al
226
 found a similar trend using a commercially available silver alginate 
wound dressing (AMS, Winsford, UK) prepared in 1 x 1 cm squares. This dressing 
had antimicrobial activity against a broad range of clinically isolated strains of fungi  
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Fig. 4.1: Control plates of (a) S. aureus, (b) C. albicans and (c) image depicting zones of inhibition (ZOI) of AgNO3-Bioglue (0.1 g) against S. 
aureus. 
(b) 
 
(B) 
(a) 
(c) 
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Table 4.1: Zones of inhibition (ZOI) for AgNO3- and [Ag2(3,6,9-tdda)].2H2O- 
Bioglues. 
                
      d.i. = direct inhibition 
 
 
Ag(I)-Bioglue 
formulation 
(added  AgNO3 
(g)) 
C. 
albicans 
(mm
2
) 
M.R.S.A. 
(mm
2
) 
S. 
aureus 
(mm
2
) 
E. coli 
(mm
2
) 
P. 
aeruginosa 
10145 
(mm
2
) 
P. 
aeruginosa 
27853 
(mm
2
) 
0.00001 d.i. 0 0 0 0 0 
0.0001 d.i. 13 21 14 0 41 
0.001 d.i. 23 26 35 38 38 
0.01 d.i. 31 36 41 49 58 
0.1 100 45 49 66 72 74 
Ag(I)-Bioglue 
formulation 
(added 
[Ag2(3,6,9-
tdda)].2H2O) 
 
  
 
 
 
0.0001 0 0 0 0 0 0 
0.001 d.i. 18 31 36 14 27 
0.01 d.i. 14 18 12 12 21 
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Fig 4.2:  The effect of AgNO3-Bioglues on zones of inhibition against (a) M.R.S.A. 
(b) S. aureus and (c) E. coli. 
(a) 
(b) 
(c) 
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Fig. 4.2 Contd: The effect of AgNO3-Bioglues on zones of inhibition against (d) P. 
aeruginosa 10145  and (e) P. aeruginosa 27853. 
(d) 
(e) 
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Fig. 4.3: The effect of [Ag2(3,6,9-tdda)].2H2O-Bioglues against (a) M.R.S.A., (b) S. 
aureus  and (c) E. coli. 
 
(b) 
 
(B) 
(a) 
 
(A) 
(c) 
 
(C) 
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Fig. 4.3 Contd: The effect of [Ag2(3,6,9-tdda)].2H2O-Bioglues on zones of 
inhibition (d) P. aeruginosa 10145 and  (e) P. aeruginosa 27853. 
(e) 
 
(A) 
(d) 
 
(A) 
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and bacteria in comparison to a non-silver gauze and a non-silver hydrofiber dressing 
(Convatec, Flintshire UK). Experiments revealed zones of inhibition of 7.2 mm
2
 
against P. aeruginosa, 3.8mm
2 
against E. coli, 7.1 mm
2
 against S. aureus and 5.3 
mm
2
 against M.R.S.A., whereas no zones of inhibition were found for the non-silver 
gauze and dressing. The smaller ZOI for E. coli contrasts with that found in the 
present studies, and may be attributed to the use of a more virulent clinical isolate 
than the clinical strain used in the present study. Castellano et al
27
 reported a similar 
trend to the one presented in this study, with the activity trend of a Silvercel dressing 
P. aeruginosa > E. coli > S. aureus. 
In contrast to the trends observed with the present AgNO3-Bioglues, increasing the 
amount of added [Ag2(3,6,9-tdda)].2H2O surprisingly lead to a decrease in activity. 
This was particularly noticeable for E. coli and S. aureus. 
 
4.2 Conclusion 
In conclusion, the AgNO3- and [Ag2(3,6,9-tdda)].2H2O-Bioglues both exhibit direct 
inhibition against C. albicans. The AgNO3-Bioglues were more active against the 
bacterial strains than the [Ag2(3,6,9-tdda)].2H2O-Bioglues. 
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5.0 Introduction 
It has previously been shown
174
 that treating C. albicans with AgClO4 induces an 
increase in SOD activity, with the maximum effect occurring after 1 h. Catalase 
(CAT) activity was increased by a factor of 10 fold when C. albicans was exposed to 
Ag(I) ions for 1 h.
174
 In parallel, an increase in glutathione reductase (GLR) activity 
was also observed after an exposure time of 1 h.
174
 These results suggested that the 
yeast was mounting a response to oxidative stress. This part of the research aimed to 
assess the effect of AgNO3 on S. aureus and to determine whether or not an 
oxidative stress response was generated in response to exposure to Ag(I). The study 
sought to establish a possible mode(s) of action of the Ag(I) ion against the 
bacterium.  
Oxidative stress is caused by a serious imbalance between the production of reactive 
oxygen species (ROS) and antioxidant defense (Scheme 1).
227
 There are a number of 
antioxidant enzymes, such as superoxide dismutase (SOD), that catalyze the 
dismutation of radical anions (e.g. O2
-.
)
228
 which are involved in the generation of 
unstable and damaging species, such as hydroxyl radicals (OH
.
) and hydrogen 
peroxide (H2O2), which can lead to cytotoxicity.
229
 Copper- and zinc-containing 
SODs are located mainly in the cytosol of animal cells, whilst manganese-SODs are 
found usually in the mitochondria of animal cells.
230
 Reduced glutathione (GSH) is 
synthesised de novo from the amino acids glutamine, cysteine and glycine
231
 and is 
responsible for maintaining the redox state within cells. GSH performs its 
antioxidant activity by scavenging radical species.
232
 GSH peroxidase (GPx) 
detoxifies peroxidases, with GSH acting as an electron donor in the reduction 
reaction, producing GSSG as the oxidised end product. The reduction of GSSG back 
to GSH is catalysed by gluatathione reductase (GLR) and requires NADPH.
231
 The 
FAD moiety of GLR is reduced by NADPH in the reduction half-reaction. In the 
oxidation half-reaction, the resulting dithiol reacts with the glutathione disulfide and 
the electron acceptor GSSG is reduced to two GSH at the active site of GLR.
227
 
Catalase (CAT), has the ability to break down hydrogen peroxide and has the 
advantage of not producing free radicals.
233
 These reactions are summarised in 
Scheme 1. 
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Scheme 1: Antioxidant defence mechanism of glutathione reductase, superoxide dismutase and catalase. Adapted from Tandoğan et al.227  
glutamylcysteine synthetase 
L-glutamate + cysteine L-glutamylcysteine 
L-glutamylcysteine + glycine 
glutathione synthetase 
glutathione (GSH) 
Radical 
Formation 
SOD 
catalase 
GSSG 
NADPH 
O2
-∙ 
O2 + H2O 
H2O2       ROOH 
ROH + H2O 
2GSH NADP
+
 
glutathione reductase 
glucose-6-phosphate 
dehydrogenase 
 
glutathione peroxidise  
glutathione-S-transferase 
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5.1 Antimicrobial susceptibility testing with AgNO3 and [Ag2(3,6,8-
tdda)].2H2O (without Bioglue) 
The aim of these experiments was to determine the in vitro susceptibility of the 
fungal pathogen, C. albicans, and the bacterial pathogens,  S. aureus and M.R.S.A., 
to the pure compounds, AgNO3 and [Ag2(3,6,9-tdda)].2H2O (without Bioglue). After 
a 24 h incubation period at 37 °C, OD600 readings were taken and the anti-fungal and 
anti-bacterial activities were measured (Sections 2.15.1 and 2.15.2). Growth was 
expressed as a percentage of untreated controls (Figs. 5.1-5.4). 
AgNO3 inhibited the growth of C. albicans in the concentration range of 6.25-100 
µg/ml with an MIC90 value of 6.3 µg/ml (36.8 µM) (Fig. 5.1 and Table 5.1). A 
similar trend was found for [Ag2(3,6,9-tdda)].2H2O (Fig. 5.2 and Table 5.1) where 
an MIC90 value of 15.6 µg/ml (35.8 µM) was ascertained. In comparing activity 
based on Ag(I) content, AgNO3 was more active than [Ag2(3,6,9-tdda)].2H2O 
against C. albicans (MIC90 36.8 and 71.6 µM Ag(I), respectively). Previous studies 
by Thati et al
180
 showed that the anti-fungal activity against C. albicans increased 
upon complexation of the coumarin anion to an Ag(I) centre (MIC80 332  µM for 
coumarin carboxylic acid (CcaH) and 163 µM for [Ag(Cca)]) (Table 5.2). Rowan et 
al
179
 established the MIC100 value of  AgClO4 against C. albicans to be 1.4 µM. The 
di-silver(I) complex, [Ag2(NH3)2(salH)2], tested by Coyle et al,
234
 had excellent 
activity against C. albicans (MIC100 of 0.5 µM).  
AgNO3 and [Ag2(3,6,9-tdda)].2H2O inhibited the growth of the bacterial species, S. 
aureus and M.R.S.A. (Figs. 5.3, 5.4 and Table 5.1). Whereas AgNO3 was equally 
active against both species (MIC80 ca. 3.0 µg/ml (17.7 µM)), [Ag2(3,6,9-tdda)].2H2O 
was more effective against S. aureus (MIC80 ca. 3.9 µg/ml (17.9 µM)) than M.R.S.A. 
(MIC80 31.3 µg/ml (143.5 µM)). When comparing activities based on Ag(I) content, 
AgNO3 and [Ag2(3,6,9-tdda)].2H2O had similar activities against S. aureus (MIC80 
17.7 and 17.9 µM, respectively). However, a large difference in activity against 
M.R.S.A. was observed between the two Ag(I) compounds, with AgNO3 being more 
effective than [Ag2(3,6,9-tdda)].2H2O (MIC80 values of 17.7 and 143.5 µM, 
respectively). 
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Fig. 5.1: Susceptibility of C. albicans to AgNO3. The anti-fungal activity of AgNO3 against C. albicans was determined using the microdilution 
assay (Section 2.17.1). Results are presented as a percentage of the control growth. 
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Fig. 5.2: Susceptibility of C. albicans to [Ag2(3,6,9-tdda)].2H2O. The anti-fungal activity of [Ag2(3,6,9-tdda)].2H2O against C. albicans was 
determined using the microdilution assay (Section 2.17.1). Results are presented as a percentage of the control growth. 
[Ag2(3,6,9-tdda)].2H2O 
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Fig. 5.3: Susceptibility of M.R.S.A. and S. aureus to AgNO3. The anti-bacterial activity of AgNO3 against M.R.S.A. and S. aureus was 
determined using the microdilution assay (Section 2.17.2). Results are presented as a percentage of the control growth. 
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Fig. 5.4: Susceptibility of M.R.S.A. and S. aureus to [Ag2(3,6,9-tdda)].2H2O. The anti-bacterial activity of [Ag2(3,6,9-tdda)] 
.2H2O against M.R.S.A. and S. aureus was determined using the microdilution assay (Section 2.17.2). Results are presented as a percentage of 
the control growth. 
[Ag2(3,6,9-tdda)].2H2O 
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Table 5.1: Minimum inhibitory concentrations (MIC80, *MIC90) of AgNO3 and 
[Ag2(3,6,9-tdda)].2H2O against C. albicans, S. aureus and M.R.S.A. in the present 
study. 
Organism 
AgNO3 [Ag2(3,6,9-tdda)].2H2O 
 
MIC80 
(µg/ml) 
 
MIC80 
(µM) 
 
MIC80 
(µM Ag
+
) 
 
MIC80 
(µg/ml) 
 
MIC80 
(µM) 
 
MIC80 
(µM Ag
+
) 
C. albicans 6.3* 36.8 36.8 15.6* 35.8 71.6 
S. aureus 3.0 17.7 17.7 3.9 8.9 17.9 
M.R.S.A. 3.0 17.7 17.7 31.3 71.8 143.5 
 
 
Table 5.2: Minimum inhibitory concentrations (MICs) of various compounds tested 
against C. albicans, S. aureus and M.R.S.A. References superscripted. 
                        
CcaH = Coumarin carboxylic acid                  (SalH2) =  Salicylic acid 
Compounds Tested 
C. albicans 
(µM) 
M.R.S.A. 
(µM) 
S. aureus 
(µM) 
AgNO3 
MIC80 66.8 
235
 MIC80 123.9 
235
 MIC80 69.5 
235
 
MIC100 1.8 
179
 MIC50 36.8 
179
  
AgClO4·H2O MIC100 1.4 
179
 MIC50 43.4 
179
  
CcaH MIC80 331.6 
180
 MIC80 > 2500 
235
 MIC80 > 2500 
235
 
[Ag(Cca)] MIC80 163 
180
 MIC80 0.6 
235
 MIC80 71. 9
235
 
[Ag2(NH3)2(SalH)2] MIC100 0.5 
234
 MIC50 17.2 
179
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Creaven et al
235
 reported the MIC80 values of AgNO3 against S. aureus and M.R.S.A. 
to be 69.5 µM and 123.9 µM, respectively (Table 5.2). These somewhat large MIC80 
values may be attributed to the fact that both of the strains used in their study were 
clinical isolates, which can be more virulent than the strains used in the present 
study. The present results show that [Ag2(3,6,9-tdda)].2H2O is slightly more active 
than AgNO3 against C. albicans and S. aureus, whereas AgNO3 is substantially more 
active against M.R.S.A.   
 
5.2 Assessment of the Oxidative Stress Response of S. aureus and 
AgNO3 
5.2.1 Assessment of superoxide dismutase activity in H2O2-treated and AgNO3-
treated S. aureus cells 
The activity of the superoxide dismutase enzymes was determined in cells following 
treatment with either H2O2 (the positive control, 0.5 mM), AgNO3 (3.0 µg/ml) or no 
treatment (negative control) for 15, 30 and 60 min. The SOD activity was measured 
(Section 2.19.2) and the results are presented in Fig. 5.5. For cells which were 
exposed for 15 min to H2O2 and AgNO3, the SOD activity increased by 1.7 ± 0.2 and 
1.9 ± 0.02 fold, respectively, relative to the control. An increase in SOD activity was 
also observed at 30 min (1.9 ± 0.1 fold in H2O2-treated cells) with the most 
significant increase in activity being found for AgNO3-treated cells (3.8 ± 0.4 fold 
increase (p< 0.001)). At the 60 min timepoint, a decrease in activity was observed 
compared to the control (0.8 ± 0.16 fold) to 0.4 ± 0.05 fold in the H2O2-treated cells. 
In contrast there was a large increase (2.6 ±0.25 fold) for the AgNO3-treated cells 
(p< 0.01). It is interesting to note that the SOD activity decreased dramatically from 
the 30 min to the 60 min timepoint in H2O2-treated cells, which was chosen as the 
positive control. It is known that S. aureus has the ability to produce a single, major 
catalase, KatA,
236
 which might explain why a decrease in activity was observed for 
the H2O2-treated cells. The longer the S. aureus cells were exposed to H2O2, the less 
SOD activity was detected as S. aureus had the ability to disproportionate H2O2 
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Fig. 5.5: Superoxide dismutase activity in S. aureus cells treated with H2O2 and AgNO3. S. aureus cells were treated with the MIC80 value of 
AgNO3 for 15, 30 and 60 min. Cells were also exposed to H2O2 for the relevant time-points and protein was extracted from the cells (Section 
2.18) and superoxide dismutase activity assessed (Section 2.19.2). Results are presented as % SOD activity along the x-axis and as fold changes 
in the bar chart. Differences in activity were deemed statistically significant at p < 0.05(*), p < 0.01 (**) and p < 0.001 (***). 
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using its own KatA catalase. Therefore, oxidative stress was not induced and so 
greater levels of SOD were not detected. In relation to AgNO3 exposure, oxidative 
stress was induced at both 30 and 60 min, with the greatest increase in activity 
observed at 30 min. 
 
5.2.2 Assessment of catalase activity in H2O2-treated and AgNO3-treated S. 
aureus cells 
Catalase activity was measured (Section 2.19.3) in cells exposed to AgNO3 (3.0 
µg/ml), H2O2 (positive control, 0.5 mM) or no treatment (negative control) for 15, 30 
and 60 min (Fig. 5.6). After 15 min an increase was observed from 1.0 fold in the 
negative control cells to 1.7 ± 0.13 fold and 1.3 ± 0.19 fold in H2O2-treated cells and 
AgNO3-treated cells, respectively. At 30 min, there was an increase of 1.7 ± 0.2 fold 
in control cells and a slight increase of 1.4 ± 0.1 fold in H2O2-treated cells. The most 
significant increase in catalase activity was observed with the AgNO3-treated cells at 
30 min (4.1 ± 0.4 fold (p<0.01)). The 60 min timepoint remained significantly higher 
in the AgNO3-treated cells (1.2 ± 0.2 fold in negative control cells to 3.3 ± 0.5 fold). 
However, this represented a decrease in activity when compared to the 30 min 
timepoint. 
It was also observed that a fold decrease in the H2O2-treated cells occurred (1.7 ± 
0.13 fold at 15 min to 1.4 ± 0.06 fold at 30 min and finally to 1.2 ± 0.05 fold at 60 
min). As already mentioned in relation to the SOD assay results, the minor decreases 
in catalase activity found for the H2O2-treated cells might be attributed to the 
presence of KatA, which could break down the H2O2 before the catalase activity was 
measured. 
 
5.2.3 Assessment of glutathione reductase activity in H2O2-treated and AgNO3-
treated S. aureus cells 
The aim of these experiments was to determine if S. aureus cells demonstrated an 
oxidative stress response as a result of exposure to Ag(I) ions. Normally, cells 
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Fig. 5.6: Catalase activity in S. aureus cells treated with H2O2 and AgNO3. S. aureus cells were treated with the MIC80 value of AgNO3 for 15, 
30 and 60 min. Cells were also exposed to H2O2 for the relevant time-points and protein was extracted from the cells (Section 2.18) and catalase 
activity was assessed (2.19.3). Results are presented as absorbance along the x-axis and as fold changes in the bar chart. Differences in activity 
were deemed statistically significant at p < 0.05 (*), p < 0.01 (**) and p <0.001 (***). 
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respond by increasing the activity of antioxidant enzymes in order to deal with this 
stress. S. aureus cells were exposed to AgNO3 at the MIC80 concentration (3.0 
µg/ml) for 15, 30 and 60 min. Hydrogen peroxide (0.5 mM) was used as a positive 
control and no treatment as a negative control. The GLR activity was assessed 
(Section 2.19.1) and the results are presented in Fig. 5.7. When cells were exposed to 
H2O2 and AgNO3 for 15 min, the GLR activity increased from 1.0 fold in the 
negative control to 1.2 ± 0.1 fold in the H2O2-treated cells and decreased to 0.6 ± 0.2 
fold for the AgNO3-treated cells. At the 30 min timepoint, the GLR activity 
increased to 1.2 ± 0.5 fold in the H2O2-treated cells and also increased to 1.6 ± 0.4 
fold in the AgNO3-treated cells. Finally, at the 60 min timepoint, there was an 
increase in activity to 1.3 ± 0.1 fold in the AgNO3-treated cells. Even though an 
increase in activity for AgNO3-treated cells was observed at both the 30 and 60 min 
timepoints, these changes were not deemed to be statistically significant (p > 0.05).  
As GSH is known to chelate Cu(II) ions,
230
 it is possible that it is also chelating the 
Ag(I) ions through its carboxylate and amine groups thus inhibiting the antioxidant 
defense properties of the GSH. Similar results were found when Ag(0) nanoparticles 
were used on eukaryotic cells.
12
 Another possibility may be the interaction of Ag(I) 
ions with the glutathione reductase enzyme. Cardosa et al
237
 suggested that the 
transfer of electrons from the NADPH to the FAD moiety of GLR results in making 
the oxidised thiol groups at the active site more prone to interact with Fe(II) ions, 
rendering the glutathione reductase inactive. 
 
5.3 Evaluation of S. aureus RNA Extraction Methods 
The aim of this part of the research work was to determine if specific genes in S. 
aureus encoding for SOD enzymes were differentially expressed as a result of 
exposure to AgNO3. Most organisms produce enzymes such as superoxide dismutase 
and catalase to deal with the harmful effects of reactive oxygen species. S. aureus 
contains two genes, sodA and sodM, which encode for SOD and are important for the 
viability of the organism when it is experiencing stressful conditions.
206
 The sodA 
gene encodes for the manganese-dependent SOD, which inactivates harmful 
 161 
 
 
Fig. 5.7: Glutathione reductase activity in S. aureus cells treated with H2O2 and AgNO3. S. aureus cells were treated with the MIC80 values of 
AgNO3 for 15, 30 and 60 min. Cells were also exposed to H2O2 for the relevant time-points and protein was extracted from the cells (Section 
2.18) and glutathione reductase activity was assessed (Section 2.19.1). Results are presented as GLR activity along the x-axis and as fold 
changes in the bar chart. Differences in activity were deemed statistically significant at p < 0.05(*), p < 0.01 (**) and p < 0.001 (***).
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superoxide radicals
205
 and protect the cells from oxidative stress. The metal 
requirement for sodM has been suggested to also be manganese.
238
 The gene 
encoding for DNA gyraseA (a housekeeping gene) was also assessed and this was 
used as a positive control.  
Following RNA extraction, samples were analysed for purity using RNA 
electrophoresis (Section 2.20.6), and the samples were also analysed at OD260/280nm. 
A variety of RNA extraction procedures (Section 2.20) were used in an attempt to 
recover the nucleic acid in sufficient quantity and quality but none were successful. 
A brief overview of the unsuccessful extraction methods is given below and reasons 
for their failure are offered. 
 RNA electrophoretic analysis of S. aureus samples was carried out using each of the 
following extraction methods: a) Qiagen kit RNeasy® minikit, b) Qiagen RNeasy® 
minikit with RNAprotect bacteria reagent, and c) Tri reagent (Appendix IV, Fig. 1). 
Bands were observed using the Tri reagent method. Following RNA extraction, 
DNase treatment was carried out, after which cDNA synthesis was also performed. 
The extraction protocol using the Tri reagent provided the best quality RNA, with 
OD260/280nm readings in the range 1.7-2.2 which is slightly out of the range expected 
(OD260/280nm 1.9-2.1).
239
 Synthesised cDNA was also assessed spectrophotometrically 
(OD260/280nm) prior to RT-PCR analysis.  
RT-PCR was first performed using the housekeeping gene, DNA gyrase (gyrA), and 
no bands indicating a PCR product were observed (Appendix IV, Fig. 2a). It was 
then decided to try another primer set to determine if either the cDNA or the primers 
were the cause of no PCR product being recovered. The next set of primers tested 
was SodA and again no PCR product bands were observed (Appendix IV, Fig. 2b). 
Following this, a genomic DNA extraction protocol was carried out followed by 
PCR analysis using the SodA primer set. If bands were observed then the problem 
was due to the cDNA, and if no bands were observed then the problem could be 
attributed to the primers. The PCR product was visualised on a 1% agarose gel and 
again no bands were observed, suggesting that the primers were the cause (Appendix 
IV, Fig. 3a). However, when the synthesised cDNA was run on an agarose gel no 
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bands were observed suggesting that the RNA precursor was not of a high enough 
quality to proceed to the PCR analysis (Appendix IV, Fig. 3b).  
Previous research has been carried out to assess the gene expression in S. aureus 
cells.
113,205,206,240
 However, Gram-positive cocci are one of the most difficult to 
disrupt
241
 and may have contributed to the problem associated with our inability to 
extract RNA from S. aureus cells. This  may be due to the fact that staphylococci and 
other Gram-positive bacteria have a rigid cell wall which is thicker (15-80 nm) in 
comparison to Gram-negative bacteria (10 nm)
242
 which, in turn, makes it more 
difficult to lyse.
243
 This may explain the low quantity of RNA obtained. The general 
instability of mRNA also adds to the problem and this is due to the presence of a 
hydroxyl group on the pentose ring of the RNA, making it more susceptible to 
hydrolysis and therefore less stable than DNA.
244
 For most bacteria, mRNA has a 
half-life between 0.5-50 min and an average half-life of 3 min.
245
 This short half-life 
explains why gene expression is much more difficult to determine in prokaryotes 
than eukaryotes. As numerous extraction methods resulted in poor yields of RNA 
and no PCR product, it was decided not to proceed any further with this line of 
research. 
 
5.4 Conclusion 
In conclusion, the results presented in this Chapter suggest that exposure of S. aureus 
to AgNO3, at a concentration of 3.0 µg/ml, causes a significant increase in the 
activity of two detoxifying enzymes (SOD and CAT), which become upregulated in 
an effort by the cells to minimise the damage caused by exposure to the Ag(I) ion. 
The elevation in enzymatic activity of SOD and CAT at 30 min is evidence of a 
response to oxidative stress, but the decline in activity by 60 min suggest a loss in 
cell function or even cell death. Furthermore, exposure to AgNO3 also caused an 
increase in the amount of amino acid leakage from the cells, suggesting that the cell 
membrane integrity was compromised. These findings demonstrate the antimicrobial 
activity of AgNO3 and assist in elucidating the modes of action.  
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6.0 Introduction 
The results presented in this Chapter set out to further establish possible mode(s) of 
action of AgNO3 against S. aureus cells through the assessment of amino acid 
leakage and proteomic analysis following exposure to Ag(I) ions.  
 
6.1 Assessment of amino acid leakage from S. aureus cells as a result 
of exposure to AgNO3  
It has been suggested that the release of amino acids from the bacterial cell could be 
due to damage to the membrane integrity.
246
 It was decided to use a ninhydrin 
calorimetric assay to determine amino acid leakage from untreated cells (negative 
control) and cells exposed to either DMSO (positive control) or AgNO3 (3.0 µg/ml) 
for 1, 2, 4 and 24 h (Section 2.19.4). The results were determined by reference to a 
standard curve of known amino acid concentration. As shown in Fig. 6.1, treating 
cells with 10% DMSO led to significant amino acid leakage at all timepoints (p < 
0.001). This was to be expected, as DMSO is known to alter membrane 
permeability
246
 and was therefore employed as the positive control. Specifically, it 
was found that, in relation to the negative control in which 34 ± 2.9 µg/ml of amino 
acid leakage was detected, 60 ± 3.8 µg/ml of amino acid was detected at the 1 h 
timepoint in DMSO-treated cells (p < 0.001). This increased from 55 ± 1.9 µg/ml 
(negative control) to 69 ± 3.2 µg/ml after 2 h DMSO treatment, and from 47 ± 2.6 
µg/ml (negative control) to 71 ± 1.0 µg/ml in the case of the 4 h DMSO treatment. 
After 24 h DMSO treatment, an increase from 48 ± 3.0 µg/ml in the negative control 
to 65 ± 2.3 µg/ml was observed.  
For cells treated with AgNO3, a minor increase in amino acid leakage was observed 
at the 1 h timepoint (38 ± 1.2 µg/ml) compared to the negative control. By 2 h, no 
statistical difference was observed between the AgNO3-treated and the control cells. 
After 4 h treatment, an increase from 47 ± 2.6 µg/ml in the negative control to 58 ± 
2.1 µg/ml in the AgNO3-treated cells (p < 0.001) was observed. At the 24 h 
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Fig. 6.1: Effect of AgNO3 on amino acid leakage from S. aureus cells. The leakage of amino acids from S. aureus cells, which had been exposed 
to the MIC80 value of AgNO3 for 1, 2, 4 or 24 h, was assessed using the method described in Section 2.19.4. Differences in activity were deemed 
statistically significant at p < 0.05 (*), p < 0.01 (**) and p <0.001 (***). 
Proteomic response of Staphylococcus aureus as a result of exposure to AgNO3              Chapter 6 
167 
 
timepoint, an increase from 48 ± 3 µg/ml in the negative control to 57 ± 2.0 µg/ml 
amino acids leaked from AgNO3-treated cells (p< 0.01).  
Thus, treatment with DMSO resulted in the greatest leakage of amino acids. The 
maximum amount of amino acid leakage for AgNO3-treated cells occurred at 4 h (58 
µg/ml of amino acids). The quantity of amino acids released from the cell had 
plateaued by the 4 h timepoint as no further increase was observed by 24 h, 
suggesting that at this time the cells had reached the maximum leakage stage. 
Research into the effect of Ag(0) nanoparticles on S. aureus cells was conducted by 
Mirzajani et al
247
 who showed that the metal atoms interact with the peptidoglycan 
layer and lead to the formation of pits. It was found that the Ag(0) nanoparticles 
increased the amount of muramic acid, a major component of the peptidoglycan 
layer. Similar studies into the effect of Ag(0) nanoparticles on the Gram-negative 
bacterium, E. coli, showed an increase in the amount of reducing sugars and proteins 
released from the cells upon treatment with Ag(0) atoms.
248
 Kim et al
249
 suggested 
that exposure of C. albicans to Ag(0) nanoparticles promoted an antifungal effect 
through disruption of the cell membrane structure. This effect was assessed by 
measuring the release of glucose and trehalose. The Ag(0) nanoparticles induced 
30.3 µg/mg of glucose and trehalose release in comparison to the release of 6.8 
µg/mg in the untreated control cells. The results of the present studies suggest that 
Ag(I) ions do affect the membrane permeability of the S. aureus cells as a 
statistically significant increase in amino acid leakage from the cell was observed. 
 
6.2 Proteomic analysis of the proteins released by S. aureus   
following exposure to AgNO3 
Following the assessment of changes in the enzymatic function and membrane 
permeability of S. aureus cells, it was decided to further investigate the response of 
S. aureus to AgNO3 using proteomic analysis involving one- and two-dimensional 
SDS-PAGE (Summarised in Section 6.0). S. aureus cells were exposed to the MIC80 
value of AgNO3 (3.0 µg/ml) for 2 h. Protein was extracted from AgNO3-treated and 
untreated S. aureus cells for comparison (Section 2.18), separated by 1-D 
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electrophoresis (Section 2.21.1) and visualised using Coomassie blue (Section 2.3). 
Protein expression in treated and untreated cells is illustrated in Fig. 6.2. It is evident 
from this gel that administering AgNO3 has an effect on the protein leakage in 
relation to the control, particularly at 2 h. 
For 2-D SDS-PAGE, protein was first separated by isoelectric focusing and secondly 
by molecular weight (Section 2.21.2) (Fig. 6.3-6.4). Protein was visualised using 
colloidal Coomassie (Section 2.3). Following the visualisation of protein, spot 
intensities were analysed using ImageQuant 5.0 software and changes in protein 
expression were evaluated relative to the control. The spots of interest were excised, 
washed and trypsin digested (Section 2.22) and LC/MS analysis was then carried out 
to determine the identity and function of these proteins. The extracellular leaked 
proteins which had changed significantly in their fold expression (Tables 6.1-6.4) 
were identified following LC/MS analysis and their biochemical functions were 
established using MASCOT and Uniprot software programmes.  
A total of 30 leaked proteins were identified (Tables 6.1-6.4). Of these, 17 were 
involved in metabolism (Table 6.1), 6 were involved in virulence (Table 6.2), 4 in 
the stress response of S. aureus (Table 6.3) and 3 were uncharacterised proteins 
(Table 6.4). Proteins which were involved in metabolism included (a) the 
tricarboxylic acid cycle enzymes; malate:quinone oxidoreductase (Spot 1), acetate 
kinase (Spot 4) and succinyl Coenzyme A synthetase (Spot 7), (b) the glycolytic 
enzyme; phosphoglycerate mutase (Spot 10), (c) proteins involved in translation; 
30S ribosomal protein (Spot 8), 50S ribosomal protein L25 (Spot 9) and 50S 
ribosomal protein L31 (Spot 17), (d) protein biosynthesis enzymes; translation 
elongation factor Tu (Spot 11) and elongation factor G (Spot 16), (e) other metabolic 
processes; glycerol phosphate lipoteichoic acid synthetase (Spot 2), serine 
hydroxymethyltransferase (Spot 3), aminoacyltransferase FemB FemB protein (Spot 
5), lipase (Spot 6), 2-C-methyl-D- erythritol 4-phosphate cytidylyltransferase (Spot 
12), 3-hexulose-6-phosphate synthetase (Spot 13), glutamine amidotransferase 
subunit PdxT (Spot 14) and uracil phosphoribosyltransferase (Spot 15) (Table 6.1). 
There were also significant changes in fold expression of proteins involved in the 
virulence of S. aureus (Table 6.2) such as leukocidin F (Spot 18), transcriptional 
repressor CodY (Spot 19), ABC transporter (Spot 20), alpha-hemolysin (Spot 21),  
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Fig. 6.2: One-Dimensional SDS-PAGE analysis of proteins leaked from S. aureus cells. Protein was extracted using mild sonication (Section 
2.18) and separated by 1-D SDS PAGE (Section 2.21.1). Protein bands (highlighted) appear to be altered in expression as a result of AgNO3 
treatment at various times in relation to the control (no AgNO3 added). 
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Fig. 6.3: Two-Dimensional SDS-PAGE analysis of proteins leaked from S. aureus cells. Protein was extracted using mild sonication (Section 
2.18) and separated by 2-D SDS PAGE  (Section 2.21.2). (a) Control cells (untreated) and (b) cells incubated for 2 h with AgNO3 (3.0 µg/ml) 
 
(a) (b) 
pH 3                                                            10 pH 3                                                            10 
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Fig. 6.4: Two-Dimensional SDS-PAGE analysis of metabolic proteins leaked from S. aureus cells. Protein was extracted using mild sonication 
(Section 2.18) and separated by 2-D SDS PAGE  (Section 2.21.2). (a) Control cells (untreated) and (b) cells incubated for 2 h with AgNO3 (3.0 
µg/ml). 
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Table 6.1: Identification of  proteins involved in metabolic processes associated with S. aureus cells. 
Spot No. 
Accession  
No. 
Protein Function 
 
Mass 
 (kDa) 
Score pI 
% 
Coverage 
Fold 
Difference 
1 Q6G669 
Malate:quinone 
oxidoreductase 2 
Tricarboxylic acid 
cycle 56138 
957 6.12 
47% 
- 3.1 
2 Q99VQ4 
Glycerol phosphate 
lipoteichoic acid synthase  
Cell wall biogenesis  74353 395 9.04 15% - 1.7 
3 C5PZ99 
Serine 
hydroxymethyltransferase 
Metabolic process 45299 517 5.72 27% + 2.0 
4 C8MFH1 Acetate kinase 
Tricarboxylic acid 
cycle 
44074 1081 5.58 61% + 2.1 
5 P0A0A8 
Aminoacyltransferase 
femB FemB protein  
Formation of the 
pentaglycine 
interpeptide bridge  
49761 376 5.44 16% - 1.6 
6 Q6GJZ6 Lipase  
Triglyceride lipase 
activity 
44344 390 8.95 20% + 2.4 
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Table 6.1: Continued. 
Spot No. 
Accession 
No. 
Protein Function 
 
Mass 
 (kDa) 
Score pI 
% 
Coverage 
Fold 
Difference 
7 P99070 Succinyl-CoA synthetase  
Tricarboxylic acid 
cycle 
31754 377 5.47 27% + 1.6 
8 P66545 30S ribosomal protein S2  Translation 29134 647 5.44 47% + 1.6 
9 Q7A1s4 
50S ribosomal protein 
L25/general stress protein 
Translation 23773 464 4.39 34% + 1.7 
10 D2UHN7 Phosphoglycerate mutase Glycolysis 26722 898 5.14 78% + 2.1 
11 C8MB74 
Translation elongation 
factor Tu  
Protein biosynthesis 43135 573 4.77 38% - 1.6 
12 Q2G1C0 
2-C-methyl-D-erythritol 4-
phosphate 
cytidylyltransferase 
Nucleotidyl-
transferase 
26698 449 5.42 46% + 1.5 
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Table 6.1: Continued. 
 
Spot No. 
Accession 
No. 
Protein Function 
 
Mass 
 (kDa) 
Score pI 
% 
Coverage 
Fold 
Difference 
13 D0K9M2 
3-hexulose-6-phosphate 
synthase 
Carbohydrate 
metabolic process 
22422 620 4.61 64% - 1.8 
14 Q7A1R6 
Glutamine 
amidotransferase subunit 
PdxT  
Hydrolysis of 
glutamine to 
glutamate and 
ammonia 
20733 693 5.69 61% + 2.3 
15 P67397 
Uracil 
phosphoribosyltransferase 
Glycosyltransferase 
23093 
652 6.08 
65% 
+ 1.5 
16 
 
P68791 
 
Elongation factor G Protein biosynthesis 76854 365 4.8 14% + 1.8 
17 P66197 
50S ribosomal protein L31 
type B  
Translation 9717 166 8.04 61% + 1.7 
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bifunctional autolysin (Spot 22) and signal transduction protein TRAP (Spot 23). 
The proteins involved in the stress response of S. aureus all showed increases in 
release upon exposure to AgNO3 (Table 6.3). These proteins included a putative 
universal stress response protein (Spot 24), methionine sulfoxide reductase A (Spot 
25), alkaline shock protein 23 (Spot 26) and transcription repressor of class III stress 
genes-like protein (Spot 27). Finally, there were three proteins with a significant fold 
change whose identity and function remains unknown (Table 6.4). 
Acetate kinase (Spot 4) and succinyl CoA synthetase (Spot 7) are two enzymes 
involved in the tricarboxylic acid cycle (Appendix VI). This cycle involves the initial 
conversion of pyruvate (the product of glycolysis) into acetyl CoA and, through a 
series of steps, it is converted to oxaloacetate. Acetate kinase catalyses the first 
reaction in the conversion of acetate to acetyl CoA, where acetate is converted to 
acetyl phosphate, whereas the second reaction is mediated by 
phosphotransacetylase.
250
 Succinyl CoA synthetase is involved in the cycle at a later 
stage in which it catalyses the transformation of succinyl CoA to succinate.
251
 This 
cycle results in the production of two molecules of ATP, carbon dioxide and also the 
reduction of NAD
+
 to NADH. It was found that these proteins were increased in 
abundance by 2.1 fold and 1.6 fold, respectively, suggesting that S. aureus cells are 
trying to increase cellular respiration as a result of AgNO3 exposure.  
Glycolysis is one of the major metabolic pathways which produces energy needed to 
fuel all other cellular processes (Appendix V). It can be divided into two parts; 
firstly, the energy investment phase and secondly, the energy pay-off phase. In the 
first phase, energy is consumed in the process of converting glucose to triose 
phosphates whilst in the second phase energy is gained in the form of ATP 
production.
252
 Phosphoglycerate mutase (Spot 10) was found to have increased in 
expression by 2.1 fold. Sigdel et al
253
 also found that this protein was increased due 
to Zn(II) ion exposure in E. coli cells. This protein is also involved in the energy 
pay-off phase and is responsible for the interconversion of 3-phosphoglycerate and 
2-phosphoglycerate within the glycolysis pathway.
254
  
The virulence of S. aureus can be attributed to the expression of adhesins and also to 
the secretion of toxins.
255
 Alpha hemolysin is one of the main pore-forming toxins of 
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Fig. 6.5: Two-Dimensional SDS-PAGE analysis of virulence proteins leaked from S. aureus cells. Protein was extracted using mild sonication 
(Section 2.18) and separated by 2-D SDS PAGE  (Section 2.21.2). (a) Control cells (untreated) and (b) cells incubated for 2 h with AgNO3 (3.0 
µg/ml). 
18 
20 21 
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23 
19 
pH 3                                                            10 pH 3                                                            10 
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Table 6.2: Identification of proteins involved in the virulence of S. aureus. 
Spot No. 
Accession 
No. 
Protein Function 
 
Mass 
 (kDa) 
Score pI 
% 
Coverage 
Fold 
Difference 
18 Q53747 Leucocidin F  
Cytolysis in other 
organism 
pathogenesis 
36986 98 9.12 7% - 1.5 
19 P63845 
Transcriptional repressor 
CodY 
Transcription 
regulation 
28737 532 5.87 56% + 1.6 
20 Q5HIU3 ABC transporter ATP-binding 31575 609 5.25 41% + 1.7 
21 P09616 Alpha-hemolysin Pore formation 
33227 
633 
7.94 49% 
- 2.1 
22 P0Z5Z8 Bifunctional autolysin 
Cellular cell wall 
organization 
62644 219 9.29 10% - 1.7 
23 Q7A4W3 
Signal transduction 
protein TRAP 
Major regulator of 
staphylococcal 
pathogenesis 
19594 187 6.12 37% + 3.1 
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S. aureus and integrates into a target cell membrane forming a cylindrical heptamer. 
This leads to pore formation and allows the efflux of cellular contents and the influx 
of Na
+
 and Ca
2+
 into the cell causing osmotic swelling and resulting in cell 
rupture.
142
 Proteomic analysis identified a 2.1 fold decrease in expression of alpha 
hemolysin (Spot 21), suggesting that, at the MIC80 value, AgNO3 reduces the 
expression of an S. aureus virulence factor. Bernardo et al
255
 also found that the 
abundance of secreted exoproteins, such as alpha- and beta-hemolysin, were reduced 
in S. aureus cells after exposure to the antibiotic, linezolid. Another virulence factor 
which was found to be increased in expression was the signal transduction protein, 
TRAP (target of RNAIII-activating protein) (Spot 23). S. aureus TRAP is known to 
play a key role in regulating the pathogenesis of S. aureus by controlling a range of 
virulence factors.
256
 It has been suggested that RNAIII allows S. aureus to adhere to 
host cells when they are in a low density. The bacterial cells then express toxins in 
the late exponential growth phase, thus allowing the organism to establish an 
infection.
257
 It has also been shown that without the expression or the 
phosphorylation of TRAP, virulence factors, such as hemolysins, are not 
expressed.
258
 Korem et al
258
 have also shown that cells which are defective in the 
expression or the phosphorylation of TRAP do not adhere as strongly in vitro to 
plastic polymers or mammalian host cells and fail to form biofilms in vivo. The 
expression TRAP was found to have increased by 3.1 fold, suggesting that S. aureus 
cells are responding by upregulating virulence factors to combat AgNO3 exposure. 
As already mentioned, organisms defend against ROS using a range of antioxidant 
enzymes such as SOD, catalase and glutathione. In spite of these antioxidant 
mechanisms cellular damage can still occur. This is where methionine sulfoxide 
reductase A (MsrA) can intervene and function as a repair enzyme.
259
 The Msr 
enzyme family are made up of MsrA and MsrB which reduce S-MetO and R-MetO, 
respectively, back to methionine.
260
 The proteins involved in the stress response of S. 
aureus were all found to be up-regulated (1.2-2.9 fold) upon AgNO3 treatment. 
Methionine sulphoxide reductase A (Spot 25) was the protein most induced, with a 
2.9 fold increase in abundance. Singh et al
261
 also found that this protein was 
induced upon exposure of S. aureus cells to the antibiotic, oxacillin. The 
identification of these proteins confirm that S. aureus cells are experiencing stress as  
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Fig. 6.6: Two-Dimensional SDS-PAGE analysis of proteins leaked from S. aureus cells involved in stress response (blue) and unknown function 
(purple). Protein was extracted using sonication (Section 2.18) and separated by 2-D SDS PAGE  (Section 2.21.2). (a) Control cells (untreated) 
and (b) cells incubated for 2 h with AgNO3 (3.0 µg/ml) 
24 25 
26 
27 
28 29 
30 
pH 3                                                            10 pH 3                                                            10 
(a) (b) 
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Table 6.3: Identification of proteins involved in the stress response of S. aureus.
Spot No. 
Accession 
No. 
Protein Function 
 
Mass 
 (kDa) 
Score pI 
% 
Coverage 
Fold 
Difference 
24 Q2FXL6 
Putative universal stress 
protein 
Response to stress 18522 639 5.60 69% + 1.2 
25 P65446 
Methionine sulfoxide 
reductase A 
Repair enzyme 20749 254 6.37 35% + 2.9 
26 P0A0P7 Alkaline shock protein 23 Alkaline pH tolerance 19180 466 5.13 55% + 2.8 
27 Q7A1R4 
Transcription repressor of 
class III stress genes-like 
protein 
 
Stress response 
 
17888 467 5.93 52% + 1.6 
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Table 6.4: Identification of proteins of unknown function
Spot No. 
Accession 
No. 
Protein Function 
 
Mass 
 (kDa) 
Score pI 
% 
Coverage 
Fold 
Difference 
28 Q99UP3 
Hypothetical protein 
SAV1225  
Function unknown 13435 365 5.78 72% + 1.5 
29 Q2FW79 
 
UPF0457 protein 
SAOUHSC_02425 
 
Belongs to the 
uncharacterised 
protein (UPF0457) 
family  
10000 
152 
 
6.07 51% + 1.5 
30 Q99TW8 
Hypothetical protein 
SAV1525  
Putative 
uncharacterised 
protein 
13323 316 6.84 65% - 1.6 
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as a result of AgNO3 exposure, and this correlates with the earlier oxidative stress 
response found using the SOD and CAT assays (Chapter 5). 
 
6.3 Proteomic analysis of the effect of AgNO3 on S. aureus 
intracellular protein expression 
Following the analysis of the extracellular proteins released from S. aureus cells it 
was decided to examine the intracellular proteins which may have changed in 
expression as a result of AgNO3 exposure. This was determined using one- and two-
dimensional SDS-PAGE. S. aureus cells were exposed to the MIC80 value of AgNO3 
(3.0 µg/ml) for either 1 or 4 h. Protein was extracted using the glass beads method 
(Section 2.18), separated by 1-D electrophoresis (Section 2.21.1) and visualised 
using Coomassie blue (Section 2.3). Protein expression in treated and untreated 
bacterial cells is illustrated in Fig. 6.6. It is evident from this gel that treatment with 
AgNO3 has an effect on the protein expression (in relation to the control) and it was 
decided to focus attention on the protein expression at 1 and 4 h. 
Glass beads were used as a more robust method of protein extraction to ensure that 
the cells were totally lysed and the intracellular content released. 2-D SDS-PAGE 
analysis was performed and protein was visualised using colloidal Coomassie 
(Section 2.3). Following the visualisation of protein spots, spot intensities were 
analysed using Progenesis SameSpot™ software and changes in expression were 
evaluated relative to the control. The spots of interest were excised, washed and 
trypsin digested (Section 2.22) and LC/MS analysis was carried out to determine the 
identity and function of these proteins. Listed in Table 6.5 are the identified 
intracellular proteins found following LC/MS analysis with their functions were 
identified using MASCOT and Uniprot software programmes. Protein expression in 
untreated S. aureus cells (control cells) in comparison the AgNO3-treated cells for 1 
and 4 h is shown in Fig. 6.7 and the reference image for Progenesis is shown in Fig. 
6.8. 
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Fig. 6.6: One-Dimensional SDS-PAGE analysis of intracellular proteins from S. aureus cells. Protein was extracted using the glass beads 
method (Section 2.18) and separated by 1-D SDS PAGE (Section 2.21.1). Protein bands highlighted appear to be altered in expression as a result 
of AgNO3 treatment at various times in relation to the control. 
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In total, 12 spots were identified (Table 6.5). AgNO3 induced an increase in the 
expression of proteins after 1 h treatment. Of these, 9 proteins were identified to be 
involved in metabolism, 2 were involved in virulence and 1 in the stress response of 
S. aureus. The metabolic proteins included elongation factors Ts, Tu and G (spot 
236, 155 and 78, respectively), ornithine carbamoyltransferase (spot 237), 
hypothetical protein EF0177 (spot 217), dihydrolipoamide dehydrogenase (Spot 
147), fructose-bisphosphate aldolase (spot 314), 30S ribosomal protein S3 (spot 333) 
and triosephosphate isomerase (spot 340).  
Protein biosynthesis is one of the essential processes of living cells and is the driving 
force behind the growth and development of all organisms, with the protein 
elongation cycle being one of the main steps.
262
 Elongation factors play an important 
role in the translation stage of protein biosynthesis, i.e. the progressive addition of 
amino acids to the growing polypeptide chain. The elongation factors are involved in 
the addition of amino acids in the elongation stage of this process. The elongation 
factors, Ts, Tu and G, followed a similar trend with expression increases peaking at 
1 h (4.1, 2.3 and 1.3 fold, respectively) and decreasing in expression by 4 h (2.1, 1.1 
and -3.2 fold, respectively). Each of the elongation factors have a specific role, with 
elongation factor Tu (EF-Tu) being activated upon exchange of GDP for GTP
263
 and 
responsible for the transportation of the aminoacyl-tRNA to the ribosome.
262
 The 
exchange of GDP for GTP is carried out by the elongation factor Ts (EF-Ts), which 
is a nucleotide exchange factor.
264
 The last of the elongation factors, EF-G, is 
involved in the translocation of tRNA and mRNA by one codon on the ribosome.
265
 
The increase in expression of these elongation factors at 1 h suggests that the S. 
aureus cells are responding to AgNO3 treatment by increasing protein biosynthesis. 
However, this effect is lost by 4 h as a decrease in expression is observed, suggesting 
cell death. Kaakoush et al
266
 also found that the elongation factors Tu and G of 
Campylobacter jejuni were upregulated as a result of exposure to Cd(II) ions, 
suggesting that additional protein biosynthesis occurs in response to metal ion 
exposure. 
A number of the identified proteins were involved in cellular respiration in either the 
glycolytic pathway or the tricarboxylic acid pathway (Appendices IV and V, 
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Fig. 6.7: Two-Dimensional SDS-PAGE analysis of S. aureus cells treated with MIC80 AgNO3. Protein was extracted using the glass beads 
method (Section 2.18) and separated by 2-D SDS PAGE (Section 2.21.2). (a) Control cells (untreated), cells incubated in AgNO3 (3 µg/ml) for 
(b) 1 h and (c) 4 h. 
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Fig. 6.8: Progenesis SameSpot™ software reference image. Protein spots were analysed for fold changes in comparison to untreated cells. 
Protein spots were extracted for identification using LC/MS (Section 2.22). 
97.4 
 
97.4 
14.4 
66.2 
 
66.2 
45 
31 
21.5 
kDa 
 
kDa 
   pH3                                                                                   10 
 187 
 
Table 6.5: Summary of S. aureus intracellular proteins identified using LC/MS. 
                         
 
 
 
Spot No. Accession No. Protein Function 
 
Mass 
 (kDa) 
Score 
% 
Coverage 
pI 
Fold Changes 
0 h 1 h 4 h 
111 
 
NP_814413 
 
Oligoendopeptidase F Proteolysis 69025 260 10% 4.85 1 1.1 1.5 
236 NP_816048 Elongation factor Ts Protein biosynthesis 32113 335 43% 4.87 1 4.1 2.1 
237 ZP_05425197 
Ornithine 
carbamoyltransferase 
Transferase activity 38135 1126 74% 5.02 1 1.7 - 1.6 
217 
NP_813980 
 
Hypothetical protein 
EF0177 
Lipid binding 37784 930 65% 4.88 1 1.9 - 1.6 
155 NP_371072 Elongation factor Tu Protein biosynthesis 43135 281 15% 4.74 1 2.3 1.0 
314 NP_814897 
Fructose-bisphosphate 
aldolase 
Fructose 1,6-
bisphosphate metabolic 
process 
31025 387 33% 4.86 1 1.4 - 1.6 
147 NP_815077 
Dihydrolipoamide 
dehydrogenase 
Flavin adenine 
dinucleotide binding 
49229 683 45% 4.95 1 2.3 - 1.1 
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Table 6.5: Continued. 
 
Spot No. Accession No. Protein Function 
 
Mass 
 (kDa) 
Score 
% 
Coverage 
pI 
Fold Changes 
0 h 1 h 4 h 
333 NP_814010 
30S ribosomal protein 
S3 
 
Translation 
 
24355 221 23% 
 
9.80 
 
1 2.0 - 1.1 
78 
 
NP_371071 
 
Elongation factor G Protein biosynthesis 76854 362 16% 
 
4.80 
 
1 1.3 - 3.2 
340 NP_815638 
Triosephosphate 
isomerase 
Glycolysis 27130 324 39% 
 
4.63 
 
1 1.9 - 1.3 
294 YP_002559945 ABC transporter ATP-binding 29096 404 25% 4.85 1 1.5 2.7 
417 1FU0_A 
Chain A, Crystal 
Structure Analysis Of 
The Phospho-Serine 
46 Hpr 
Phosphotransferase 
system 
9210 98 13% 5.00 1 1.7 1.0 
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respectively). The metabolic proteins, fructose-bisphosphate aldolase and 
triosephosphate isomerase, are involved in the glycolysis pathway, which is a major 
source of energy for cells and which involves the metabolism of glucose. Fructose-
bisphosphate aldolase is involved in step four of the glycolysis pathway, in which 
fructose-1,6-bisphosphate is cleaved into the two 3-carbon sugars, dihydroxyacetone 
phosphate and glyceraldehyde-3-phosphate.
267
 It is in the next step of the glycolytic 
pathway that triosephosphate isomerase is responsible for the interconversion of 
these two sugars.
268
 It was found that both of these proteins were increased in 
expression (1.4 fold for fructose-bisphosphate aldolase and 1.9 fold for 
triosephosphate isomerase) at 1 h and decreased in expression at 4 h (fructose-
bisphosphate aldolase by 1.6 fold and triosephosphate isomerase decreased by 1.3 
fold, both in relation to the control). The dihydrolipoamide dehydrogenase protein 
was increased in expression by 2.3 fold at 1 h, but this decreased by 1.1 fold at 4 h. 
This latter protein is the third enzyme involved in the pyruvate dehydrogenase 
complex. The enzyme converts pyruvate, the product of glycolysis, into acetyl-CoA 
which is then used in the tricarboxylic acid cycle
269
 for cellular respiration and 
therefore linking the two processes of glycolysis and the tricarboxylic acid cycle.
270
 
These observations suggest that S. aureus cells are responding to AgNO3 exposure 
by increasing cellular respiration. Fructose-bisphosphate aldolase has previously 
been reported to be increased in expression in caspofungin-treated C. albicans cells, 
where it was postulated to be contributing to a stronger immune response.
271
 
Triosephosphate isomerase and dihydrolipoamide dehydrogenase were both found to 
be up-regulated following exposure to Cd(II) ions, suggesting that these cations have 
a significant impact upon carbohydrate metabolism in C. albicans cells.
272
 
The bacterial ribosome (70S) is made up of two subunits; a small subunit (30S) and a 
larger subunit (50S). The 30S subunit itself is made up of 21 proteins and a single 
strand of RNA
273
 of around 1500 nucleotides (which corresponds to a 16S 
sedimentation coefficient).
274
 The larger subunit (50S) is made up of 34 proteins and 
2 strands of RNA which correspond to a 23S and a 5S sedimentation coefficient.
273
 It 
is only when the 30S and 50S subunits attach to an mRNA molecule that a functional 
ribosome is formed and this subsequently plays an important role in the translation 
of a protein. The 30S ribosomal subunit is central to the selection of a start site on 
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the mRNA which is a critical phase of the initiation process of translation.
274
 In the 
current study, the 30S ribosomal protein, S3, was found to have increased in 
expression by 2.0 fold at 1 h and decreased by 1.1 fold at 4 h. This suggests that the 
S. aureus cells are increasing protein biosynthesis as a result of AgNO3 exposure. 
The proteins involved in the virulence of S. aureus include an ABC (ATP binding 
cassette) transporter protein (spot 294) and also the protein, phosphoserine 46 Hpr 
(spot 417). The ABC transporter protein is one of the largest classes of transporters 
which, by their nature, are responsible for mediating the movement of small 
molecules, ions and even macromolecules across membranes.
275
 ABC transporters 
are involved in many processes such as the uptake of nutrients, energy generation 
and cell signalling.
276
 They have also been implicated in the removal of waste 
products, xenobiotic protection and bacterial immunity and virulence.
277
 S. aureus 
cells respond to AgNO3 treatment by significantly increasing the expression of this 
ABC transporter at 1 and 4 h (1.5 fold and 2.7 fold, respectively), suggesting that the 
cells are attempting to prevent the entry of AgNO3 into the cell or the efflux of 
metabolites. Bacteria have developed mechanisms to decrease the residence time of 
toxic materials in the cell by effluxing them from the cell across the cytoplasmic 
membrane.
277
 ABC transporters have received considerable attention due to their 
contribution to the resistance of cells to antibiotics and has led to the development of 
synthetic inhibitors whose function is to prevent the interference of these transporters 
with administered drugs.
278
  
The phosphoserine 46 HPr, plays an important role in the carbon catabolite 
repression system, which is a regulatory mechanism to help bacteria make efficient 
use of the available carbon sources, of which glucose is the most preferred.
279
 As 
bacteria can be exposed to a variety of carbon sources in their natural habitat, this 
mechanism allows for selective uptake and the metabolism of carbon sources which 
will encourage the most rapid growth of the organism.
280
 As bacteria aim to gain 
access to nutrients, the HPr protein contributes to the pathogenicity of S. aureus. The 
phosphorylation of HPr is catalysed by HPrK kinase which is triggered by the 
availability of fructose-1,6-bisphosphate.
279
 This is interesting to note, as 
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phosphoserine 46 HPr was increased by 1.7 fold at 1 h and the expression of 
fructose-1,6-bisphosphate was also found to be increased (as previously discussed).   
Oligoendopeptidase F (spot 111) is implicated in the stress response of S. aureus and 
is involved in proteolysis, which allows for the controlled degradation of proteins.
281
 
Proteolysis is an essential process and is required for quality control and also for the 
regulatory response to environmental stimuli.
282
 Proteolysis has been implicated in 
many processes such as regulation of the cell cycle, stress response and also 
apoptosis. Proteases have been known to contribute to the ability of an organism to 
withstand stressful conditions, such as oxidative stress.
283
 It is interesting to note that 
this protein was found to be increased by 1.5 fold in expression at 4 h after AgNO3 
treatment, suggesting that the S. aureus cells are trying to withstand the stressful 
environment. Oligoendopeptidase F is suspected to also contribute to the virulence 
of this organism since Group A Streptococci has been shown to evade the host 
immune response by disrupting the recruitment of phagocytic cells through the 
action of a serine endopeptidase.
284
 
As was found in the case of the extracellular leaked proteins, a protein of unknown 
function was also significantly changed in expression. The hypothetical protein, EF-
177, was increased in expression by 1.9 fold at 1 h and reduced by 1.6 fold at 4 h (in 
relation to the control). 
 
6.4 Conclusion 
In conclusion, it has been discovered that when S. aureus cells were exposed to 
AgNO3 there were significant fold changes (increases and decreases) in extracellular 
leaked proteins and also the expression of intracellular proteins, such as metabolic 
proteins, proteins involved in virulence and also those implicated in the stress 
response of the bacterium. For the extracellular proteins, at the 2 h timepoint, 12 
metabolic proteins, 3 virulence proteins and all 4 stress response proteins were 
increased in abundance, whereas 5 metabolic proteins and 3 virulence proteins were 
decreased. For the intracellular proteins, at the 1 h timepoint, 9 metabolic proteins 
were increased in expression, but by 4 h they had decreased. These findings suggest 
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that the cells are responding to administered AgNO3 by increasing the expression of 
proteins involved in essential cellular processes such as translation (which is 
involved in protein biosynthesis), glycolysis and the tricarboxylic acid cycle, which 
results in the production of ATP and is essential for metabolism within the cell. 
Ultimately, in the case of the intracellular proteins, the cells were unable to maintain 
this protective response after 4 h of exposure to AgNO3. It is interesting to note that 
of the proteins involved in virulence, the ABC transporter was identified amongst 
both the extracellular leaked proteins and the intracellular proteins. This ABC 
protein was increased in expression at all timepoints, suggesting that the organism 
was mounting an efflux response in an attempt to remove toxins from the cell as a 
result of AgNO3 exposure. The results presented in this Chapter demonstrate the 
impact of AgNO3 on essential cellular processes in S. aureus cells up to 4 h. The 
study also revealed the response of S. aureus to this antimicrobial agent at a 
proteomic level. 
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7.0 Concluding Remarks 
 
The main aims of this research were (i) to synthesise a surgical Bioglue 
incorporating Ag(I) ions in order to prevent the occurrence of nosocomial infections, 
and (ii) to determine a possible mode(s) of action of the Ag(I) ion against 
Staphylococcus aureus.  
Clinically used Bioglue hydrogel, prepared by reacting bovine serum albumin with 
glutaraldehyde, is very susceptible to colonization by pathogenic microbes. Addition 
of specific amounts of Ag(I) ions to the albumin/aldehyde mixture gives an Ag(I)-
Bioglue that offers protection against fungal and bacterial growth. 
Bioglue hydrogel samples prepared in the absence and in the presence of the Ag(I) 
ions (from AgNO3 and [Ag2(3,6,9-tdda)].2H2O), were thermally stable and had 
reversible swelling properties in the presence of water. As the amount of added Ag(I) 
ions in the Bioglue formulation decreased the swelling ratio in water increased. The 
Ag(I) ions crosslink the gel network giving a more rigid structure and limit the 
amount of hydrogen-bonding sites available for water molecules to access and cause 
swelling. After 24-48 h, Bioglue without Ag(I) ions and Bioglues containing very 
small amounts of Ag(I) ions start to break down due to hydrolysis. Bioglues without 
added Ag(I) ions have a very porous surface morphology, whilst the addition of 
Ag(I) ions into the formulation gives a product with a smoother surface due to the 
formation of a more rigid structure.  
Adherence of wood and pigskin samples bonded together with Bioglue decreases as 
the amount of added Ag(I) ions in the formulation increases. Elasticity of the 
Bioglue is also inversely proportional to the quantity of added Ag(I) ions. Leaching 
of Ag(I) ions from the AgNO3-Bioglues occurred rapidly over the first 10 h and 
steadily reached an equilibrium after 55 h.  
Bioglue samples containing AgNO3 (0.01 g) could be reduced using sodium 
borohydride and sodium citrate. However, no Ag(0) nanoparticles were detected 
using either UV-Visible spectroscopy or SEM analysis. Exposing Bioglue (without 
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Ag(I) ions) to Ag(0) nanoparticles does not lead to uptake of Ag(0) into the Bioglue 
matrix.  
Ag(I)-Bioglues inhibit the growth of the fungal pathogen, Candida albicans, and 
they also exhibit potent activity against the bacterial species, Pseudomonas 
aeruginosa, Escherichia coli, Staphylococcus aureus and Methicillin-Resistant 
Staphylococcus aureus. Bioglues formulated using AgNO3 exhibited superior anti-
bacterial activity than those made from [Ag2(3,6,9-tdda)].2H2O. Based on Ag(I) ion 
content, AgNO3 was more active than [Ag2(3,6,9-tdda)].2H2O against Candida 
albicans (36.8 µM and 71.6 µM Ag(I), respectively). AgNO3 and [Ag2(3,6,9-
tdda)].2H2O were equally active against S. aureus (MIC80 ca. 18 µM) and AgNO3 
was more effective against M.R.S.A. than [Ag2(3,6,9-tdda)].2H2O (MIC80 17.7 µM 
and 143.5 µM, respectively).  
Exposing S. aureus cells to a MIC80 value of AgNO3 results in an increase in activity 
of the antioxidant enzymes superoxide dismutase, catalase and, to a lesser extent, 
glutathione reductase, after a 30 min exposure time. This activity subsequently 
decreases after 60 min due to the loss of cell viability. Furthermore, exposing these 
bacterial cells to AgNO3 results in an increase in the amount of amino acid leakage 
from the cells, suggesting that Ag(I) ions affect membrane permeability. In addition, 
proteomic analysis revealed that S. aureus cells exposed to AgNO3 resulted in an 
increase in expression of a number of proteins involved in the stress response of the 
organism and as the bacterium attempts to mount a protective response. This is 
evident by the increase in expression of virulent and essential metabolic proteins. 
Exposure of S. aureus to AgNO3 causes a short-term protective response within the 
organism but ultimately these defense strategies are overwhelmed and the cells die. 
The exposure of patients to harmful microorganisms within the first few hours of 
admission to hospital makes these Ag(I)-Bioglues an attractive option. They have the 
ability to prevent such an infection, due to the rapid availability of bioactive Ag(I) 
ions within these crucial first few hours and also provide a steady accessibility of 
Ag(I) ions over a 55 h period. The reduction in adherence and elasticity properties of 
the Ag(I)-Bioglue may be a worthwhile compromise for the availability of 
antimicrobial Ag(I) ions. 
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Appendix I: Mass Spectra for [Ag2(3,6,9-tdda].2H2O 
 
 
(a) 
 
 
(b) 
Fig. 1: Mass spectra for [Ag2(3,6,9-tdda)].2H2O: (a) complete mass spectrum 
indicating 3,6,9-tddaH2 + Na
+
 fragment (245.06 g mol
-1
) and (b) mass spectrum 
indicating isotopes of [Ag2(3,6,9-tdda) + H]
+
 (434.87, 436.87 and 438.87 g mol
-1
). 
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Appendix II: Atomic Absorption Spectroscopy Data 
 
Table 1: Atomic Absorption Spectroscopy data for AgNO3-Bioglue (0.1 g). 
 
Sample (1) 
(%) 
Sample (2) 
(%) 
Sample (3) 
(%) 
Run 1 10.56 13.31 14.28 
Run 2 11.99 10.44 12.28 
Run 3 10.75 9.91 10.97 
 
 
Table 2: Atomic Absorption Spectroscopy data for AgNO3-Bioglue (0.01 g). 
 
Sample (1) 
(%) 
Sample (2) 
(%) 
Sample (3) 
(%) 
Run 1 1.77 1.89 3.29 
Run 2 1.50 1.37 1.24 
Run 3 1.36 1.22 1.09 
 
 
Table 3: Atomic Absorption Spectroscopy data for AgNO3-Bioglue (0.001 g). 
 
Sample (1) 
(%) 
Sample (2) 
(%) 
Sample (3) 
(%) 
Run 1 1.04 1.07 0.90 
Run 2 0.35 0.34 0.29 
Run 3 0.24 0.24 0.22 
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Table 4: Atomic Absorption Spectroscopy data for AgNO3-Bioglue (0.0001 g). 
 
Sample (1) 
(%) 
Sample (2) 
(%) 
Sample (3) 
(%) 
Run 1 0.23 0.26 0.31 
Run 2 0.40 0.29 0.19 
Run 3 0.14 0.13 0.21 
 
 
Table 5: Atomic Absorption Spectroscopy data for [Ag2(3,6,9-tdda)].2H2O-Bioglue 
(0.01 g). 
 
Sample (1) 
(%) 
Sample (2) 
(%) 
Sample (3) 
(%) 
Run 1 1.10 1.35 1.08 
Run 2 1.18 1.13 1.29 
Run 3 0.77 0.88 0.93 
 
 
Table 6: Atomic Absorption Spectroscopy data for [Ag2(3,6,9-tdda)].2H2O-Bioglue 
(0.001 g). 
 
Sample (1) 
(%) 
Sample (2) 
(%) 
Sample (3) 
(%) 
Run 1 0.51 0.54 0.47 
Run 2 0.23 0.31 0.36 
Run 3 0.15 0.16 0.15 
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Table 7: Atomic Absorption Spectroscopy data for [Ag2(3,6,9-tdda)].2H2O-Bioglue 
(0.0001 g). 
 
 
 
 
 
 
Table 8: Atomic Absorption Spectroscopy data for [Ag2(3,6,9-tdda)].2H2O-Bioglue 
(0.00001 g). 
 
Sample (1) 
(%) 
Sample (2) 
(%) 
Sample (3) 
(%) 
Run 1 0.41 0.65 0.56 
Run 2 0.26 0.22 0.19 
Run 3 0.16 0.19 0.21 
 
 
 
 
Sample (1) 
(%) 
Sample (2) 
(%) 
Sample (3) 
(%) 
Run 1 0.09 0.48 0.53 
Run 2 0.31 0.26 0.36 
Run 3 0.09 0.06 0.12 
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Appendix III: Ag(I) Leaching Studies 
  
                  (a) 
   
                  (b) 
Fig. 1: Initial study to determine concentration of leached silver from Bioglue (0.01 
g added AgNO3) calculated by (a) peak height (Ip) and (b) charge. 
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               (a) 
 
                                                                            (b) 
Fig. 2: Concentration of leached silver from Bioglue (0.01 g added AgNO3) 
calculated by (a) peak height (Ip) and (b) charge. 
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Appendix IV: Molecular Biology Images 
 
         
                                                                 (a)                                                           (b)                                                      (c) 
Fig. 1: RNA gel electrophoresis using various RNA extraction methods (a) Qiagen RNeasy® minikit (b) Qiagen RNeasy® minikit and RNAprotect 
bacteria reagent and (c) Tri Reagent 
 (a) Lane 1; Molecular weight marker, Lane 2; Untreated S. aureus cells, Lane 3; AgNO3 treated cells, Lane 4; Duplicate of untreated S. aureus cells 
and Lane 5; Duplicate of AgNO3 treated cells (b) Lane 1; Molecular weight marker, Lane 2; Untreated S. aureus cells and Lane 3; AgNO3 treated S. 
aureus cells (c) Lane 1; Molecular weight marker, Lane 2-4; Untreated S. aureus cells and Lanes 5-7; AgNO3 treated S. aureus cells 
 
       1         2           3          4         5             1         2       3                  1       2     3     4     5     6       7  
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                                                                             (a)                                                                       (b) 
Fig. 2: PCR product visualisation of (a) gyrA primer set and (b) SodA primer set. 
(a) Lane 1; Molecular weight marker, Lane 2; Blank, Lane 3; Untreated S. aureus cells and Lane 4; AgNO3 treated cells and (b) Lane 1; Molecular 
weight marker, Lane 2; Blank, Lane 3; Untreated S. aureus cells and Lane 4; AgNO3 treated cells 
             1           2            3            4                                  1          2        3        4               
766 
500 
300 
150 
50 
Size (bp) 
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                                                                               (a)                                                                  (b) 
Fig. 3: Image depicting (a) PCR product using genomic DNA and (b) cDNA on a 1% agarose gel 
(a) Lane 1 and 9; Molecular weight marker, Lanes 2-4; Untreated S. aureus cells and Lanes 5-7; AgNO3 treated S. aureus cells and (b) Lane 1; 
cDNA
            1    2      3      4      5     6     7     8      9                    1       
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Appendix V: Glycolysis 
Energy Investment Phase 
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Energy Pay-off Phase 
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ATP – Adenosine triphosphate                        Pi – Inorganic phosphate H2PO4 
ADP – Adenosine diphosphate                      NAD+ – Nicotinamide adenine dinucleotide 
GTP – Guanine triphosphate                              Reversible 
GDP – Guanine diphosphate                                                     Irreversible 
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Appendix VI: Tricarboxylic Acid Cycle 
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